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When a man approaches middle-age and the ephemeral, or for some the perpetual mid-
life crisis, a junction appears and a decision needs to be made as to which direction he 
will take. Shall he get fit, loose the waistline and acquire a mistress? Shall he buy the 
Maserati, put his foot down, and hope his wife doesn’t notice that the car won’t carry 
more than two? Shall he bumble along for the remainder of his career, losing the will 
to live and eventually retire with arthritis and an ever increasing and unhealthy 
cynicism about how your profession has been corrupted by the NHS?  Or, do as I did, 
take the thoroughfare marked with both a question and an exclamation mark; or as my 
children proclaimed when I told the family – do a PhD?! 
 
I had spent 10 years, along with a few others, getting the BAOS from a small peer 
group of oral surgeons to the established Association that it is today with over 400 
members, its own Journal, and a bit of professional clout.  During this time, however, 
I did not have the time to develop my career in the way in which I had wanted it to go. 
Along with getting the Association established and all the political lobbying that we 
had to do, I did not really have the time to focus on the other aspects of my career 
development. I had previously registered for a doctorate at my alma mater, however a 
change in job and the inability to find a suitable replacement supervisor put paid to 
that and my initial flurry into academia was quickly dowsed. At the end of my tenure 
with the Association it was time to do something professionally for me.  
 
In 2000, NICE had carelessly given me the opportunity to get my teeth into (pun 
intended) the consequences of their own doing. No one was satisfied with NICE’s 
guidance and over the first 10 years after the millennium I anecdotally observed these 
consequences in the form of distal cervical caries becoming a more common 
presentation amongst older patients. Hence the thesis that you are about to read.  
 
Undertaking a PhD places many demands on many people not least of all family. A 
special thank you to my wife, Teresa, who has put up with 7 years of me coming home 
late of an evening, though I secretly think that she was glad of the peace and quiet. My 
two daughters, Ellie and Grace, both of whom have grown up into responsible and 
beautiful young adults during this time, and whose company is always a pleasure, 
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especially when I’m paying. Each has contributed in their own way in giving me the 
space and opportunity to undertake this challenge – a big thank you to you all, 
especially my own mother who gave me all her brains as she keeps reminding me. 
 
Thank you to Judith Jones, my second PhD supervisor, for her help and guidance – 
she may not feel that she has supported me enough but you have! In addition, a thank 
you to Manorahan Andiappan and Iftekhar Khan who helped me with the databases, 
statistical advice and answering all my statistics questions – I think I now know my 
mean from median from mode! My penultimate personal thanks to both Professor 
William Wade and Dr Erica Prosdocimi for their laboratory processing and analysis 
for the bacteriological samples. In addition, I would express my appreciations to my 
fellow consultants and registrars who have had to listen to my continuous pontificating 
in the office; the latter being the more captive audience! 
 
A huge, sincere thanks to Fraser McDonald, my principal supervisor, who has advised 
and supported me through all this. I have always had a great professional admiration 
for Fraser and there was no one better qualified in my opinion who could, and would, 
provide the support needed in undertaking this academic task. Our bi-weekly PhD 
meetings were always interrupted by our joint clinic but we always found the time to 
see the patients as well. And why did I ask an orthodontist to be my principal 
supervisor? They are the only authority who can bond everything together and make 
things straight! 
 
My father, Louie, died in 2017 and his influence on my professional career cannot be 
underestimated. He was a carpenter by trade and all the carpentry skills that he 
imparted to me have found their way into the surgical skill set that I have and into the 
skill sets of countless thousands of other dentists and oral surgeons that I have had the 
privilege to teach and tutor over the last 30 years.  His great belief, imparted to him 
by his own father, was that everyone should have a trade. Once you have a trade, you 
can follow your dreams and do what every you want; knowing that your trade will 
always be there to fall back upon if those dreams don’t become realised. His dream 
was to become a professional footballer and he won the under-21, Scottish Cup in 
1954 with the Campsie Black Watch FC. Unfortunately, his football ambitions were 
ended with irreparable damage to his knee ligaments that eventually required a knee 
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replacement in later life. Fortunately, he did have his trade to fall back upon and was 
a well-regarded craftsman and gentleman. I remain very proud of him.  
 
I, personally, have never really had any particular dreams nor ambitions out-with my 
professional career; perhaps it is time that I had, after all I’ve always got my trade to 
fall back upon….!   
 









The treatment or otherwise of third molars has been a controversy for a number of 
years. In 2000, with an emphasis on unnecessary financial costs, untoward patient 
outcomes and surgical morbidity, and a lack of evidence of any benefits to support 
prophylactic third molar removal, The National Institute of Health and Clinical 
Excellence (NICE) moved to eliminate the practice of prophylactic third molar 
removal from the National Health Service (NHS) with the introduction of its clinical 
guidance on the removal of wisdom teeth. This guidance led to a significant change in 
clinical practice in the UK and, as a consequence the practice of prophylactic third 
molar removal has been significantly reduced.   
Following the introduction of NICE’s guidance, the number of patients having third 
molars removed in secondary care decreased over the first 3-5 years of the decade. 
Third molar patient data sourced from the NHS Hospital Episodes Statistics (HES) 
databases determined treatment patterns for secondary care patients, and from the 
NHS Business Services Authority (NHSBSA) for primary care patients. For secondary 
care, patient numbers declined by approximately 30%, from a 90’s decade average of 
58k cases per annum, to a low of 39k cases in 2003. In primary care the number of 
mandibular third molars removed fell by 60% from an average of 77k mandibular third 
molars in the 90’s to a low of 28k by 2004/5. Following this, and over the last 15 years, 
there has been a steady increase in the number of patients having third molar removal 
in secondary care from 39k cases per annum in 2003 to an average of 92k cases per 
annum for the three years of 2014-17: an increase of 136%. There is no comparable 
data for primary care in England as such data is no longer collected by the NHS. 
Patients having third molars removed have been shown to be 4 years older on average; 
from an average age of 28 years in the 90’s, to an average 32 years now. The pattern 
and nature of diseases indicating third molar removal have also changed. From 1995-
2000 caries and its related disease, such as dental abscess and peri-apical infection 
accounted for 7% of all third molars removed. By the end of the first decade of the 
millennium caries and related disease was accounting for approximately 26% of all 
third molars removed: an increase of over 300%. 
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Third molar related caries can be classified in two ways. Impacted mandibular third 
molars (Md3M) can succumb to dental caries themselves, or contribute to the 
formation of distal cervical caries (DCC) on the adjacent mandibular second molar 
(Md2M). These two types of dental caries cannot be discriminated from the NHS 
databases and consequently the true frequency of third molar caries or Md2M DCC 
cannot be determined. Historically, Md2M DCC has been reported to account for less 
than 5% of all third molars removed. With the change in patient management brought 
about by NICE and the 300% increase in the frequency of caries related to third molars 
requiring removal, the frequency of Md2M DCC as the reason for third molar removal 
cannot be determined directly. 
Approximately 90% of DCC lesions of the Md2M are seen related to mesio-angular 
impacted Md3M and 10% of lesions related to horizontal impactions. Md2M DCC 
now accounts for 14% of all Md3M removed but remarkably accounts for 44% of all 
mesio-angular Md3M removed and 60% of all mesio-angular Md3M in patients over 
the age of 30 years. It is estimated that approximately 23k patients per annum and 27k 
Md3M are removed per annum due to Md2M DCC, costing approximately £27m per 
annum to treat with additional potential costs of £28m if patients elected to have 
remedial implant treatment to replace second molars. 
Md2M DCC as an indication for the removal of the impacted third molar challenges 
previous concepts and provides evidence for consideration of the prophylactic 
removal of Md3M. 
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Aims of studies 
The aims of this thesis are to identify and evaluate the changes in third molar disease. 
Specific aims were: 
• To identify if there has been a change in disease pattern following the 
introduction of NICE guidance. 
• To determine if age, dental health, and the varying types of impactions alter 
the character of third molar disease. 
• To determine if DCC can be predicted. 
• To evaluate the costs to healthcare of current third molar treatment strategies 
in relation to Md2M DCC. 
• To establish what type of bacteriological profile is found in the caries in distal 
cervical lesions of the Md2M. 
The Null Hypothesis 
In this series of studies, we have identified the null hypothesis is, that the introduction 
of NICE guidance has not affected the profile of disease or treatment of third molars. 
Methodology and Data collection  
• Literature search utilised online library resources including Ovid Medline 
(1974 to Dec 2018), Embase (1946 to Dec 2018) and Google Scholar. Principle 
medical subject headings (MeSH) search terms included: Molar, Third; 
Tooth/Teeth, Wisdom; Disease, Dental; Distal Cervical Caries; Guidelines, 
Third Molar; Clinical Indication; Prophylactic Removal. Inclusion criteria: 
English language articles. Exclusion criteria: non English language articles. 
• Data collection in relation to the effects of NICE guidance was sought from 
Hospital Episodes Statistics (HES). Open access to data is available at HES 
online (https://digital.nhs.uk/data-and-information/data-tools-and-
services/data-services/hospital-episode-statistics). In addition, diagnosis data 
for patients was formally requested from HES for evaluation. HES collects 
data for the NHS in England. Third molar data for Scotland; both secondary 
and primary care was requested from the Information Service Division for 
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NHS Scotland. Primary care data for England was accessed from the 
NHSBSA, formally the Dental Practice Board (DPB). 
• Data extracted from HES referred to the Office of Population Censuses and 
Surveys OPCS classification of surgical operations and procedures version 4.6. 
Data included patients having procedure codes F0910 (removal of impacted 
third molar) and F0930 (removal of third molar). Procedure code F0920 
(removal of impacted tooth) was excluded as this code is non-specific and 
includes removal of any impacted tooth. 
• Data related to clinical diagnosis resulting in third molar removal is recorded 
but not reported online by HES. A special request was made to HES for all 
diagnostic data related to OPCS codes F0910 and F0930. Diagnostic data is 
recorded using the World Health Organisation (WHO) international 
classification of diseases (ICD) reporting codes. 
• Third molar data for primary dental care was recorded by the NHS Dental 
Practice Board now the NHS Business Service Authority (NHSBSA) up until 
2005 when the data recording process was reformed and exclude this level of 
recording. Codes for third molar removal are specific to both maxillary and 
mandibular third molar teeth. General Dental Services statement of dental 
remuneration codes 2203 and 2204 relate to the specific removal of impacted 
third molar teeth and can be linked to mandibular third molar teeth. Data was 
extracted from open access online datasets at the NHSBSA. 
• Third molar data for Scotland was specially requested from the Information 
Service Division for NHS Scotland. As with HES, data related to procedure 
codes F0910 and F0930 and for primary dental care codes 2203 and 2204 was 
requested. 
• For the clinical case-series of patients attending for third molar removal, a 
prospective database was created of patients over a two-year period. Data was 
collected over 2 years, 2013-15. This included all patients seen under my 
personal care for third molar removal undertaken in both primary care and 
secondary care, and included patients attending for treatment under local 
anaesthesia, local anaesthesia with sedation, and day-case general anaesthesia. 
Patient data was documented on a data recording proforma (see appendix I). 
Data recorded included patient identifier; patient gender as recorded on clinical 
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notes; age of patient at presentation; Decayed Missing Filled Teeth (DMFT) 
score: presence/absence of specific third molar based on FDI notation (18, 28, 
38 ,48); eruption status of third molar (erupted, partially erupted, unerupted); 
angulation of third molar defined by convention (vertical, mesio-angular, 
horizontal, disto-angular or ectopic), whether removal of the third molar was 
indicated or not, and the clinical diagnosis for each individual third molar 
indicated for removal. Data was transferred onto an Excel master database and 
then anonymised to eliminate patient identifiers. Date was then analysed using 
IBM SPSS Statistics for Windows, version 23.0 (IBM Corp) and online 
statistical software MedCalc.  In total, 1011 patients who had 1431 mandibular 
third molar removed were assessed. See appendix I for third molar study 
proforma. 
• For clinical case-series data related to patients with Md2M DCC – two 
databases had been collated. 239 patients attending and diagnosed with Md2M 
DCC during 2011-13 had been collated (2013 cohort). This recorded an 
anonymised patient identifier, gender, age, DMFT score and angulation of the 
Md3M. This 2013 cohort were separate from the second cohort (2015 cohort) 
which was filtered from the master database of 1011 patients who included 
180 patients who had Md3M removed due to Md2M DCC.  
• Angulations of the third molar was defined by accepted standard convention. 
Third molars were categorised into vertical, mesio-angular, horizontal, disto-
angular or ectopic impactions. Vertical was defined as the third molar having 
a vertical positional plane parallel to the relative vertical plane of the adjacent 
second molar; i.e. both second molar and third molar in the same vertical plane 
or long axis of third molar perpendicular to the occlusal plane through the 
premolar and molar teeth.  Mesio-angular was calculation as the angulation of 
the occlusal plane of the third molar to the occlusal plane of molar and 
premolar teeth. This angle is the same as the angle between the long axis of 
the third molar and the second molar tooth.  Horizontal was defined as the 
angulation of the occlusal plane of the third molar to the occlusal plane of 
molar and premolar teeth. This angle is the same as the angle between the long 
axis of the third molar and the second molar tooth. Intra-rater and inter-rater 
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reliability for assessing angulation of the third molar was assessed using 
Cohen’s Kappa co-efficient. 
• For the bacteriological study of Md2M DCC, caries and plaque was sampled 
from 16 patients who had their Md2M removed due to Md2M DCC. Caries 
was sampled from the DCC lesion of the extracted mandibular second molar 
and plaque was sampled from both ipsilateral and contralateral gingival 
crevices of the Md2M. Samples were cryogenically stored and processed to 
extract bacteriological DNA and results compared with Human Microbiome 
Database reference dataset. 
Ethics:  
Advice was sought from KCL Dental Institute ethics committee in 2012 (now Faculty 
of Dentistry and Oral & Craniofacial Sciences) regarding ethics application.  Ethical 
advice was sought prior to the introduction of GDPR in 2018. For the clinical case-
series database it was deemed that formal ethics approval was not required as no 
patient identifiable data would be retained or patient’s treatment altered as a 
consequence of the data collection. For the bacteriological study of Md2M DCC, 
formal ethics approval was advised. Research ethics application was submitted via the 
online Integrated Research Application System (IRAS) and approved October 2015 
(IRAS 14678), substantial amendment was applied for and approved September 2017. 




Patient age and the angulation of the mandibular third molar tooth were identified as 
the primary independent variables. Disease of the mandibular third molar was 
identified as the primary dependant variable. The original sample size was calculated 
by a power calculator (G*Power 3.1.5, Universität Düsseldorf), which allowed for a 
CI of 95% with a 5% margin of error (standard power level of 80% and alpha level of 
p = 0.05). A sample size of 969 was calculated, but 1011 patients with 1431 
mandibular third molars indicated for removal were finally assessed. The sample and 
outcome characteristics were summarised using descriptive statistics. The mean age 
of the patients for different diseases and types of impaction were compared using one-
way ANOVA. Significance was assumed at the 5% level, and analyses were done with 
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the help of IBM SPSS Statistics for Windows, version 23.0 (IBM Corp) and online 
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Introduction: Defining the third molar and the history behind NICE guidance 





1.1 Defining the third molar. 
 
Third molar teeth are the last teeth to erupt into the mouth, normally between the ages 
of 18 and 24 years (Howe, 1985; Killey, 1975; Rantanen, 1967). Third molars can, 
naturally and uneventfully, erupt into a functional position. Others, however, will fail 
to erupt and remain impacted and unerupted within the jaw. Many will undergo 
eruption but fail to attain a functional position and thus become impacted in a partially 
erupted position (Kjær, 2014). The mandibular third molar is the most frequently 
impacted tooth in the jaw though impaction can occur with the maxillary third molar 
also. As a consequence, most published literature and comment regarding third molars 
relates to the mandibular third molar due to the variation and complexities of its 
impaction and the notable morbidity that it can cause.  
The fully erupted third molar has the potential for normal function and longevity but 
may experience dental disease in a similar manner to the rest of the dentition. The 
unerupted and embedded third molar is unlikely to cause or experience disease 
although it may contribute to a relatively small incidence of dento-alveolar disease 
such as cyst formation. However, the partially erupted impacted third molar tooth is 
in an anomalous position that is compromised and has the greater potential to cause 
disease (Howe, 1985; Killey, 1975). The mandibular third molar is the most 
commonly impacted tooth in the jaw with the incidence of third molar impaction being 
as high as 70% in some population studies (Hashemipour, 2013; Venta, 2012). 
The causes of third molar impaction are theoretical and attributed, in part, to a lack of 
available distal alveolar space for these teeth to erupt into. It is hypothesised that the 
long-term sociological change in diet from an abrasive type of diet to a contemporary, 
softer processed diet is responsible (Lombardi, 1982; Macho, 1992).  Dental attrition 
will not only cause functional occlusal wear but will also result in interproximal wear 
between the teeth. Wear between the teeth, in this manner, should result in the creation 
of an interproximal gap, however physiological mesial drift of the dentition allows the 
teeth to move mesially thus maintaining contact with its neighbour. Inter-proximal 
wear is slow but continually occurs, resulting in the premolar and molar teeth drifting 
towards and assuming a more mesial position within the alveolus. This contributes to 
an increase in space distal to the second molar that is a factor in the development of 
space for the eruption of the third molar (Lombardi, 1982; Macho, 1992).   
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Furthermore, research also suggests that evolutionary changes in the human body have 
resulted in changes to the dental arches with shortening of the alveolus (Abu Alhaija 
et al., 2011; Tompkins, 1996). This is also considered to contribute to a lack of 
development of available alveolar space for third molar eruption (Abu Alhaija et al., 
2011; Tompkins, 1996). Combined, both of these factors create a dysfunctional 
eruption process for the third molar, which results in failure of eruption and 
consequent impaction (Abu Alhaija et al., 2011; Lombardi, 1982; Macho, 1992; 
Tompkins, 1996). The significance of third molar impaction is recognised and 
categorised as a developmental disease by the World Health Organisation (WHO) in 
its classification of diseases (WHO, 2016).  The definition of an impacted tooth as a 
developmental anomaly of the dentition results in the impacted third molar being, by 
default, the primary disease associated with the third molar.   
An impacted third molar cannot and should not be singularly defined just as an 
impacted tooth. Dentists have recognised that the third molar exists in a variety of 
states: unerupted, partially erupted, and either functionally or non-functionally 
erupted. Depending on the age of the patient, it may be developing and unerupted or 
in older patients, either erupted or developmentally impacted and embedded. Spatially 
the tooth may be disorientated from a normal vertical position and angulation with 
recognised abnormal variations of angulation such as, mesio-angular, disto-angular, 
horizontal, inverted and ectopic (Howe, 1985; Killey, 1975).  It is this wide variability 
of position, angle and state of eruption that gives an individual third molar its salient 
characteristics. These, in turn, affect the potential outcome for the third molar and the 
patient, either in a positive or negative manner. In addition, third molar teeth can be 
present in both the mandible and the maxilla and can display and contribute to similar 
yet differing clinical problems and disease. 
 
Data presented in chapter two was collected from the NHS’ online hospital episodes 
statistics datasets. This data collects information on how many patients had a third 
molar removed, however HES data does not distinguish between mandibular and 
maxillary third molar teeth. Reference to ‘third molar teeth’ is therefore collective to 
both mandibular and maxillary third molar teeth however over 90% of patients having 
third molar teeth removed have at least one mandibular third molar tooth removed 
(Worrall et al 1998).    
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1.2 Diseases related to third molars. 
 
As stated, third molars in all three states of existence (unerupted, partially erupted and 
erupted), can experience a broad variety and spectrum of dental disease (Adeyemo et 
al., 2008; Anderson, 1998; Dogan et al., 2007; Forssel and Miettinen, 1988; Knutsson 
et al., 1996; Liedholm et al., 1999; Maurel, 1954; McArdle et al., 2018; Pratt et al., 
1998; van der Linden et al., 1995). 
 
Unerupted third molars can result in a number of diseases, such as cyst formation, 
internal resorption of the third molar and external resorption of the adjacent second 
molar. However, the incidence of these types of disease are extremely small and will 
often indicate the removal of the third molar. The limited potential for these diseases 
to occur cannot form any basis for the early removal of third molars to prevent them 
from arising (Friedman, 2007). With the incidence being so small the number needed 
to treat to prevent the development of such disease is so large and neither cost-effective 
nor cost-beneficial (Brickley et al., 1995; Edwards et al., 1999). 
 
For the erupted and functional third molar, associated disease that can occur will often 
be the same diseases that can affect all the other teeth within the dentition. These 
diseases are namely dental caries, periodontal disease and their consequences. These 
types of diseases, however, are preventable with appropriate diet and effective oral 
hygiene and tend to be associated with older patients (McArdle et al., 2018). 
 
The partially erupted impacted third molar is the most common third molar to require 
removal and accounts for the majority of third molars removed. This tooth is habitually 
inaccessible for adequate oral hygiene and consequently promotes and contributes to 
a variety of dental disease. The impaction, being considered as a developmental 
anomaly, may provide minimal clinical symptoms but can lead to secondary dental 
disease. The most common secondary disease associated with impacted third molars 
is pericoronitis; a local inflammation and infection of the surrounding operculum and 
gingival tissues of the third molar. It can vary in its clinical presentation and has many 
variants including subacute, acute, chronic and recurrent (Howe, 1985).   In extreme 
forms it can lead to life threatening infections such as cellulitis, acute cervico-facial 
infections and sepsis. As with other teeth, caries and its related consequences (e.g. 
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pulpitis and abscess formation) can also affect the third molar. Although periodontal 
disease can be general and affect the dentition as a whole, it can also be localised to 
the third molar region and compromise the periodontal foundation of the second molar 
tooth (Elter et al., 2004a; Elter et al., 2004b).   
 
Partially erupted third molars can be removed to facilitate other forms of treatment 
such as orthodontic/orthognathic considerations, trauma and tumour resection, 
however these indications are surgically specific and unique to individual patients and 
constitute a small proportion of third molars removed.  
 
Critically, the partially erupted third molar can not only give rise to periodontal issues 
related to the second molar, but can also give rise to distal cervical caries on the 




1.3 Incidence of third molar removal 
 
Third molar surgery is one of the most common surgical procedures undertaken by the 
NHS in the UK and is also one of the most common surgical procedures in other 
developed countries around the world (McArdle and Renton, 2012; Renton et al., 
2012). The exact number of patients having third molar removal in the UK is unknown 
due to the poor availability of data from all providers of third molar surgery (McArdle, 
2013).  For the period of 2016/17, conservative estimates suggest that approximately 
152,000 patients had third molar teeth removed in England (McArdle et al., 2018). In 
England, approximately 93,000 patients were admitted to NHS hospitals for removal 
of third molar teeth in 2016/17, with an estimated cost in the region of £100m/annum 
(HES, 2018; NHS, 2014). This figure does not include patients having treatment 
undertaken under local anaesthetic in hospital, nor patients having treatment in 
primary dental care.   
In North America, it is estimated that 5million patients/annum undergo third molar 
removal, with costs estimated at $3billion/annum (ADA, 1999; Eklund and Pittman, 
2001;  Friedman, 2007; Huang et al., 2014).  Of all health insurance patients between 
the ages of 16-21 years 50% will have had third molar removal undertaken (Friedman, 
2007; Friedman, 1983).  Critics have questioned the significant volume of third molar 
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removal undertaken and ask why so many third molars are removed and particularly 
whether the removal of so many third molars is indicated and justified  (Friedman, 
2007; NICE, 2000; Song et al., 1997; Song, 2000).   
Third molar teeth often cause problems for patients and are commonly removed as a 
consequence of dental diseases (Liedholm et al., 1999; Precious, 1992; van der Linden 
et al., 1995). Historically, however, it was common practice for dentists and oral 
surgeons to undertake the removal of impacted third molar teeth in younger patients 
before disease and symptoms could arise and therefore eliminating the potential for 
disease (Friedman, 1983; AAOMS, 2013). The basis of this was the implied 
perception that the impacted third molar would frequently cause disease and should 
be considered for removal as soon as possible.  In essence the impacted third molar, 
in isolation, was an indicator for removal whether associated with disease and 
symptoms or not. This practice of early prophylactic third molar removal had been 
relatively universal in most developed countries with historical reports of over 40% of 
all third molars removed in the UK having no clinical indication for removal and 
subjected to prophylactic removal (NICE, 2000; Song et al., 2000).    In the USA, 70% 
of all third molars subjected to early removal have been reported to be disease free 
(Friedman, 2007). 
Critics noted that there was no evidence to demonstrate that any particular impacted 
third molar would cause disease and that prophylactic third molar removal should be 
discouraged and contraindicated (A.P.H.A., 2008; Brickley et al., 1990; NHS Centre 
for Reviews and Dissemination, 1998; Friedman, 1983; NICE, 2000). Clearly, one of 
the major aspects of this criticism is the inability to predict which third molars will 
lead to clinical problems (FDSRCS(Eng), 1997; Mettes et al., 2008; Song et al., 1997). 
 
1.4  Cost implications 
Prophylactic third molar removal has consequences in terms of financial, social and 
health costs. It was estimated that for England, based on calculations made from data 
of 1999 that £4million/annum could be saved. In the USA, based on calculations from 
2006, $2billion/annum could be saved by not removing disease free impacted third 
molars (Friedman, 2007; NICE, 2000).  The debate and controversy concerning 
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prophylactic third molar removal is not just isolated to the United Kingdom and USA. 
The practice has also been widespread in Europe, Oceania, Africa and the Americas 
(AAOMS, 2013; Adeyemo, 2006; Inst German Dentists, 2010; Dodson, 2010; HTA, 
2010; Knutsson et al., 2001; Stordeur, 2012). 
For individual patients, costs are measured in terms of post-surgery disability in time 
off work, reduced productivity and loss of earnings; and in terms of potential clinical 
and morbidity outcomes such as post-operative debilitation and complications such as 
nerve injury (Friedman, 2007; Mercier and Precious, 1992; NICE, 2000).   In the USA, 
for example, it is estimated that up to 25,000 patients per annum experience avoidable 
permanent nerve injury as a result of unnecessary third molar removal (Friedman, 
2007).  Third molar removal costs money, which providers have to pay for and patients 
are subjected to potentially unpleasant and questionably unnecessary surgery which 
can result in significant morbidity. As a consequence, there is an element of suspicion 
on dentists and oral surgeons, as to the motivation for continuing the practice. With 
oral surgeons in the USA earning in the region of $500,000/annum from third molar 
removal alone, there is also further suspicion by healthcare providers of the probity of 
the dental profession in relation to this practice (Friedman, 2007).  With all the variety 
of costs involved and no proven benefits of prophylactic removal – can it be justified? 
It is not controversial to acknowledge that prophylactic third molar removal had been 
standard practice, along with symptomatic removal in the past, and this essentially 
qualifies the criticism related to the significant volume of third molar removal 
undertaken (Friedman, 2007; Song et al., 1997; Song et al., 1999).  Criticism of 
prophylactic third molar removal has therefore been significant yet there has been an 
overwhelming failure within the dental profession to properly justify this practice with 
evidence to show that there is any benefit to support it (Friedman, 2007; Ghaeminia et 
al., 2016; NICE, 2000; Song et al., 2000).  Prophylactic removal has been 
controversial because the clinical evidence to support early removal has been lacking 
and is based primarily upon consensus expert opinion (Friedman, 2007; NIH, 1980). 
In this era of evidence based medicine however, clinical practice has to be supported 
by high quality evidence, not solely from expert opinion (Keeley, 2003).  It is not that 
clinical research demonstrates that prophylactic removal is inappropriate; it is merely 
that appropriate clinical research has not been undertaken to support prophylactic 
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intervention and consequently does not exist (Ghaeminia et al., 2016; Mettes et al., 
2008; Mettes et al., 2012). 
This significant lack of evidence is, however, counterbalanced by the complexities of 
undertaking clinical research to ascertain if prophylactic third molar has a role to play 
as the type of research required would be impractical to undertake and probably 
unethical. Consequently, prophylactic third molar removal is shrouded in controversy 
as there is no way to refute it nor support it (Mettes et al., 2012). 
The concept of evidence based practice is the modern model in the delivery of 
healthcare whereas historically the majority of clinical interventions and treatments 
were consensus based as conceptualised by the Bolam principle of clinical practice 
(Bolam v Friern HMC, 1957; Sackett et al., 2000).  Evidence based practice is reliant 
upon on empirical clinical research as the foundation of good clinical practice rather 
than the Bolam principle where the consensus opinion of a learned body of 
professionals defines what good clinical practice is (Bolam v Friern HMC, 1957; 
Sackett et al., 2000).  Consensus opinion has been shown to be wrong in the past as a 
result of systematic clinical research and the resultant evidence that then changes 
practice. Gastric & duodenal ulceration was commonly treated with a variety of 
invasive gastro-intestinal surgical procedures until the cause of such ulceration was 
found to be bacterial in origin and the condition is now treated with simple antibiotics 
(Adkins et al., 1985; Malfertheiner et al., 2006). Likewise, congenital talipes 
equinovarus (club foot) was previously treated with complex surgery until it was 
superseded by the non-surgical Ponseti method (Bridgens, 2010). 
Clinical research may provide the evidence base for consensus opinion resulting in 
parity of both, however, in the case of third molar management, there is a lack of 
clinical research and evidence base to ascertain whether prophylactic third molar 
removal has any benefit  (Ghaeminia et al., 2016).  This lack of evidence has become 
the main driver of third molar clinical practice, led not so much by clinicians but by 
third party administrators and commissioners. Consequently, prophylactic third molar 
removal is now generally proscribed in the UK (NICE, 2000). 
A criticism of evidence-based practice is that it can demonstrate subliminal bias 
towards clinical outcomes for population groups of patients rather than for individuals 
(Sackett et al., 2000).  Its doctrine is often what is best for the majority and what is the 
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most cost-effective form of healthcare where healthcare budgets are finite, for example 
in the use of controversial and expensive cancer drugs. Evidence-based practice does 
not necessarily recognise and accommodate the patient as an individual, in that 
evidence-based practice offers solutions for the majority rather than a bespoke and 
tailored solution for an individual: the two do not necessarily go hand-in-hand. It is 
fundamental that all medical interventions need to be supported by clinical evidence 
but tailored to the individual patients needs and expectations: both are synonymous 
with the other. 
The practice of prophylactic third molar removal has been based primarily on the 
consensus opinion of the profession as it was generally considered that the probability 
of successful third molar eruption and function was unlikely and that early 
prophylactic removal would eliminate the consequences of failed eruption, i.e. 
impaction, disease and clinical symptoms (Friedman, 2007; Friedman, 1983; NIH, 
1980).  Although it is accepted that an impacted third molar can result in disease; that 
in turn will lead to its removal, it is unclear, however, as to whether all developing 
third molars will become impacted and result in disease (Brickley, et al., 1996; 
Friedman, 2007; Ghaeminia et al., 2016; Song et al., 2000).  For those that do become 
impacted the question of, if, when and what type of disease will result and necessitate 
the removal of the third molar is also unclear. In addition to non evidence-based 
consensus opinion, researchers in the past have attempted to justify the prophylactic 
removal of third molars based on the potential local periodontal outcomes of third 
molar impaction, in that periodontal disease has a correlation with cardiovascular 
disease and other systemic diseases (Beck et al., 2001; Elter et al., 2005). 
The removal of third molar teeth as a universal health provision in the absence of 
disease is financially expensive, and can be argued to be unnecessary and a waste of 
healthcare resources - how can any benefit be perceived, justified and measured before 
any disease occurs and is realised? (Friedman, 1983; NICE, 2000; Shepherd et al., 
1994b).  Intervention should target disease, or substantial high risk of disease, rather 
than an unknown potential for disease unless it can be accurately predicted. 
Prevention of disease is always better than cure but disease prevention in the form of 
a surgical intervention has a contentious cost-benefit value as the financial cost can be 
significant and can also have non-beneficial and unfavourable outcomes in the form 
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of surgical morbidity (Bramley, 1981; Brann et al., 1999; Brickley et al., 1996; 
Friedman, 2007; Venta et al., 2014).  Although a positive benefit to the individual can 
be claimed and realised, irrelevant of cost, the collective financial cost to society as a 
whole can be excessive and disproportionate (Friedman, 2007; HTA, 2010; NICE, 
2000).  In defining and measuring a positive cost-benefit of an intervention, the said 
intervention should ideally have a small cost and a significant benefit for the individual 
and society as a whole (Jamison et al., 2006).  For example, national immunization 
programmes for infectious diseases such as polio, diphtheria, measles, mumps, 
rubella, and human papilloma virus are relatively inexpensive interventions on an 
individual level that collectively offer protection for society as a whole (Zhou, 2014). 
Although these diseases can be relatively minor, exceptional complications can arise 
leading to life changing issues for those not immunized and subsequently infected. 
The cost-benefit to society of these immunisation programmes outweighs societies 
financial cost of implementation and cost of treating such diseases and complications 
and for the individual avoidance of disease and rare but life changing complications.  
In dentistry the model of prevention being better than cure is universally accepted. 
Preventive dentistry in its many forms has vastly improved the dental health of the 
population with patients retaining more of their teeth for longer (ADHS, 2000; ADHS, 
2011). It could be argued that the prophylactic removal of third molar teeth is a form 
of preventive dentistry, where the impacted third molar is removed before it causes 
problems.  Whereas the use of fluoride and good oral hygiene techniques, for example, 
are minimally invasive, self-administered and hugely cost-effective, prophylactic third 
molar removal could be considered significantly invasive and, by its nature, high in 
monetary cost, requiring significant surgical training and potentially high in patient 
morbidity (Friedman, 2007; Hill, 2006). The removal of third molars is expensive and 
can cost up to £1200 per day-case on the NHS and £3000 from private providers (NHS, 
2014).  The cost-effectiveness of prophylactic third molar removal has been deemed 
to be questionable from both a financial and clinical perspective as there is no 
comprehensive evidence to support it (Ghaeminia et al., 2016; NICE, 2000; Song et 
al., 2000). However, prophylactic surgical intervention is not a practice isolated to 
dentistry: prophylactic mastectomy in individuals with BRAC-1 gene to reduce the 
risk of breast cancer and bariatric weight-loss surgery as a supplemental indication for 
the prevention and reversal of type II diabetes in clinically obese patients have been 
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prominent in the popular press as well as the scientific literature (Buchwald, 2009; 
Rebbeck, 2004). Prophylactic surgery does appear to have a role to play in the 
management of patients however qualifying its place is not so straightforward. 
 
1.5 NICE Guidance 
In 2000, with an emphasis on unnecessary financial costs, untoward patient outcomes, 
a growing criticism questioning prophylactic third molar removal and a lack of 
evidence of any benefits to support it, The National Institute of Clinical Excellence 
moved to eliminate this practice of prophylactic removal from the NHS with the 
introduction of clinical guidance on the removal of wisdom teeth sic (NICE, 2000). 
This guidance has led to a significant change in clinical practice in the UK and, as a 
consequence the practice of prophylactic removal within the NHS and medical 
insurance sector has largely ceased. The effects of this guidance and the moratorium 
of prophylactic removal has had significant and unforeseen consequences for the 
patient, the NHS and the dental profession. 
 
1.5.1 Background 
Clinical guidance on the removal of wisdom teeth was published in 2000 (NICE, 
2000). The main driver for this was the perception that in the UK up to 44% of all 
third molars removed were disease free and consequently had no clinical indication 
for removal. (NICE, 2000; Song et al., 1997; Song et al., 2000) NICE based its 
guidance on a report they commissioned from the University of York’s NHS Centre 
for reviews and dissemination which was published in 2000 (Song et al., 2000). 
Although the principle aim of the report was to look at the effectiveness and cost-
effectiveness for prophylactic third molar removal, the report focussed on the evidence 
related to third molar surgery and the lack of high quality evidence that supported 
prophylactic removal. 
In the 90’s there was growing criticism regarding the seemingly unnecessary volume 
of third molar removal being undertaken in the UK (Brickley et al., 1996; Shepherd, 
1993; Song et al., 2000). Studies being undertaken demonstrated that a significant 
proportion of patients were having asymptomatic, disease free third molars removed 
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which was, in essence, an unnecessary use and waste of NHS resources. In a review 
of 500 patients having third molars removed, Brickley and Shepherd (1996) 
demonstrated that only 59% of third molars removed had a defined clinical indication 
for removal based on the criteria established by the National Institute of Health in the 
USA: in essence 41% of third molars had no clinical indication for removal (Brickley 
et al 1996; NIH, 1980). In addition to the 41% of third molars reportedly removed 
unnecessarily they also observed that 34% of the patients had no clinical indication 
for the removal of any of their third molars and consequently underwent unnecessary 
and apparently needless surgery (Brickley, et al., 1996). 
In 1995, the British Association of Oral & Maxillofacial Surgeons undertook a 
national audit of third molar surgery and their findings were reported in 1998 (Worrall 
et al., 1998). Approximately 8000 patients were included in this audit with 25,000 
third molars assessed and approximately 20,000 subsequently removed. Based on NIH 
criteria, it was reported that 44% of these third molars were disease free (Song et al., 
2000; Worrall et al., 1998). This evidence would appear to be the source of NICE’s 
observation of third molar practice and prophylactic removal, and justification for the 
consequent proscription of prophylactic third molar removal (Song et al., 2000; NICE, 
2000). In this author’s opinion, Song’s and NICE’s focus on the 44% of third molars 
that lacked a clinical indication for removal creates a myopic perspective on the audit’s 
conclusions and overlooks additional salient facts derived from the national audit that 
should be put into perspective. 
The national audit assessed both maxillary and mandibular third molars that had been 
removed with most patients having had their third molars removed under general 
anaesthesia. Historically, it was common practice to remove asymptomatic teeth that 
had potential to become diseased to avoid further surgery at a later occasion especially 
under general anaesthesia (Brickley et al., 1996). Analysis of the 44% of disease free 
third molars removed demonstrated that 79% of these were maxillary third molars and 
21% were mandibular third molars (Worrall et al., 1998).  
Maxillary third molars accounted for the majority of asymptomatic third molars 
removed. Maxillary third molars were commonly removed as the loss of the 
mandibular third molar would often lead to the overeruption of a retained non-
functional maxillary third molar. This would consequently lead to clinical problems 
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and symptoms which would result in subsequent removal. Previously, the accepted 
tenet was to remove the maxillary third molar at the time of mandibular third molar 
removal as the maxillary third molar is usually simple to remove, adding minimal 
additional time to the procedure, with minimal post-surgical morbidity, generally 
masked by the post-surgical morbidity of the mandibular removal. 
Worrall’s analysis could be described as somewhat overcomplicated but further 
analysis of the data suggests that all patients who had disease free third molars 
removed also had diseased third molars removed. In essence no patient had solely 
disease free third molars removed; vis-a-vis all patients had at least one symptomatic 
tooth removed as part of their treatment. Although 44% of all third molars removed 
were disease free and did not have a defined clinical indication for removal, 100% of 
the 6,000 patients who had their third molars removed had at least one diseased third 
molar (Worrall et al., 1998). There is a subliminal conclusion to be drawn that possibly 
44% of all patients had no indication for any treatment at all. 
It could be asserted that 44% of patients did have additional third molar surgery at the 
same time as indicated third molar surgery. Defining whether it was wholly 
unnecessary is a point for debate and not necessarily monochrome in explanation: the 
question is multifaceted. Undertaking additional treatment may expose the patient to 
additional morbidity and the additional risk of adverse complications, however clinical 
risk and outcomes, both positive and negative, have to be weighed up against the 
overall benefit, not only for the patient, but for limited and finite resources of the NHS. 
Furthermore, additional third molar surgery is not proposed without due consideration 
by the clinician and the prior informed consent of the patient and more importantly 
but less appreciated is that it does not have any direct additional cost implications to 
the NHS if undertaken as a single course of treatment as is the case with treatment 
under general anaesthesia.  
In the NHS, the cost for third molar surgery in secondary care, and more recently in 
primary care, are remunerated on a ‘course of treatment’ basis (NHS National Tariff 
payment system, 2014; NHS England IMOS contract, 2014). In effect, the cost of 
treatment is the same whether one third molar is removed or all four are removed, 
when carried out in a single course of treatment. What does cost the NHS more, is 
patients having multiple courses of treatment spread out over separate periods. If four 
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third molars are removed over different treatment episodes then this will attract four 
separate fees for each of the third molars removed (NHS, National Tariff Payment 
System 2014; NHSBSA, Satement of Dental Remuneration 2005; NHSEngland IMOS 
contract 2014).   This will increase the cost to the NHS over time and it does not 
require a complex cost-benefit or cost-effectiveness study to demonstrate that it is 
more expensive to treat four third molars on four separate occasions than to treat all 
four third molars in a single treatment episode. Where the cost of treatment can be 
concentrated and isolated to one single treatment episode then it will always be more 
cost-effective. From a consumer perspective it is always more cost-effective to buy 
four for the price of one rather than the contrary. There is anecdotal evidence that the 
increase in the number of patients having third molar surgery over the last 15 years is 
due to patients being subject to multiple treatment episodes over long time periods due 
to the asynchronous nature of the presentation of disease affecting individual third 
molars in a single patient.  
In the late 90’s the NHS commissioned the NHS Centre for Reviews and 
Dissemination at the University of York to undertake a review of third molar surgery 
to look at the relative effectiveness and cost-effectiveness of prophylactic removal. 
This review was led by Song who initially reported in 1997 and finally in 2000 in the 
NHS R&D Health Technology Assessment report (Song et al., 1997; Song et al., 
2000). 
Song undertook a review of the available literature with the aim of providing a 
summary of evidence related to prophylactic third molar removal (Song et al., 2000). 
Forty studies were identified that fulfilled the search criteria of randomised control 
trials (RCTs), literature reviews and decision analysis studies. Of the two RCTs 
identified, one was still ongoing and the second was an orthodontic RCT which dwelt 
on the variation of incisal crowding in patients who had third molars prophylactically 
removed as part of orthodontic treatment and those that had not (Harradine, 1998; 
Vondeling, 1999). Vondeling undertook an RCT comparing the effects and costs of 
prophylactic third molar removal and symptomatic third molar removal according to 
morbidity. This study, of less than 200 patients over a 4 year period concluded that 
non-intervention may be better, however the longer follow up of patients would be 
required to evaluate adequately (Vondeling, 1999). Realistically, the time period of 
this study was insufficient and the number of recruits relatively small to draw any 
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significant conclusions, either preliminary or final. Although the conclusions drawn 
were preliminary the study does not appear to have been followed through to a final 
end point and consequently no conclusion can therefore be made regarding the original 
study.  
The inclusion of Harradine’s study seems inappropriate as this RCT looked at a very 
narrow and specific outcome which is irrelevant to the principal question related to 
prophylactic third molar surgery and the nature of third molar disease (Harradine, 
1998).  The variability of lower incisor crowding secondary to third molar retention 
versus removal is a specific clinical outcome for orthodontists and has, arguably, 
minimal significant clinical or practical relevance for either patients and clinicians. 
Although it is an RCT related to third molars, it does not address the fundamental 
questions of prophylactic third molar removal, which is whether early asymptomatic 
removal is better than symptomatic removal for a patient’s overall well-being and for  
the payers of healthcare in relation to costs.  
Finally, Song also includes a number of literature reviews and decision analyses in the 
review however most of these are criticised for poor study design and outcomes and 
ultimately not seen as strong enough evidence to provide a robust conclusion and 
recommendation for prophylactic removal (Song et al., 2000). 
With a lack of evidence to support prophylactic removal a focus of the report is the 
substantiation by others that third molars are removed with no apparent clinical 
indication. With 44% of third molars from the BAOMS national audit having no 
indication for removal and the reported 41% from Brickley’s study the observation 
and conclusion is that third molars are being removed unnecessarily and that patients 
are having treatment unnecessarily (Brickley et al., 1996; Worrall et al., 1998). This 
in turn, represents an apparent avoidable financial cost to the NHS and taxpayer and 
an apparent preventable burden of morbidity for the patient (NICE, 2000). 
However, the results of Worrall and Brickley, that were used by Song appear to have 
been taken literally with no apparent appreciation of the underlying facts and nuances 
related to clinical practice. As discussed earlier, although 44% of third molars from 
the national audit may have had no clinical indication for removal, 100% of patients 
appear to have had at least one diseased and symptomatic third molar removed in 
conjunction with other asymptomatic teeth at no additional cost. This fundamental fact 
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does not appear to have been appreciated either by Song or by NICE (McArdle, 2013; 
Worrall et al., 1998). 
In the UK, Song’s report is the main source of NICE’s evidence and criticism of 
unnecessary prophylactic removal of third molars within oral surgery practice and 
forms the main reason by NICE for the proscription and moratorium on prophylactic 
third molar surgery (McArdle, 2013). 
NICE’s conclusion was that there is no evidence to support prophylactic third molar 
removal and recommended that only third molars with evidence of disease should be 
removed. A list of prescribed clinical reasons are shown in Figure 1.1 and these form 
the basis for the management of patients within the NHS (NICE, 2000). 
 
Figure 1.1 Clinical Indications for the removal of third molar teeth as defined 
by NICE. 
 
Legend: This table lists the clinical indications, as defined by the National Institute of Health and 
Clinical Excellence, for the removal of third molar teeth (NICE, 2000).  
 
1.6 
NICE’s guidance remains unchanged to this date and although at the time of 
introduction it attracted some individual criticism, the general response by the dental 
profession had been indifferent (Godden, 2000; McArdle, 2013). Critically, it remains 
unchanged and is still being used as the gold standard for management of patients with 
third molars within the NHS and also within the private healthcare sector. NHS 
 
i. Pericoronitis (severe single, second recurrent). 
ii. Unrestorable caries.  
iii. Non-treatable pulpal and/or periapical pathology.  
iv. Cellulitis, abscess and osteomyelitis.  
v. Internal/external resorption of the tooth or adjacent teeth.  
vi. Fracture of tooth.  
vii. Disease of follicle including cyst/tumour.  
viii. Tooth/teeth impeding surgery or reconstructive jaw surgery, and when a 
tooth is involved in or within the field of tumour resection. 
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commissioners are using the guide as a reference document for commissioning clinical 
services with only those fulfilling NICE’s criteria being eligible for NHS treatment 
(NHSEngland, 2014). More disturbingly, anecdotal evidence suggests the NHS 
secondary care providers are also using them to manage already overloaded service 
waiting lists. Referrals are being vetted and patients who do not appear to fulfil NICE 
criteria being refused consultations to reduce pressure on clinic waiting lists and the 
18-week pathway.  In cases were complications have developed and litigation has 
resulted, non-conformity with NICE’s guidance have been used to suggest breach of 
duty of care, clinical negligence and consequent liability (McArdle, 2013). In response 
to growing concern that NICE’s guidance was having an untoward effect on patient 
management and dental health, NICE began a stakeholder review of its guidance in 
2015 and a protocol for the review of the evidence was commissioned by NICE from 
the Liverpool Reviews and Implementation Group in 2016 (LRiG, 2016). For reasons 
unknown NICE have suspended this review and consequently NICE’s guidance 
remains unchanged and continues to be contentious (NICE, 2017). 
The consequences of NICE’s guidance in the management of patients with third 
molars has been researched and published as part of this thesis, however one 
significant clinical observation after NICE’s introduction was the observed increase 
in the frequency of caries arising in the distal cervical region of second molars as a 
consequence of the third molar impaction and retention  (Allen et al., 2009; Chang et 
al., 2009; Falci et al., 2012; McArdle et al., 2006; Oderinu et al., 2012; Ozeç I et al., 
2009; Toedtling and Yates, 2015). 
The consequent formation of distal cervical caries necessitates the removal of the third 
molar to allow restoration of the second molar tooth and in some situations the loss of 
the second molar tooth as well. The location of the caries often dictates that restoration   
is generally complex and expensive especially if root canal treatment is indicated 
(McArdle et al., 2016).   
If we consider that the third molar has had a definitive causal influence on the 
formation of distal cervical caries on the second molar and regress from this endpoint 
it would suggest that had the third molar been removed early, before the caries forms, 
it would have an overall benefit for the patient. This suggests a possible clinical 
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indication for targeted prophylactic removal of mandibular third molar teeth (McArdle 
and Renton, 2006; McArdle et al., 2014). 
Following the introduction of NICE’s guidance in 2000, a fall of 30% third molar 
removal in secondary care, and a fall of 60% third molar removal in primary care, was 
observed over the first 3-5years in England. Following this, and over the last 15 years, 
there has been an increase of 136% in secondary care third molar removal (McArdle 
and Renton, 2012). Patients having third molars removed are now older on average, 
and the pattern and nature of diseases indicating third molar removal have also 
changed. Annually, from 1995-2000, caries and related disease accounted for 
approximately 7% of all third molars removed, however, by the end of the first decade 
of the millennium ‘caries & related disease’ was accounting for approximately 26% 
of all third molars removed: an increase in the region of 300% (McArdle and Renton, 
2012; Renton et al., 2012). 
Distal cervical caries of the mandibular second molar is an anomalous disease caused 
by retained impacted mandibular third molar teeth (Figure. 1.2)  (Bruce et al., 1980; 
McArdle and Renton, 2006). Approximately 14% of all mandibular third molars are 
removed due to distal cervical caries on the second molar (McArdle et al., 2018). It 
only occurs in the presence of an impacted third molar and has been shown to result 
in the potential loss of up to 40% of all second molar teeth affected by it (McArdle et 
al., 2016).  The development of mandibular second molar distal cervical caries 
challenges NICE’s guidance and re-opens the debate on prophylactic third molar 
removal. mandibular second molar distal cervical caries is seen predominantly related 
to partially erupted mesio-angular impacted mandibular third molar teeth (MAMd3M) 
and in older population groups whose general dental health is better than average. 
(McArdle et al., 2019; McArdle and Renton, 2006; McArdle et al., 2014) It is seen to 
a lesser extent in partially erupted horizontally impacted mandibular third molar teeth 





Figure 1.2  Distal cervical caries (DCC) on the mandibular second molar 
(Md2M). 
 
Legend: This radiographic image demonstrates: (i) dental caries formation on the distal cervical 
region of the mandibular second molar tooth secondary to the mesio-angular impaction of the third 
molar tooth, and (ii) dental caries formation on the third molar. 
 
This research was undertaken to evaluate the nature and characteristics of mandibular 
second molar distal cervical caries and to ascertain the consequences and costs of this. 
Furthermore, to ascertain the factors that will allow the risk of mandibular second 
molar distal cervical caries to be predicted, how it should be managed and discuss the 
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During the immediate years preceding the introduction of NICE’s guidance the dental 
profession began to be challenged regarding the management of third molar teeth. 
Emerging published research and opinion questioned the perceived practice of 
prophylactic third molar removal which resulted in detailed scrutiny by NICE (Toth, 
1993; NHS Centre for reviews and dissemination, 1998; Shepherd, 1993; Shepherd 
and Brickley, 1994a). 
In 2000 NICE published its clinical guidance on the removal of wisdom teeth (NICE, 
2000).  As previously discussed, one of the main drivers for this was the observation 
by NICE and their commissioned review by the Health Technology Assessment 
programme at the University of York; that in the UK, up to 44% of all third molars 
removed were disease free and consequently had no clinical indication for removal 
(NICE, 2000; Song et al., 2000). The resultant recommendations directed that 
prophylactic removal of third molars should be discontinued within the NHS and that 
third molars should only be removed were disease indicated. The list of NICE’s 
clinical indicators for third molar removal are tabulated in Figure. 2.1 and these form 
the basis for the management of patients within the NHS.  
Figure 2.1 Clinical Indications for the removal of third molar teeth as defined by 
NICE. 
 
Legend: This table lists the clinical indications, as defined by the National Institute of Health and 
Clinical Excellence, for the removal of third molar teeth (NICE, 2000). 
Clinical Indications for the removal of third molar teeth as defined by 
NICE. 
 
i. Pericoronitis (severe single, second recurrent). 
ii. Unrestorable caries.  
iii. Non-treatable pulpal and/or periapical pathology.  
iv. Cellulitis, abscess and osteomyelitis.  
v. Internal/external resorption of the tooth or adjacent teeth.  
vi. Fracture of tooth.  
vii. Disease of follicle including cyst/tumour.  
viii. Tooth/teeth impeding surgery or reconstructive jaw surgery, and when a 
tooth is involved in or within the field of tumour resection. 
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NICE’s guidance recommended changes to clinical practice in the UK with 
questioning of customary clinical practice for third molar removal, not only 
prophylactic removal, but also symptomatic third molar removal as well. Although 
NICE only covers clinical practice in England, it’s influence guides clinical practice 
in Wales, Northern Ireland and Scotland. In Scotland, the Scottish Intercollegiate 
Guidance Network (SIGN) introduced its own guidance in 2000, however this is now 
redundant (SIGN, 2000). 
 
2.2 Aims 
The principle aim of this study was to identify the effects that NICE’s clinical guidance 
on the management of third molar teeth has had on patients and clinical practice. In 
particular, what have been the changes in the annual number of patients having third 
molar teeth removed in England on a year-by-year basis over a 15-20 year period and 
what the primary clinical indicators and reasons for third molar removal were. In 
addition the trend in third molar removal in primary and secondary care in England 
was compared with Scotland. 
 
2.2.1 Ethics 
The KCL Dental Institute ethics committee was approached for advice regarding the 
need for ethical approval and as data collection would neither identify individual 




To identify the effects that NICE guidance has had on the management of patients 
with third molar teeth, data was collected to identify any changes in the annual number 
of patients requiring third molar removal and any variation in the nature of disease 
that had occurred. To ascertain the number of patients having third molar teeth 
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removed, and the type of disease affecting third molars, data was gathered from the 
NHS from the following: 
• Data collection in relation to the annual number of patients undergoing third 
molar removal in England was sought from Hospital Episodes Statistics 
(HES). This data was accessed from HES online at (https://digital.nhs.uk/data-
and-information/data-tools-and-services/data-services/hospital-episode-
statistics). In addition, diagnosis data for patients was formally requested from 
HES for evaluation. Third molar data for Scotland, both secondary and primary 
care, was requested from the Information Service Division for NHS Scotland. 
England primary care data was accessed from the NHSBSA, formally the 
Dental Practice Board (DPB). 
• Data extracted from HES referred to the Office of Population Censuses and 
Surveys (OPCS) classification of surgical operations and procedures version 
4.6. The total number of patients having procedure codes F0910 (removal of 
impacted third molar) and F0930 (removal of third molar) was calculated. The 
procedure code F0920 (removal of impacted tooth) was excluded as this code 
was non-specific and includes removal of any impacted tooth. 
• Data related to clinical diagnosis resulting in third molar removal was recorded 
but not reported online by HES. A special request was made to HES for all 
diagnostic data related to OPCS codes F0910 and F0930. Diagnostic data was 
recorded using the World Health Organisation (WHO) international 
classification of diseases (ICD) reporting codes. All recorded ICD data related 
to OPCS codes F0910 and F0930 was calculated. All relevant subgroups of 
ICD diagnostic codes were categorised into the main ICD category including 
all subgroups of caries, periodontal disease and impacted teeth.  
• Third molar data for primary dental care in England was recorded by the NHS 
Dental Practice Board now the NHS Business Service Authority (NHSBSA) 
up until 2005 when the data recording process was reformed and excluded this 
level of recording. General Dental Services statement of dental remuneration 
codes 2204 and 2205 related to the specific removal of impacted third molar 
teeth and can be categorised to both mandibular and maxillary third molar 
teeth. Data was extracted from open access online datasets at the 
DPB/NHSBSA. 
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• Third molar data for Scotland was specifically requested from the Information 
Service Division for NHS Scotland. As with HES, data related to procedure 
codes F0910 and F0930 and for primary dental care codes 2203 and 2204 was 
requested. 
• All data extracted was collated on Excel spreadsheets and evaluated to 
ascertain the annual number of patients having third molar removal. Principal 
diagnostic data was collated and recorded as the proportion of all third molar 
disease on an annual basis. 
 
Data to establish what changes NICE may have had on third molar management are 
available through national NHS data records. The NHS manages a number of separate 
databases that record varying parameters that can be accessed and from these we can 
identify the annual trends in clinical practice as it relates to third molar removal. NHS 
Hospital Episodes Statistics (HES) online (England); the NHS Business Service 
Authority (NHSBSA), previously the Dental Practice Board (DPB); and data from 
NHS Scotland’s own databases, provide global records of service delivery within the 
England and Scotland (HES, 2018; NHS Scotland, 2012; NHSBSA, 2006). Amongst 
other things, HES’s data records the annual number of patients having a specific 
surgical procedure undertaken: these are recorded based on the NHS’s Operative 
Procedure Coding System version 4.6 (OPCS 4.6 codes) (NHS OPCS, 2016).   The 
OPCS Codes used by HES for third molar surgery are F0910 (removal of impacted 
third molar tooth), and F0930 (removal third molar tooth). In addition, HES records 
the primary diagnosis based on the World Health Organisation’s International 
Classification of Diseases, version 10 (WHO ICD-10 codes), that indicates such a 
clinical intervention (WHO, 2016).  Up until 2005 and the introduction of the new 
NHS General Dental Services (GDS) contract, the DPB recorded the actual volume of 
third molar teeth removed. Third molars were ascribed specific codes as part of the 
NHS General Dental Services (GDS) contract (GDS codes 2204/5). In Scotland, the 
management of NHS dental services is different from England however similar 
databases record the same information. Data analysis of these databases allowed 
comparisons of the volume of third molar surgery undertaken in both primary and 
secondary care settings on a year-by-year basis. In addition, it will allow assessment 
of the nature and range of third molar disease.  
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HES data is available online at https://digital.nhs.uk/data-services/hospital-episode-
statistics where main surgical procedures can be traced and summative totals 
calculated for third molar removal in England. Data for GDS third molar procedures 
is available from the NHSBSA dental services at http://www.nhsbsa.nhs.uk. Data 
from NHS Scotland was supplied by the information services division NHS Scotland, 
Edinburgh. 
 
It is important to appreciate that the data recording by HES and the DPB/NHSBSA 
are different. Patients may have more than one third molar removed during a course 
of treatment and if one does not appreciate the nuances of data recording by these 
systems then the interpretation could be confusing. HES records the number of 
patients that have had one or more third molars removed whereas the DPB records the 
actual number of third molars removed. Consequently, from HES data we do not 
know how many third molars were actually removed and conversely from the 
NHSBSA/DPB data we do not know the actual number of patients who had third 
molars removed. Because of this more third molars could be being removed in 
secondary care than the data would suggest as patients may have had more than one 
third molar removed. Conversely the numbers of third molars being removed in 
primary care does not reflect the total number of patients for the same reason and this 
has to be taken into consideration in collating, analysing and interpreting the data.  
Primary care data has been limited to mandibular third molar removal, as this specific 
data can be isolated by the NHSBSA. Secondary care HES data records the number 
of patients who have an OPCS coding of F0910 or F0930. These codes relate to the 
removal of third molars but do not identify whether the third molars are maxillary or 
mandibular, however most problematic impacted third molars that are removed are 




2.2.3 Statistical analysis 
Statistical evaluation of data was limited to basic descriptive statistics, total number 
of patients undergoing third molar removal, or number of Md3M removed on an 





HES finished consultant episodes - Data recorded by HES relates to the number of 
patients who have been admitted to hospital for either a day-case or in-patient 
procedure under either general anaesthesia (GA). Patients having treatment carried out 
under conscious sedation and local anaesthesia on an out-patient basis have been 
known to be recorded as either day-case or as an out-patient procedure. In general, 
patients who have had third molars removed under local anaesthesia on an out-patient 
basis do not get included in HES data as this activity is generally recorded as an 
anonymous out-patient appointment and not as out-patient surgical activity as with 
other surgical specialties.  Out-patient surgical activity may encompass treatment 
undertaken solely under local anaesthesia but may also include treatment undertaken 
with conscious sedation and local anaesthesia. Since 2003/4 outpatient activity 
appears to have been individually recorded but it is unclear whether this relates to 
treatment under taken under conscious sedation and local anaesthesia or local 
anaesthesia alone. The true level of out-patient third molar removal is unknown as the 
vast majority of out-patient local anaesthetic procedures are not recorded as surgical 
activity. Activity therefore may be significantly underestimated.  
 
From the HES data, approximately 60k people per annum in England had third molar 
teeth removed in the early period of the 90’s (Figure 2.2) (HES, 2018). This number 
rose to 70k by the mid 90’s and averaged approximately 60k patients per year for the 
whole of that decade. In the first half of the 00’s patient numbers started to decline 
significantly and by 2003 HES data suggests that just less than 40k patients (39,000 
patients) per annum where having third molar treatment undertaken in hospital setting 
as either in-patient or day-case procedures: a reduction on the 1990’s average of over 
30% (HES, 2018). 
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From the mid 00’s onwards the recording of a small amount of out-patient activity is 
included in HES data along with inpatient and day-case data and over the latter 5 years 
of the 00’s the number of patients having third molars removed had increased to almost 
77k patients per annum in 2009/10 (≈65k in-patient/day-case and 12k outpatient). This 
equates to an increase of approximately 67% of in-patient and day-case activity 
recorded in the secondary care sector but a 97% increase in all recorded patient activity 
compared with the lowest recorded activity of 2002/3. By 2009/10 patients having 
third molars removed in a hospital setting was most notably at its highest level for 20 
years (HES, 2018). Since 2010 the numbers of patients having third molars removed 
has continued to rise and has reached levels beyond those of the 90s and for 2014/15, 
2015/16 and 2016/17 have averaged over 90k patient treatment episodes per annum 
(Figure 2.2) (HES, 2018). An increase of approximately 50% per annum compared 
with the average over the 1990’s decade.  
 
Figure 2.2 Annual number of patients requiring third molar removal in 
secondary care: NHS England 1990/91 – 2016/17. 
 
Legend: This graph illustrates the total annual number of patients recorded as having third molar teeth 
removed in secondary care within the NHS in England from 1990/91 until 2016/17. For 1990/91 the 
total number of patients recorded was 57,000. The average annual number of patients having third 
molars removed during the 1990s was in the region of 60,000 per annum. For the first 3 years of the 
00’s this figure declined by approximately 30% to a low of 39,000 patients in 2002/3. From 2003/4, 
this figure increased on a year-by-year basis with the total number of patients having third molars 































































































Patients requiring third molar removal in NHS secondary care (England). 
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In Scotland, figures for in-patient/day-case activity follow a similar trend for England 
(Figure 2.3) (NHS Scotland, 2012). For most of the 90’s just under 5,000 cases of third 
molar removal were undertaken per annum. Subsequent to the introduction of the 
SIGN guidelines a similar trend in the number of cases per annum is noted, dropping 
to approximately 1,600 cases per annum by 2005: a reduction of approximately 70%. 
Post 2005, however a steady year-by-year increase is noted and by 2009/10 the number 
of patients had increased to approximately 2,800 cases: an increase of 75% from the 
low of 2004/5, although still 50% less than the average from the 1990s (NHS Scotland, 
2012). 
 
Figure 2.3 Annual number of patients requiring third molar removal in 




Legend: This graph illustrates the total annual number of patients recorded as having third molar teeth 
removed in secondary care within the NHS in Scotland from 1990/91 to 2009/10. For 1990/91 the total 
number of patients recorded was 3,031. The average annual number of patients having third molars 
removed during the 1990s was in the region of 4,600 per annum. For the first 5 years of the 00’s this 
figure declined by approximately 70% to a low of 1,606 patients in 2004/5. From 2004/5, this figure 
increased on a year-by-year basis with the total number of patients having third molars removed by 
2009/10 reaching in excess of 2,807. Whilst this trend is increasing this is still approximately 50% less 



































































































Annual number of patients requiring third molar removal 
in secondary care: NHS Scotland 
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2.4. NHSBSA/DPB 2204/2205 codes. 
 
The NHSBSA/DPB records items of treatment of each patient rather than treatment 
episodes for patients (NHSBSA, 2006). The Statement of Dental Remuneration (SDR) 
document provides the item of service codes used previously under the old GDS 
Contract (NHSBSA, 2005).   SDR Codes 2204 and 2005 are third molar specific and 
although third molars would have undoubtedly been removed under other codes such 
as 2101 and 2201, these codes are not tooth specific and cannot be used to identify 
third molar activity. In addition, SDR codes 2204/5 can identify both mandibular and 
maxillary teeth separately. This data set is limited to exclusively mandibular third 
molars (Md3M) as the combined total of both maxillary and mandibular third molars 
removed may not accurately reflect the actual number of patients having third molar 
surgery. By restricting our data set to exclusively Md3M we get a less distorted picture 
on the actual number of patients. In addition, Md3M tend to cause greater clinical 
problems, are more surgically complex and have greater post-operative morbidity 
making them the focus for most published research. 
 
For the period of 1992–2005 in England GDS, the trend in third molar activity follows 
a comparatively similar pattern to secondary care (Figure 2.4). For most of the 90’s 
approximately 80k Md3M were being removed per annum. Subsequent to 2000 the 
numbers of Md3M removed declines steadily by over 60% reaching a level of 28k per 
annum for 2004/5. Data for after this period is not available, as the NHSBSA does not 




Figure 2.4 Annual number of mandibular third molars (Md3M) removed in 




Legend: This graph illustrates the total annual number of patients recorded as having mandibular third 
molar (Md3M) teeth removed in primary care within the NHS in England. For 1992/3 the total number 
of Md3M teeth removed was recorded as approximately 78,000. The average annual number of Md3M 
removed during the 1990s was in the region of 79,000 per annum. During the 00’s this figure declined 
year–by-year to a low of approximately 28,000 Md3M in 2004/5 (a reduction of approximately 60%). 
From 2004/5, the NHSBSA stopped recording this data (McArdle and Renton, 2012).  
 
 
In Scotland, data for third molar activity continues to be collated for general dental 
practice (Figure 2.5) (NHS Scotland, 2012). In the first half of the 00’s decade, there 
is a 36% reduction in mandibular third molars removed which mirrors the yearly trend 
of reduction in England. After 2004, however, mandibular third molar removal 
progressively increases and by the end of the decade is 130% greater than at its lowest 
level of 2004. This trend cannot be properly compared with the post 2005 trend for 
general dental practice in England but it does complement the upward trend of 
secondary care third molar activity seen in both England, and in Scotland which saw 






























Annual number of mandibular third molars removed 
in primary care: NHS England
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Figure 2.5 Annual number of mandibular third molars (M3M) removed in 
primary care: NHS Scotland. 
 
 
Legend: This graph illustrates the total annual number of mandibular third molar (Md3M) teeth 
removed in primary care within the NHS in Scotland for the period 1999/00 through to 2010/11. For 
1990/00 the total number of Md3M teeth removed was recorded as 2,078. Over the ensuing four-year 
period the number of Md3M teeth removed declined to 1,327 by 2003/04 (a reduction of 40%). For the 
latter half of this decade the number of Md3M teeth removed rose on a year-by-year basis to a total of 
3,076 (an increase of approximately 130%) by 2009/10 and 3,196 (an increase of approximately 140%) 















































































HES data reports that the average age of patients requiring third molar removal within 
the NHS has increased over the last 20 years. In 1990 the average age of a patient 
having third molars removed as a day-case procedure under general anaesthesia or 
intravenous sedation was 25 years. This mean age has steadily risen and now the mean 
age for patients having third molars removed is 32 (Figure 2.6) (HES, 2018) . 
 
 
Figure 2.6 Annual average age of patients requiring third molar removal in 




Legend: This graph illustrates the rise of the average age of patients having third molar teeth removed 
on a year-by-year basis from 1989/90 through to 2009/10. In 1989/90 the average age of patients 
having third molar teeth removed was 25 years. This has steadily increased over the ensuing 20-year 
period and in 2009/10 the average age of patients having third molar teeth removed was 32 years 
(McArdle and Renton, 2012). (n.b. HES data does not report Standard Deviation or Standard Error 
















































































Annual average age of patients requiring third molar removal 
in secondary care: England.
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2.6 Clinical indications for third molar removal in secondary care. 
 
HES data also records the main clinical diagnosis for third molar removal (Figure 2.7) 
(HES, 2018). The most common recorded WHO ICD-10 coding and indication for 
third molar removal relates to embedded and impacted teeth (K01.0/K01.1) 
paradoxically these are not a defined NICE indication for third molar removal. For 
1995 embedded/impaction is recorded as the main diagnosis for approximately 88% 
of all third molars removed. Over the next 15 years there is an increase in the 
proportion of caries or related peri-apical abscess (K02.9/K04.7) being recorded as the 
main diagnosis from less than 10% in 1995, rising to almost 30% by 2009. In the same 
period, periodontitis (K05.2/K05.3), as a recorded main diagnosis, increased from a 
level of approximately 7% in 1997 to 15% in 2009. One notable anomaly of the coding 
system is that pericoronitis does not have a distinct identifiable ICD code and is coded 





Figure 2.7 Main clinical diagnosis and annual frequency of disease for third 




Legend: This graph illustrates the recorded main clinical diagnosis/indication, and its annual 
frequency, for patients having third molar teeth removed in England from 1995 until 2009. In 1995, 
impacted or embedded third molars accounted for 88%; periodontal disease - 5%, and caries & related 
infection - 5% of all patients having third molars removed. During this period and up until 2009, the 
incidence of impacted and embedded teeth had steadily declined from 88% to an incidence level of 
approximately 50%. For caries & related infection, the incidence has increased from 5% in 1990 to 
approximately 30% in 2009. The incidence of periodontal disease has increased from 5% to 10% (a 
100% increase). The average annual incidence of caries & related infection during the latter 90’s was 
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In 2004, a review by Sheldon et al., of the impact that NICE guidance was having over 
a range of clinical interventions suggested that NICE had no discernible effect on the 
management of patients with third molar teeth (Sheldon et al., 2004).  Data used by 
this study covered the period from 1995-2001 which observed a downward trend in 
third molar removal during this time. It was suggested that the downward trend in third 
molar removal had already began as a consequence of guidance issued by the Royal 
College of Surgeons of England in 1997 and by the University of York in 1998  (NHS 
Centre for Reviews and Dissemination, 1998; FDSRCS(Eng), 1997).  The sampling 
period of data was short and only included a single year after the introduction of NICE. 
HES data prior to 1995, however, suggests that third molar removal was at a similar 
level for most of the 90’s with 1995 being the peak year within that decade (HES, 
2018).  With the introduction of NICE’s guidelines only in 2000, it seems 
inappropriate to make this conclusion after only one year’s worth of post NICE data 
and a relatively short sample period.  
 
It would appear that a decline in patients having third molars removed did start in the 
late 90’s with the introduction FDSRCS(Eng) guidelines but this data suggests a 
significant reduction of third molar removal with the introduction of the NICE/SIGN 
guidelines in 2000 (McArdle and Renton, 2012).  It may be that the staggered 
introduction of the FDSRCS(Eng) guidelines, the University of York’s clinical 
effectiveness document and the NICE/SIGN guidance continued to re-enforce the 
advice to the dental profession that asymptomatic third molars should not be removed 
(NHS Centre for Reviews and Dissemination, 1998; FDSRCS(Eng), 1997; SIGN, 
2000; NICE, 2000). 
 
In general dental practice the numbers of third molars being removed reduced by over 
50% by 2005. For secondary care, data showed a 40% reduction in patients having 
third molars removed from a peak of 70k in the late ‘90s down to 40k in the mid ‘00s. 
On NICE’s premise that 40% of all third molars being removed had no clinical 
indication for removal, then this data suggests that third molar guidelines were having 
the desired effect of reducing the number of third molars being removed and therefore 
reducing healthcare expenditure in this area.  
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Although data post 2005 is not available for the GDS in England, the data from 
Scotland and HES would suggest that this dip in primary care third molar activity in 
England might also be only temporary. Within secondary care in England, the fall in 
third molar activity mirrors primary care with numbers steadily falling from the late 
90’s until 2002/3. Following this, however, the numbers for third molar removal in 
secondary care had begun to rise steadily with an increase from 45k patients per year 
in 2004/5 to almost 80k patients by 2009/10: an increase of almost 80% in 5 years. By 
2016/17 this had risen to 92k patients: an increase of over 100% since 2004/5.  
Furthermore, the data from NHS Scotland mirrors this increase in third molar activity 
by 67% in secondary care provision, and by 130% for general dental services for the 
latter half of the 00’s.  
 
The reasons for this increase in third molar activity in the latter half of the 00’s and 
the specific increase in secondary care activity may be explained by three possible 
hypotheses: 
  
• The possible influence of the new General Dental Services (nGDS) contract in 
England in 2006. 
• A link between the increasing age of patients and the increasing incidence of 
caries related to third molars. 




The new General Dental Services (nGDS) contract was introduced in England in 
March 2006 whereas the GDS contract in Scotland has remained relatively unchanged. 
Dental treatment was previously provided at a cost per treatment item however the 
new GDS contract is based on the provision of treatment within treatment bands 
(NHSBSA, 2005). Consequently, the treatment band generates the fee rather than the 
service item, or the quantity of different service items. This results in NHS dentists 
receiving the same fee for a course of treatment that may include just a single 
restorative procedure but the exact same fee for a course of treatment for multiple 
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restorative procedures, endodontic procedures and extractions. In this example the fee 
for a band 2 course of treatment may be in the region of £60-£70 and realistically this 
limited fee for multiple items of treatment does not necessarily cover the actual cost 
of providing the treatment. 
 
As the contract does not offer remuneration based on the time the dentist spends with 
the patient, nor for the number nor complexity of treatment items, it has been 
suggested that dentists are unwilling to undertake some of the more complex treatment 
items on the NHS and are subsequently referring patients to other providers for 
treatment (Dispatches C4, 2011).  Up until 2015, the new GDS contract allowed 
GDP’s to refer patients for treatment that they themselves did not feel able to provide 
whilst still claiming payment for the treatment. This may explain why referrals to 
hospital secondary care providers for Oral Surgery procedures, such as third molar 
extractions, had dramatically increased. Oral surgery referrals to Guy’s and St 
Thomas’s NHS Foundation Trust in London had observed a 100% increase between 
2004/5 and 2009/10 (McArdle, 2010). These observations may only be partly 
attributable to the increase in third molar removal in secondary care, as the trend in 
secondary care third molar removal had already started to rise prior to the introduction 
of the new contract. From the trough of 2003 through to 2005, the year before the new 
contract was introduced in England, third molar activity was already on the increase 
HES, 2018).  In Scotland, this upward trend in third molar removal post 2005 is 
mirrored in both primary and secondary care settings suggesting that the upward trend 





2.9 Dental Caries and Age 
 
In relation to third molars, caries can affect the third molar itself or more significantly 
occur in the distal cervical area of the second molar tooth due to the mesio-angular 
impaction of the third molar against it. Caries is a disease that is relatively slow to 
develop compared with pericoronitis and as a consequence caries develops later in 
patients by comparison (Bruce et al., 1980; McArdle and Renton, 2006; McArdle et 
al., 2018).  From the HES data a significant increase in the number of patients 
requiring third molar removal was observed. From 1995 up until 2009 the recorded 
incidence of caries and its sequalae, as an indication for removal, had increased from 
approximately 7% to almost 30% of all patients requiring third molar removal, an 
increase of over 300% (McArdle and Renton, 2012).  
 
It may be that the rapid dip in the number of third molar extractions in the early 00’s 
was due to a rigid interpretation and application of third molar guidelines and as such 
third molars were actively not removed. This may be true in cases of single or mild 
forms of pericoronitis or solely the presence of a partially erupted and impacted third 
molar that may have been used as the indication for removal pre-2000.  
 
Third molars are not erupting later in life to account for the increase in mean age from 
25 years to 32 years during the last 25 years. Third molars are being retained for 
longer, either as a result of lack of disease affecting younger patients, or a more 
palliative approach to the management of third molar disease. Patients may be more 
inclined to be treated with antibiotics for recurring episodes of pericoronitis and thus 
avoid, or more likely, delay the removal of the third molar. 
 
The fact that patients are retaining third molars later into life makes them more 
vulnerable to one of the problematic consequences of the oral environment: dental 
caries. The likelihood of this will be evident especially if the teeth are impacted, 
partially erupted and difficult to clean. Older patients with good dental health are more 
prone to having third molar teeth removed because of caries related indications such 
as DCC in the second molar (Adeyemo et al., 2008; Bruce et al., 1980; Chang et al., 
2009; Chu et al., 2003; McArdle and Renton, 2006; Ozeç et al., 2009; Patel et al., 
2017; Toedtling and Yates, 2015).  This data confirms that as patients have become 
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older, dental caries has become an ever-increasing problem related to third molars. 
This group of patients may be contributing to the rebound increase in the number of 
third molars being removed.   
 
With the mean age of patients increasing from 25 years to 32 years of age, we see an 
increase in the number of patients requiring third molar removal due to caries. Over 
the age of 30 years patients are more likely to have third molar teeth removed due to 
the effects of caries than younger patients (Bruce et al., 1980; Chang et al., 2009; Chu 
et al., 2003; McArdle and Renton, 2006).  Consequently, would it be reasonable to 
consider that any asymptomatic, partially erupted, impacted third molar, if retained, 
may ultimately cause patients clinical problems such as caries. If these problems are 
detrimental to the dental health of the patient, then should we not consider defining 
the optimum time for removal – either at the time of disease presentation or even prior 
to the damage that the disease may cause especially if the damage is related to the 
second molar in the form of distal cervical caries. 
 
2.10 Population increase in the UK 
 
Population growth occurs by two primary means. A net increase in population can be 
brought about by there being more births than deaths per annum on a year by year 
basis or by an increase in net migration; ie, immigration being greater than emigration. 
The birth rate in the UK has been relatively uniform since the mid 1970’s with 
approximately 750k life births per year (ONS, 2016). The number of deaths per annum 
numbers approximately 600k per year giving a net natural increase in population of 
approximately 150k per annum. Since 1992 net migration into the UK has increased 
and since 1998 the net migration has been approximately 200k per annum. Although 
the number of people in the UK has continued to increase over the last 30 years, the 
rate of population increase has varied. From 1990 to 2000 the UK population increased 
by 2.8% in total, with an annual growth rate of 0.28%. From 2000 to 2010 the total 
increase was 6.5%, with an annual growth rate of 0.64%, and for the period of 2010 
to 2020 the projected increase in population will be 7.3%, with an annual growth rate 
of 0.71% (ONS, 2016).  
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The continued increase in population will undeniably contribute to an increase in the 
number of patients requiring third molar teeth removal, however the rate of population 
change during the last 20 years does not reflect the rate of increase of patients having 
third molar surgery undertaken. Based solely on HES data, the number of patients 
having third molar surgery had increased by 27% in the 10 years from 2000 to 2010 
from the 1990’s average of 60k patients. Although there was a fall in the number of 
patients having third molars removed in the late 90’s and early 00’s the rate of increase 
from 2003 to 2010 was approximately 10% per annum. In the 5 years from 2010 to 
2014/15 the total increase was 20%, with an average annual rate of increase of 4%. 
Since 2014 until 2017 the number of patients has remained fairly constant at 
approximately 92k patients per year. 
 
The increase in the number of patients having third molars removed cannot solely be 
accounted for by an increase in the population, as the increase in the annual rate of the 
number of patients having third molars removed is significantly greater than the annual 
rate of increase of the population in the UK as a whole. 
 
 
2.11 ICD-10 Coding 
 
There appears to be a lack of specificity in coding as it relates to studies such as this, 
which leads to problems in interpretation. Caries as a diagnosis is non-specific for 
coding purposes for third molar studies. Caries associated with the third molar is an 
indication for third molar removal but distal cervical caries on the second molar in the 
presence of a mesio-angular or horizontally impacted third molar is also an indication 
for third molar removal. Both of these clinical conditions appear to be on the rise in 
older age groups (Bruce et al., 1980; Chang et al., 2009; Chu et al., 2003; McArdle 
and Renton, 2006; McArdle et al., 2019).  The ICD coding system does not allow us 
to separately classify the location of caries between the third molar and the second 
molar and as a consequence this limits the ability to interpret data accordingly. 
However, the frequency of caries related to third molars has increased with age and 




Pericoronitis is a definable clinical problem that affects partially erupted teeth and 
accounts for the removal of up to 60% of all mandibular third molar teeth (Brickley et 
al., 1996; Knutsson et al., 1996; Lysell et al., 1988; Nordenram et al., 1987; van der 
Linden et al., 1995).  Pericoronitis is not, however, recognised by the WHO-ICDN 
coding system as a unique diagnosis and is categorised in an un-coded sub-category 
for periodontal disease (ICD codes K05.2 and K05.3)  (WHO, 2016).  If databases are 
recording ICD-10 codes of K05.2 or K05.3, do they mean periodontal disease or 
pericoronitis? This flaw creates serious problems in accurate data interpretation. Local 
periodontal disease affecting the second molar tooth, in addition to periodontal disease 
of the third molar itself, are distinct indications for third molar removal, but to classify 
both pericoronitis and periodontal disease together is inappropriate and makes data 
interpretation difficult. 
 
Impaction and embedded teeth are not in isolation an indication for third molar 
removal but merely an observation of the ectopic position that develops for the tooth.  
A tooth’s abnormal position is a developmental anomaly and along with other 
developmental anomalies is defined within the ICD10 coding system (WHO, 2016). 
This developmental anomaly ultimately accounts for the secondary disease processes 
that can affect impacted third molar teeth but recording the developmental anomaly 
rather than the disease that it predisposes to creates an imbalanced observation of the 
indications for third molar removal. In view of the actual HES incidence of impaction 
being comparable with the reported incidence of pericoronitis, it could be presumed 
that impaction is being recorded instead of pericoronitis (Brickley, et al., 1996; HES 
2018; Lysell et a, 1988; Nordenram et al., 1987; Ozeç et al 2009; Phillips et al., 2007; 
van der Linden et al., 1995). 
 
Accurate data collection in third molar studies and clinical coding systems is essential 
if data is to have any meaningful value. If the WHO ICD system is to be used for third 
molar data collection, then it will require an overhaul to be fit for this purpose and to 







With the introduction of clinical guidelines, a decline in patients having third molars 
removed occurred. This trend, however, has now been reversed and steadily increased 
to and beyond pre-NICE levels. The initial financial savings that the NHS would have 
incurred  have been short-term and with more patients attending secondary care for 
third molar procedures, costs are now greater than prior to the introduction of NICE. 
Patients are becoming older and more patients are experiencing caries as an indication 
for third molar removal even though the dental and oral health of the population 
continues to improve (ADHS, 2000; ADHS, 2011). Indeed patients with mandibular 
third molars who succumb to distal cervical caries on their second molar teeth have 
on average better dental health than their peers (McArdle and Renton, 2006). 
 
It has been appreciated for some time that as the dental health of the population has 
improved the early loss of first molar teeth in children and adolescents does not occur 
as frequently as before (Thomas et al., 1994).  Early loss of the first molar results in 
the forward drift and/or tipping of the second molar creating space distally for the third 
molar to erupt unhindered and thus reduces the likelihood of impaction. Conversely, 
retention of the first molar restricts this space in the retro-molar area and no doubt 
contributes to the likelihood of impaction of the third molar tooth (Thomas et al., 
1994).  The increase in third molar surgery seen over the last 30-40 years may not be 
due to inappropriate over-prescribing or prophylactic third molar removal but may, in 
fact, be due to the paradoxical consequence of improved dental health. It is likely that 
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As discussed in chapter 1, the eruption process for mandibular third molar teeth 
(Md3M) can result in two distinct end-points. Where present, many can erupt into a 
functional and natural non-impacted position, however many Md3M fail to erupt 
appropriately into a functional position and become impacted, either in a partially 
erupted state or a non-erupted and embedded state. Both impacted and non-impacted 
Md3M teeth can succumb to, or contribute to, a variety of dental related diseases that 
can indicate the removal of the mandibular third molar tooth (AAOMS, 2016; 
FDSRCS(Eng), 1997; SIGN, 2000; NICE, 2000).   Common Md3M diseases include 
pericoronitis; dental caries; caries related disease such as peri-apical infection; 
odontogenic cyst formation and periodontal disease. Md3M can contribute to and be 
a causative factor in the development of disease associated with the mandibular second 
molar teeth (Md2M) such as distal cervical caries (DCC) or periodontal disease (Allen 
et al., 2009; Blakey GH et al., 2006; Blakey et al., 2002; Chang et al., 2009; Elter et 
al., 2004; Elter et al., 2005; Falci et al., 2012; McArdle and Renton, 2006; McArdle et 
al., 2014; Oderinu et al., 2012; Ozeç et al., 2009; Toedtling et al., 2016; White et al., 
2006). In addition, Md3M may also be removed to facilitate other forms of dental 
treatment such as orthodontics and orthognathic surgery (AAOMS, 2013; 
FDRCS(Eng), 1997). 
There have been many papers written on the nature and spectrum of diseases related 
to third molar teeth, both lowers and uppers, however as has been outlined in chapter 
2, the effect and impact that NICE has had on the nature and the spectrum of disease 
has been significant. With the mean age of patients rising from 28 to 32 years of age, 
since 2000, there has been a concomitant increase in the incidence of dental caries 
related disease as the primary indication for the removal of third molar teeth (HES, 
2018; McArdle et al., 2018; McArdle and Renton, 2012) 
The diagnostic statistics obtained from HES do not reflect the impact that NICE has 
had, as this data was based on WHO ICD-10 codes (WHO, 2016). These ICD-10 
diagnostic codes can be misinterpreted in a number of ways as multiple codes exist 
for the variations of dental caries and periodontal disease. Dental caries for example 
has a single principal code of K02 but has 6 specific subcategory codes, such as K02.0 
for enamel caries, K02.1 for dentine caries, K02.9 for unspecified caries and others. 
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Likewise, periodontal disease has a single principle code of K05 and K06 subcategory 
codes, such as K05.2 for acute periodontitis, K05.3 for chronic periodontitis, etc. ICD-
10 codes also have 9 separate codes for diseases of the dental pulp, however most 
pulpal disease is a consequence of dental caries. The most common indication for the 
removal of impacted third molars is pericoronitis, however acute and chronic 
pericoronitis are in an un-coded sub-category for periodontitis: K05.2 and K05.3. 
From a dental perspective and clinical definition, pericoronitis and periodontitis are 
two separate and unrelated clinic diagnoses and why they have been categorised 
together as such is incomprehensible. Pericoronitis does not have an individual code 
and in essence does not exist as a specific and identifiable disease or diagnosis. HES 
data does code third molar teeth as impacted and embedded teeth as a defined 
diagnosis (K01.0 and K01.1) and with this coding represents approximately 50% of 
all third molar coding, there is a suspicion that codes K01.0 and K01.1 are being used 
to identify pericoronitis (McArdle and Renton, 2012). Moreover, impacted and 
embedded teeth are not a NICE defined indication for third molar removal. The 
combined consequences of these coding anomalies result in failure to accurately 
define the true spectrum of disease related to impacted third molars. HES data, based 
on ICD-10 codes, gives us an incomplete representation of diagnostic data and 
consequently the true spectrum and incidence of disease is presumptive, due to the 
ICD-10 coding limitations.   
The aim of this chapter was to more clearly define the nature and spectrum of disease 
that indicates Md3M removal in a representative group of patients who attended for 
removal from both primary and secondary care and who were treated as outpatients 
under local anaesthesia or as day-case patients under conscious sedation or general 
anaesthesia.   
This chapter presents the results from a prospective cohort of 1011 patients attending 
for Md3M removal. The aims of the chapter were to determine the primary clinical 
indication for Md3M removal and to ascertain the variation and spectrum of disease 
based on the nature of impaction of the Md3M tooth. Both impacted Md3M and 




The primary aim of the chapter was to determine the clinical diagnoses for patients 
undergoing Md3M removal from a cohort of 1011 patients. Patients were assessed and 
grouped into 5 year age cohorts to determine if there was any age-related variation in 
disease. In addition, patients’ Md3M were assessed in relation to the eruption and 
angulation status of impaction of the Md3M to determine if angulation and age of 
patients influenced clinical diagnoses. 
 
3.1.2 Ethics 
The local ethics committee of KCL Dental Institute was approached for advice 
regarding the need for ethical approval and as data collection would neither identify 
individual patients nor influence treatment or outcomes, formal ethical approval was 
not required. 
 
3.1.3 Methodology  
Data from 1011 consecutive patients attending for Md3M assessment and removal 
was collated longitudinally over a 2-year period (2013-15) and then retrospectively 
analysed. In the secondary care setting, all patients were selected and included for data 
collection from those randomly allocated to consultant clinics and treatment sessions 
under direct consultant care of the author. In primary care (NHS and private 
provision), all patients referred and treated by the author for removal of third molars 
were included. Patients were selected on a continuous basis with all patients requiring 
third molar removal being included.  
Patients were evaluated and the variables were recorded on a third molar patient 
proforma (see appendix I). Data recorded included: patient identifier; patient gender 
as recorded on clinical notes; age of patient at presentation; Decayed Missing Filled 
Teeth (DMFT) score; charting presence/absence of specific third molar (FDI notation 
18, 28, 38 ,48); eruption status of third molar (erupted, partially erupted, unerupted); 
angulation of third molar by standard convention (vertical, mesio-angular, horizontal, 
disto-angular or ectopic); whether removal of the third molar was indicated or not, and 
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the clinical diagnosis for each individual third molar indicated for removal. Data was 
transferred onto an Excel master database; anonymised to eliminate patient identifiers, 
and analysed using IBM SPSS Statistics for Windows (version 23.0 (IBM Corp)) and 
online statistical software MedCalc.  In total, 1011 patients who had 1431 mandibular 
third molar removed were assessed.  
The eruption status was defined as either unerupted, partially erupted, erupted or over-
erupted. Any tooth that was detectable either visually or clinically with a periodontal 
probe was deemed exposed to the oral environment and consequently defined as 
partially erupted. Teeth with a visible occlusal surface but with high distal gingival 
collar were also deemed partially erupted. Teeth that could not be clinically detected 
visually and could not be detected with a periodontal probe were deemed unerupted. 
Md3M, which were defined as erupted, had a complete gingival collar below the level 
of the maximum bulbosity of the crown and sitting in a vertical functional position on 
the level of the occlusal plane.  
The angulation of the Md3M was defined and categorised by recognised convention 
as either vertical, mesio-angular, disto-angular, horizontal, or ectopic (ectopic was 
defined as all other possible angles of impaction distinct of the other four; for example, 
inverted). Angulation of the Md3M was determined by the tooth’s vertical, long axial 
relationship with the perpendicular of the occlusal plane of the mandibular teeth 
(Figure 3.1). Mesio-angulation was defined as the mesial, or forward, angulation of 
the Md3M, from the occlusal perpendicular; in effect, where the mesial tilt of the  
Md3M was greater than zero degrees and less than 90 degrees (Figure 3.1.i). Where 
the long axis of the Md3M was parallel with the mandibular occlusal plane the angle 
was defined as horizontal (Figure 3.1.ii). Disto-angulation was defined as the distal 
angulation of the Md3M from the perpendicular of the mandibular occlusal plane was 
minus zero degrees and less than -90 degrees (Figure 3.1.iii). Where the long axis of 
the Md3M was perpendicular to the mandibular occlusal plane the angulation was 
defined as vertical (Figure 3.1.iv).  
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Figure 3.1 Calculating the angulation of impaction of the Md3M. 
3.1.i. Mesio-angular Md3M. 
 
 
3.1.ii. Horizontal Md3M. 
3.1.iii. Disto-angular Md3M. 3.1.iv. Vertical Md3M. 
 
 
Legend: This figure demonstrates the standard conventional definition of the angulation of impacted 
mandibular third molar teeth.   
The precise calculation of the Md3M angulation was not critical as this was defined 
solely in terms of this standard convention. The angulation of the Md3M was 
determined therefore by simple clinical and radiographic observation. Intra-rater and 
inter-rater reliability for assessing angulation of the third molar was assessed using 
Cohen’s Kappa co-efficient. Twenty patients chosen at random who had 38 Md3M 
removed were assessed to determine intra-rater and inter-rater reliability of assessing 
Mandibular occlusal plane 
Md3M long axis 
perpendicular with 
occlusal plane 
Mandibular occlusal plane 
Md3M long axis angulation mesial 
inclination from the occlusal perpendicular 
Md3M long axis angulation, 
distal inclination from the 
occlusal perpendicular 
Perpendicular 
from the occlusal 
plane Md3M Long axis parallel with occlusal plane 
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the angle of impaction. Intra-rater reliability was assessed at the end of data input with 
a time period of over one year between initial angulation assessment and re-
assessment. Inter-rater assessment was carried by a second oral surgery consultant at 
the same time. Calculation of Cohen’s Kappa co-efficient followed standard 
calculation and interpretation as defined by Landis and Koch (Landis and Koch, 1977). 
For intra-rater reliability of angulation assessment the Kappa co-efficient was 0.67 
(SE 0.095, 95% CI 0.48-0.85) demonstrating substantial intra-rater agreement. The 
Kappa co-efficient computation for inter-rater reliability of angulation calculated that 
the Kappa co-efficient was 0.6 (SE 0.1, 95% CI 0.41-0.80) demonstrating moderate to 
substantial inter-rater agreement. 
The primary diagnosis and clinical indication for Md3M removal was recorded but 
was not circumscribed nor limited to any specific clinical guidance or protocols for 
third molar removal such as NICE or NIH guidance (NICE, 2000: NIH, 1980). This 
was to permit any possible clinical diagnoses to be recorded. Patients requiring Md3M 
removal due to pulpitis, dental abscess, peri-apical periodontitis, etc; where caries of 
the Md3M tooth was the promoter lesion for the development of these consequent 
diseases, were defined and recorded collectively as ‘caries and related disease’ 
(C&RD), as these diagnoses represent specific stages of the progression of dental 
caries. All subgroups of pericoronitis, such as acute, chronic, sub-acute and recurrent 
pericoronitis were grouped collectively into a single diagnosis of pericoronitis.  
All patients attended either a primary care based specialist oral surgery clinic, or a 
secondary care oral surgery department of Guy’s and St Thomas’s NHS Foundation 
Trust Hospital. Treatment was carried out with either local anaesthesia; local 
anaesthesia and sedation, or day-case general anaesthesia. 
In relation to study bias; patients from both primary care and secondary care 
theoretically reduce bias as treatment includes patients from both primary and 
secondary clinical care provision and all levels of clinical complexity and anaesthesia 
modalities. In relation to overall prevalence of third molar disease, bias is compounded 
as only patients who have disease and are having their third molar removed were 
included and, therefore, did not include patients who may have asymptomatic and 
undiagnosed disease but had not been referred for assessment and treatment.   
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3.1.4 Statistical analysis. 
The original sample size was calculated by power calculator (G*Power 3.1.5) allowing 
for a confidence level of 95% with a 5% margin of error (standard power level of 80% 
and alpha level of p=0.05). Patient age and the angulation of the mandibular third 
molar tooth were defined as the primary independent variables, whilst disease of the 
mandibular third molar was defined as the primary dependent variable. Sample size 
calculation was determined at 969 however a total of 1011 patients were ultimately 
assessed.  
Sample and outcome characteristics were summarised using descriptive statistics. 
Sample means, number, range and standard deviation were calculated for patient age 
related to Md3M angulation and Md3M disease diagnoses. Angulation related 
frequency and distribution of disease was also calculated. The comparison of Md3M 
subgroups for the disease variation and the Md3M angulations of impaction were 
carried out using Z test for proportions. The mean age of patients for different disease 
presentation and with impaction status were compared using one way ANOVA. 
Statistical significance was assumed at 5% level and all the analyses were carried out 
using SPSS version 23.0.  
 
3.2 Results 
Of the 1011 patients who were assessed, 604 (60%) were female and 407 (40%) male. 
In total, 591 patients had one Md3M removed and 420 patients had bilateral Md3M 
removed: a total of 1431 Md3M were removed. The number of Md3M present with 
no clinical indication for removal was 376, and 215 Md3M were clinically absent. The 
mean age of patients having Md3Ms removed was 32.4 years, (SD 11.5 years, range 




3.2.1 Md3M characteristics and disease 
The overall distribution of disease that indicated Md3M removal is shown in Figure 
3.2. Pericoronitis was the most common indication recorded accounting for 49% of all 
Md3M removed. Caries & related disease (C&RD) for 27% of Md3M removed; 
Md2M DCC for 14%; periodontal disease for 5%, and dental/odontogenic cyst for 2%. 
Collectively, the remaining 10 recorded diagnoses accounted for 4% of all diagnoses, 
and individually accounted for less than 1%. Caries combined, i.e. C&RD and Md2M 
DCC, as an overall indication for removal of Md3M, accounted for the removal of 
41% of all Md3M.  
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Figure 3.2  Primary diagnosis and distribution of all Md3M requiring 
removal. 
Diagnosis for removal Number of Md3M removed Percentage (%) 
1 – Pericoronitis 698 49% 
2 – Caries & related disease (C&RD) 382 27% 
3 – Md2M DCC 198 14% 
4 – Periodontal disease 63 5% 
5 – Dentigerous/odontogenic cyst 33 2% 
6 – Prevention of Md2M 18 1% 
7 – Pre-orthognathic surgery 12 0.8% 
8 – Food trap 9 0.6% 
9 – External resorption of Md2M 4 0.3% 
10 – Prophylactic secondary to GA 4 0.3% 
11 – Fractured tooth (not caries) 3 0.2% 
12 – Pre-orthodontic 2 0.2% 
13 – Pre-radiotherapy  2 0.2% 
14 – Ramus bone graft – pre-implant 1 0.1% 
15 – Internal resorption 1 0.1% 
16 – Non-function 1 0.1% 
Total number of Md3M (1011 patients)  1431 100% 
 
Legend: This table illustrates the clinical diagnosis of 1431 Md3M removed from 1011 patients along 
with the total number and percentage distribution of 1431 Md3M removed. In total, 591 patients had 




Of the 1431 Md3M removed, a total of 82% Md3M were impacted and 18% were 
vertical, non-impacted and in a functional position.  Mesio-angular impacted Md3M 
(MAMd3M) accounted for 29% of the total removed, with horizontal Md3M 
(HORIZMd3M) impactions accounting for 14%; disto-angular Md3M impactions 
(DAMd3M) for 15%, and ectopic impactions for less than 1%. Vertically impacted 
Md3M (VERT(imp)Md3M) accounted for 24% and 18% Md3M were vertical and non-
impacted (VERT(non)Md3M). (Figure 3.3). 
 
Figure 3.3 Primary diagnoses and distribution of Md3M requiring removal 
based on angulation and impaction. 
Primary diagnosis for 

















N=198 (14%) N=413 
(29%) 
N=11 (<1%) N=251 
(18%) 
Pericoronitis 271 (78%) 176 (84%) 106 (53%) 131 (32%) 6 (54%) 8 (3%) 
C&RD 56 (16%) 26 (12%) 22 (11%) 62 (15%) Nil 213 (85%) 
Md2M DCC  Nil Nil 18 (9%) 180 (44%) Nil Nil 
Periodontal disease 2 (<1%) 3 (1.5%) 25 (13%) 13 (3%) Nil 22 (9%) 
Dentigerous/odontogenic 
cyst 
4(1%) 4 (2%) 16 (8%) 5 (1%) 4 (36%) Nil 
Prevention DCC 2nd 
molar 
Nil Nil 3 (1%) 14 (3%) Nil Nil 
Pre-orthodontic 
orthognathic surgery 
Nil Nil 4 (2%) 6 (1%) Nil Nil 
All other indications total 15 (<5%) 1(<1%) 4(2%) 2(<1%) 1(9%) 8(<4%) 
 
Legend: This table illustrates the clinical diagnoses of 1431 Md3M removed from 1011 patients based 
on angulation and impaction. Pericoronitis is the main indication for all types of impacted Md3M apart 
from mesio-angular impaction where Md2M DCC was the primary indicator. Md2M DCC was only 
observed related to MAMd3M and to HORIZMd3M. The incidence of C&RD was similar in all types of 
impaction.  (McArdle et al., 2018) 
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If non-impacted Md3M are isolated from and compared with impacted Md3M then 
the distribution of disease can be considered comparatively.  Pericoronitis accounted 
for the removal of 58% of impacted Md3M compared with 3% of non-impacted 
Md3M (p<0.0001), C&RD for 14% of impacted teeth compared with 84% of non-
impacted teeth (p<0.0001), Md2M DCC for 17% of impacted teeth and 0% of non-
impacted teeth (p<0.0001), periodontal disease for 4% of impacted teeth and 9% of 
non-impacted teeth (p<0.001), and finally dental/odontogenic cyst for 3% of impacted 
teeth compared with 0% non-impacted (p<0.01).  
The most common eruption status for Md3M requiring removal was that of partial 
eruption, which totalled 1133 Md3M (79%). Erupted teeth accounted for 251 Md3M 





3.2.2 Md3M disease diagnoses and angulations 
Disease diagnoses in relation to the angulation and impaction of the Md3M was also 
considered and are presented in figures 3.3 and 3.4. 
 
Figure 3.4 Percentage distribution of the main Md3M disease based on 
angulation and impaction status. 
 
Legend: This figure illustrates the percentage distribution of the main principal diagnoses of Md3M 
removed based on angulation and impaction. Pericoronitis is the main indication for all types of 
impacted Md3M apart from mesio-angular impaction where Md2M DCC was the primary indicator. 
Md2M DCC was only observed related to MAMd3M and to HORIZMd3M. The incidence of C&RD was 
similar in all types of impaction.  (McArdle et al., 2018) 
Of the most common diseases, pericoronitis accounted for the removal of 32% of all 
MAMd3M compared with 84% of all DAMd3M (p<0.001); 78% of all VERT(imp)MD3M  
impactions (p<0.001); 53% of all HORIZMd3M (p<0.001) and 3% of vertical non-
impacted teeth (VERT(non)Md3M) (p<0.001).  
In contrast C&RD accounted for the removal of 15% of MAMd3M compared with 12% 
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but 85% of VERT(non)Md3M (p<0.001). DCC of the Md2M accounted for the removal 
of 44% of all MAMd3M and 9% of HORIZMd3M (P<0.001) but was not recorded in any 
of the other groups (P<0.001).  
Periodontal disease accounted for the removal of 13% of all HORIZMd3M compared 
with 3% of MAMd3M (P<0.001); 1.5% of DAMd3M (P<0.001); 9% of VERT(non)Md3M 
(p=0.18) and less than 1% of VERT(imp)Md3M (P<0.001).   
The variation of disease seen in the differing types of impaction suggests that certain 
diseases, such as Md2M DCC, occur dependent upon the angulation of impaction and 
other disease, such as C&RD, independent of the angulation. 
 
3.2.3. Mean age, impaction status & disease.  
The mean age of all patients having Md3Ms removed was 32.4 years (range 12-87 
years, SD: 11.5 years). In addition, the mean age of patients, based on the angulation 
of impaction of the Md3M was calculated (Figure 3.5) and the mean age of patients 
based on the most common diagnoses (Figure 3.6).  
For patients having a MAMd3M removed, the mean age of patients was 30.1 years 
(range 12-67 years, SD: 7.7 years); for DAMd3M impactions, the mean age was 29.6 
years (range 19-86 years, SD: 8.3 years); for HORIZMd3M impactions - 31.7 years, 
(range 14-87 years, SD: 10.3 years); for VERT(imp)Md3M impactions - 28.6 years, (range 
16-57 years, SD: 7.5 years); for VERT(non)Md3M 41.6 years, (range 17-83 years, SD: 
15.6 years); and for ectopic impactions the mean age was 31.3 years, (range 18-45 
years, SD 9.6 years). For reference, the Office for National Statistics in the UK report 




Figure 3.5 Mean age of patients requiring Md3M removal based on Md3M 
angulation of impaction. 
 
Legend: This figure illustrates the mean age of patients requiring Md3M removal based on angulation 
and impaction. For non-impacted vertical Md3M the mean age was 41.6 years, compared with mean 
ages of 28.6 years to 31.7 years for impacted Md3M (McArdle et al., 2018). (Standard Deviation bars 
illustrated for mean age, see text for values). (Mean age UK 2014 ONS, 2014b. ONS does not report 
SD for mean age). 
 
In terms of disease, for the most common diagnoses related to patients having a Md3M 
removed, the mean age of patients with a diagnosis of pericoronitis was 27.5 years 
(range 16-70 years, SD: 5.8 years); for C&RD, the mean age was 36.1 years (range 
17-86 years, SD: 13.3 years); for periodontal disease, 46.3 years, (range 24-81 years, 
SD: 13.6 years); for Md2M DCC, 32.7 years, (range 21-55 years, SD: 7.3 years); and 
for dentigerous/odontogenic cyst, 43.1 years, (range 14-87 years, SD: 16.4 years). In 
relation to vertical impacted and non-impacted Md3M with a diagnosis of C&RD, the 
mean age of patients with a VERT(imp)Md3M was 31.9 years (range 19-65 years, SD: 
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Figure 3.6 Mean age of patients requiring Md3M removal based on Md3M 
diagnoses. 
 
Legend: This figure illustrates mean age of patients requiring Md3M removed based on diagnoses. For 
pericoronitis the mean age was 27.5 years, Md2M DCC was 32.7 years and periodontal disease was 
46.3 years  (McArdle et al., 2018). (Standard Deviation bars illustrated for mean age, see text for 
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3.3 Discussion 
3.3.1 The spectrum of disease and impactions 
This study, as with other reported studies, reports pericoronitis as the most common 
indication for Md3M removal, with dental caries, cyst formation and periodontal 
disease being other common diseases associated with Md3M (Knutsson et al., 1996; 
van der Linden et al., 1995). The scope of impacted Md3M angulations in this study 
is similar to other studies (Bruce et al., 1980; Knutsson et al., 1996; van der Linden et 
al., 1995). Most Md3M studies do not, however, emphasise whether non-impacted 
Md3M are included in individual case-series or whether they have been incorporated 
as vertical impacted Md3M. The spectrum of disease related to non-impacted Md3M 
in this study is significantly different to the disease spectrum for impacted teeth and 
in a significantly older population (p<0.001).  
When considering the disease spectrum of Md3M, it is important to consider Md3M 
disease in relation to each type of Md3M impaction rather than produce a summative 
account for all Md3M. By categorising disease in relation to Md3M impaction, we can 
reflect on the clinical significance that the nature of impaction may have on the 
potential disease outcome for patients.  
 
3.3.2 Pericoronitis 
Pericoronitis is the most common indication for the removal of Md3M as a whole 
(49%), but whereas it accounts for only 3% of VERT(non)Md3M it accounts for 32% of 
MAMd3M, 53% of horizontal impactions, 78% of vertical impactions and 84% of 
disto-angular impactions (p<0.001) (Figure 3.3). The reasons for the variation in 
pericoronitis related to the differing types of impaction may be explained by the local 
anatomy and the presence of an operculum of mucosa overlying the occlusal surface 
of vertical and disto-angular impactions. This would create a local environment 
conducive to local soft tissue infections secondary to poor or inadequate oral hygiene. 
Due to the inclination of a MAMd3M this would tend to elevate the distal aspect of the 
crown away from the soft tissues eliminating the operculum and exposing the distal 
surface, which may then be more accessible to oral hygiene and a reduce risk of 
pericoronitis. Pericoronitis is rarely seen in vertically non-impacted Md3M primarily 
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because there is no operculum that can become infected, hence pericoronitis is an 
uncommon feature and the tooth is retained as normal. 
 
3.3.3 Caries and Related Disease (C&RD)  
C&RD accounts for 27% of all Md3M extractions with C&RD in each of the main 
categories of impacted Md3M comparatively uniform. C&RD accounted for 15% of 
mesio-angular impactions, 12% of disto-angular impactions, 11% horizontal 
impactions and 16% of vertical impactions were removed due to C&RD. This suggests 
that the diagnosis and incidence of C&RD is independent on the type of Md3M 
impaction.  However, compared with impacted Md3M, C&RD accounts for 85% of 
all VERT(non)Md3M removed (p<0.001) (Figure 3.3). Md3M C&RD has been shown to 
increase with age and VERT(non)Md3M tend not to be associated with the common 
diseases of impaction such as pericoronitis (p<0.001). In older middle-aged patient 
groups with retained Md3M, VERT(non)Md3M are more common than impacted third 
molars (Brickley et al., 1996). A VERT(non)Md3M would not be excluded from the 
potential of experiencing dental disease at some point but they would evade 
pericoronitis, remain functional and disease free for a period of time before a 
proportion of them succumb to typical dental disease such as caries and periodontal 
disease as reported here. This is supported by the observation that the mean age of 
patients with impacted Md3M with C&RD compared with non-impacted Md3M with 
C&RD is 31.9years compared with 39.7years respectively (P<0.001).  
 
3.3.4 Mandibular Second Molar Distal Cervical Caries (Md2M DCC). 
Md2M DCC, as an indication for Md3M removal, has been reported as contributing a 
relatively small proportion of Md3M removal in older studies (Bruce et al., 1980; 
Knutsson et al., 1996; McArdle and Renton, 2006; van der Linden et al., 1995). In this 
series it is not associated with vertical, disto-angular or ectopic impactions and its 
significance should not be considered collectively with all other types of Md3M 
impactions. 
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Md2M DCC in this study accounts for 14% of all Md3M removed and 17% of all 
impacted Md3M removed. It accounts for 9% of all horizontal impactions, however, 
Md2M DCC accounts for 44% of all MAMd3M removed.  
The mean age of patients with Md2M DCC is 32.7 years compared with patients with 
pericoronitis (27.5 years) (p=0), with pericoronitis being the most common reason for 
Md3M removal. In this case series over 50% of all Md3M are removed in patients 
between 20-29 years of age suggesting that the majority of patients who will require 
Md3M removal will have lost them by the time they are 30 years old. This corroborates 
that Md2M DCC is a disease of older patients and, as pericoronitis is the most common 
indication for impacted Md3M removal, patients will generally succumb to other 
forms of disease such as this before Md2M DCC can occur (McArdle and Renton, 
2006). 
In addition to the loss of the Md3M to facilitate treatment of Md2M DCC, it has been 
reported that Md2M DCC has significant financial costs attributed to it and results in 
the eventual loss of 40% of Md2M. (McArdle et al., 2016) The primary risk factor 
related to Md2M DCC formation is the partially erupted mesio-angular or horizontally 
impacted Md3M and with such a high incidence of Md2M DCC in mesio-angular 
impactions consideration should be given to this disease’s potential.  
NICE advocated the proscription of prophylactic third molar removal in the late 1990s 
and the change in patient management had resulted in the mean age of patients 
requiring third molar removal increasing from 28 years to 32 years by 2009/10, with 
30% of third molars removed due to dental caries as the primary indication for removal 
(McArdle and Renton, 2012). This 2012 data could not, however, differentiate 
between third molar caries and Md2M DCC. In this present study Md3M C&RD 
accounted for 14% of all impacted Md3M removed and Md2M DCC for 17% of 
impacted Md3M removed: in total 31% of all impacted Md3M were removed due to 
all categories of dental caries disease. With the addition of C&RD related to non-
impacted Md3M, a total of 41% of Md3M were removed due to caries. Md2M DCC 
is the most common indication in this case series for the removal of a MAMd3M. 
With 44% of all MAMd3M and 9% of all HORIZMd3M removed due to Md2M DCC 
concern is raised that observing and retaining an MAMd3M, in particular, until disease 
occurs may be an unsound management strategy. Contrary to NICE guidance early 
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removal of MAMd3M and HORIZMd3M, in particular, may be indicated and should be 
considered so as to avoid Md2M DCC and its consequences.  
 
3.3.5 Periodontal disease 
Periodontal disease accounts for only 5% of all Md3M removed in this case series, 
however, it should be noted that only the primary indication for Md3M was recorded 
as opposed to all concomitant diseases that may have been associated with a particular 
Md3M. Nonetheless, periodontal disease was the primary indication for 12% of all 
HORIZMd3M and 9% of all VERT(non)Md3M, with smaller proportions for all other 
impacted Md3M. Periodontal disease is generally a quiescent disease that patients are 
often unaware of and generally only gives rise to significant symptoms in the later 
stages of the disease. Periodontal disease has been reported to be a clinical finding 
related to impacted third molars, however this data does not contradict these studies 
but may suggest that Md3M will become symptomatic and succumb to other Md3M 
diseases before periodontal disease becomes symptomatic and then the prime indicator 
for intervention (Blakey et al., 2006; Blakey et al., 2002; Elter et al., 2004a; Elter et 
al., 2004b; Elter et al., 2005; White et al., 2006). 
 
3.3.6 Other Disease 
All the remaining indications for Md3M removal collectively accounted for 4% of all 
indications and less than 1% individually. Some of these indications for third molar 
removal are interventional to facilitate other forms of treatment such as orthodontics 
orthognathic and dental implant treatment, others are uncommon such as internal or 
external resorption and others may be very weak indicators for removal, such as food 
packing. Food packing, and similar diagnoses, should not be dismissed as an 
indication for Md3M removal as these types of problems can be a constant source of 
irritation to a patient and the preference of the patient for the removal of the offending 
tooth is as valid a treatment option than any. Although a small number: 18 (1%) of 
Md3M were removed for the prevention of Md2M DCC, consideration has to be given 
to the weight of evidence for the potential for this disease to occur and for patients to 
be able to consider the options of intervening early or monitoring accordingly.  
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3.4 Age and Diagnoses 
The mean age of patients requiring third molar removal was 32.4 years, however there 
was marked variation of patients’ mean age based upon diagnoses. One-way ANOVA 
test was used to compare the mean ages of patients based on the most common 
diseases. Pericoronitis, with a mean age of patients 27.5 years; C&RD mean age 36.1 
years; and Md2M DCC, mean age 32.7 years, when compared individually with each 
other, showed a statistically significant relationship (P=0). 
The eruption of Md3M is generally accepted to occur between the ages of 18-24 years 
and the timing of disease presentation varies. Pericoronitis occurs frequently and 
relatively soon after failed eruption of the Md3M; It is the most common disease 
associated with impacted Md3M and in general occurs in younger age groups. Caries, 
in comparison, is a disease that will take time to develop before significant clinical 
signs and symptoms become present. As an indication for Md3M removal in all types 
of impaction, C&RD occurs more frequently in older age groups than pericoronitis. 
Likewise, Md2M DCC tends to occur in older patient groups but only with those with 
an impacted MAMd3M or HORIZMd3M. 
 
3.5 Primary v Secondary Disease 
The primary consequence of third molar impaction is the failure of the occlusion to 
reach the endpoint of maturity with the resultant dental malocclusion at the posterior 
aspect of the dental arch. An impacted tooth is a developmental anomaly and is defined 
as a disease by the WHO within the ICD10 classifications of diseases (K011) (WHO, 
2016). Impaction is often overlooked as a disease in itself and the focus of defining 
third molar disease is often given to the consequent diseases of Md3M impaction, such 
as pericoronitis. However, the primary disease affecting the third molar is the 
impaction of the tooth and it is this which can then lead to consequential diseases such 
as pericoronitis, etc. These consequential diseases will generally occur secondary to 
the impaction, with patients experiencing a variety of differing disease. Where the 
third molar is erupted and functional, disease will not occur in the same manner as an 
impacted tooth. We should acknowledge that the impaction of the third molar is the 
primary disease that can then contribute to the development of secondary disease. 
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Only in the non-impacted Md3M can we consider that caries, periodontal disease, etc 
are the primary disease. 
Variation in the characteristics of the Md3M contributes to when disease may occur 
and the type of disease that may occur. The capacity to understand the potential and 
the ability to anticipate third molar disease should guide clinical judgment in the 
management of patients. Understanding the spectrum and nature of disease in relation 
to impacted Md3M should allow better management of individual patients with 
impacted Md3M. Patients with third molars cannot be managed as a collective group 
as this can have negative outcomes especially in relation to diseases such as Md2M 
DCC.  
The prevalence of impacted third molars in the general population as a whole has been 
reported to be approximately 25% (Carter and Worthington, 2016). This number is 
misleading as it would appear to include everyone, including people who have had 
third molars removed. This miscalculates the true prevalence as it mistakenly 
presumes that if a patient has no third molars that they never had any previously.  It 
has been reported that the prevalence of impacted third molars in 20-30 year olds is 
over 70% (Hugoson, 1988). It has also been reported that for those patients in middle-
age only 13% retain an impacted Md3M (Brickley et al., 1996). Although these two 
later studies are not related, if these studies are representative of patients then 80% of 
patients with impacted third molars will have undergone third molar removal by the 
time they are middle-aged (McArdle et al., 2018).  With such a high potential 
proportion of the adult population requiring third molar removal consideration should 
be given to addressing the potential for secondary disease rather than solely addressing 





Md3M can display a wide spectrum of disease that varies with some diseases 
appearing to be dependent on the type of Md3M impaction such as Md2M DCC, and 
independent of the impaction such as pericoronitis and C&RD. Disease occurs in non-
impacted Md3M as well as impacted Md3M with diseases affecting non-impacted 
teeth tending to be the typical dental diseases of caries and periodontal disease though 
in an older patient population. Diseases related to impacted teeth reflect the more 
specific diagnoses of pericoronitis, Md3M caries and Md2M DCC, and in a younger 
patient population.  
The variation of disease and the mean-age of patients seen in the differing types of 
impaction is significant in that some diseases, such as Md2M DCC, will occur 
dependent upon the angulation of impaction, and others, such as C&RD, independent 
of the angulation. Younger patients are more affected by disease such as pericoronitis 
and less so by other diseases such as C&RD, whereas older patients are more affected 
by C&RD and Md2M DCC. 
Md2M DCC accounts for 44% of all mesio-angular impacted and 9% of horizontally 
impacted Md3M removed.  The risk factors for the development of Md2M DCC have 
been previously reported (McArdle and Renton, 2006; Nunn et al., 2013; Ozeç et al., 
2009; Toedtling et al., 2016).  Early intervention in patients with impacted Md3M at 
risk of causing Md2M DCC should be considered and consequently prophylactic 
intervention may have role to play in the management of patients at risk of DCC of 









The characteristics of disease related to mesio-angular and horizontal 
mandibular third molars: the causative third molars for  
mandibular second molar distal cervical caries. 
 
 
Aspects of this chapter were published as: 
 
McArdle LW, Jones J, McDonald F. Characteristics of disease related to mesio-
angular mandibular third molar teeth. British Journal of Oral and Maxillofacial 





The mesio-angular mandibular third molar tooth (MAMd3M) is the most common type 
of mandibular third molar (Md3M) impaction and can contribute to a variety of 
common diseases such as pericoronitis, dental caries and periodontal disease 
(Adeyemo et al., 2008; Knutsson et al., 1996; McArdle et al., 2018; Nordenram et al., 
1987; Pratt, et al., 1998; Stanley et al., 1988; van der Linden et al., 1995).  As 
previously highlighted, the partially erupted MAMd3M can also result in Distal 
Cervical Caries (DCC) of the mandibular second molar tooth (Md2M) which can have 
significant clinical consequences for the patient (Chang et al., 2009; McArdle and 
Renton, 2006; McArdle et al., 2014; Nunn et al., 2013; Oderinu et al., 2012; Ozeç et 
al., 2009; Toedtling et al., 2016).   The MAMd3M accounts for approximately 91% of 
all cases of Md2M DCC with the HORZMd3M accounting for approximately 9%. 
Although Md2M distal caries has been reported in other classifications of impacted 
Md3M, these papers have included interproximal caries rather than solely DCC. DCC 
was not observed in any other classification of Md3M impaction in this dataset and is 
not observed in the absence of an impacted Md3M. It has been demonstrated that that 
up to 40% of Md2M are lost due to Md2M DCC, with the remaining 60% requiring 
restoration (McArdle et al., 2016).  The long-term consequences for those Md2M that 
are restored due to DCC is unknown, however the long-term failure of restored Md2M 
should be expected leading to further loss of the Md2M over time. The incidence of 
Md2M DCC has been reported to vary from between 2% and 14% of patients having 
Md3M removed, however, these figures relate to all categories of Md3M rather than 
to the specific type of impaction associated with it (Brickley et al., 1996; Bruce et al., 
1980; Chu et al., 2003; McArdle at al, 2018; McArdle and Renton, 2012; Pepper et 
al., 2017). 
As previously suggested a diagnosis of Md2M DCC highlights the potential risk of 
DCC forming on a disease free Md2M associated with a partially erupted MAMd3M. 
If all, or a significant proportion of, partially erupted MAMd3M or HORZMd3M pose a 
risk then the case for early intervention and prophylactic removal of both should be 
considered, as the risk and cost of retention of the Md3M resulting in Md2M DCC 
will be greater than the early removal (McArdle et al., 2016).   Consequently, NICE’s 
guidance may be in conflict with the reality of long-term retention of impacted third 
molars, especially the MAMd3M and the latent potential for Md2M DCC to occur.  As 
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demonstrated 44% of all MAMd3M are removed due to Md2M DCC, however 56% 
are removed for other clinical indications. Not all Md2M associated with an impacted 
MAMd3M or HORZMd3M experience DCC which consequently challenges whether 
prophylactic removal of MAMd3M and HORZMd3M should be universal as we cannot 
determine if all patients will be affected by the disease in the long term.  
4.1.1 Aims 
The principle aim of this chapter was to independently evaluate two cohorts of patients 
who had MAMd3M and HORZMd3M removed; to identify the patient and Md3M 
characteristics and in particular to determine the clinical diagnoses and to ascertain if 
there was any age-related disease variation for MAMd3M and HORZMd3M removal 
based on 5 year age cohorts of patients.  Furthermore, to consider the diagnoses in 
relation to patients’ dental health as measured by the DMFT score (Decayed, Missing 
or Filled Teeth).  
4.1.2 Ethics 
The local ethics committee of KCL Dental Institute was approached for advice 
regarding the need for ethical approval and as data collection would neither identify 
individual patients nor influence treatment or outcomes, formal ethical approval was 
not required. 
4.1.3 Methodology 
Data from the main database of 1011 patients attending for Md3M removal was 
evaluated to identify patients who had a MAMd3M or HORZMd3M tooth removed 
(McArdle et al., 2018). All patients having a MAMd3M and HORZMd3M removed were 
isolated from the main database into two cohorts and the recorded data for each 
MAMd3M and HORZMd3M patient cohort was independently evaluated. Of these 1011 
patients, 319 were identified who had had at least one MAMd3M removed and 151 
patients who had at least one HORZMd3M removed. 
The recorded variables assessed were; age, patient gender, the angulation of impaction 
of the Md3M, the primary indication for removal of the Md3M tooth, and the DMFT 
score as a basic measurement of dental health.  
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Mesio-angular and horizontal angulation of the Md3M was defined by standard 
convention (Figure 4.1) . Mesio-angulation was defined as the mesial, or forward, 
angulation of the Md3M from the occlusal perpendicular; in effect, where the mesial 
tilt of the  Md3M was greater than zero degrees and less than 90 degrees (Figure 4.1.i). 
Where the long axis of the Md3M was parallel with the mandibular occlusal plane the 
angle was defined as horizontal (Figure 4.1.ii).   
 
Figure 4.1 Calculating the angulation of impaction of the Md3M. 
4.1.i. Mesio-angular Md3M. 
 
4.1.ii. Horizontal Md3M. 
 
Legend: This image demonstrates the method of calculating the mesial and horizontal inclination of 
the Md3M. The angle of intersection of the mandibular occlusal plane and the occlusal plane of the 
Md3M is equal to the mesial inclination of the Md3M relative to the vertical inclination of the 
mandibular teeth. The   
For each angulation cohort the number of Md3M teeth removed was calculated along 
with the proportion for each diagnosis. The mean age of patients as it related to each 
individual angulation and principal diagnosis was calculated. Principal diagnoses 
included pericoronitis, C&RD, Md2M DCC, periodontal disease and odontogenic 
cyst. Patients from each angulation cohort were subdivided into 5 year age groups and 
the frequency of disease as it related to Md3M angulation within these age groups was 
calculated.  
Mandibular occlusal plane 
Mandibular occlusal plane 
Md3M long axis angulation mesial 
inclination from the occlusal perpendicular 
Perpendicular 
from the occlusal 
plane Md3M Long axis parallel with occlusal plane 
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The DMFT of patients was also calculated for 10 year age groups matched to the 2009 
ADHS (ADHS, 2011). The mean DMFT was calculated as it related to each age group 
matched angulation cohort and each of the principal diagnoses for each angulation. 
The DMFT of the general population was calculated from the 2009 ADHS (ADHS, 
2011). The Adult Dental Health Survey of 2009 published data on the average number 
of sound, unrestored teeth of patients within given age groups, whereas previous Adult 
Dental Health Surveys had published the average DMFT scores for patients (ADHS, 
2000; ADHS 2011). Email communication with the Office of National Statistics and 
the authors of the 2009 ADHS confirmed that the calculation of average DMFT scores 
based on the results of the 2009 ADHS could be calculated by subtraction of the 
average value for sound, unrestored teeth from 32; the number of teeth within a fully 
dentate individual (Triffit, 2012).  
Data related to defining Md3M disease reflected that of the main database, in that all 
variants of pericoronitis were ascribed to a single diagnostic group defined as 
‘pericoronitis’ and patients whose third molar was removed due to dental caries, or 
the consequences of dental caries, such as dental abscess or per-apical abscess, were 
ascribed to the diagnostic group of caries and related disease (C&RD). 
 
4.1.4 Statistical analysis. 
As previously defined, the original sample size was calculated by power calculator 
(Gpower 3.1.9.2) allowing for a confidence level of 95% with a 5% margin of error 
(low effect size of 0.1, with a power level of 80% and alpha level of p=0.05). Patient 
variables were identified as previously described (see 3.1.4). Total sample size 
calculation for all independent variables was determined at 969 however a total of 
1011 patients were eventually assessed.  
The sample and outcome characteristics were summarised using descriptive statistics. 
Sample means, number, range and standard deviation were calculated for patient age 
related to Md3M angulation and Md3M disease diagnoses. Angulation related 
frequency and distribution of disease was also calculated. Sample means, number, 
range and standard deviation were calculated for DMFT for age matched groups. The 
mean age of patients for different disease presentation and for Md3M impaction status 
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were compared using one way ANOVA. Statistical significance was assumed at 5% 
level and analyses were carried out using SPSS version 23.0 and MedCalc software. 
 
4.2 Results MAMd3M 
Of the 319 patients who had a MAMd3M removed, 225 patients had a single MAMd3M 
removed and 94 patients had bilateral removal; a total of 413 MAMd3M removed. The 
mean age of all patients was 30.1 years, (n=319, SD: 7.7 years range 12-67 years).  
4.2.1 Disease related to MAMd3M 
The most common indication for the removal of a MAMd3M was Md2M DCC, 
accounting for 180 (44%) of all MAMd3M removed with 33 patients having bilateral 
MAMd3M removal due to bilateral Md2M DCC. Pericoronitis accounted for 131(32%) 
of all MAMd3M removed; C&RD for 62 MAMd3M (15%); periodontal disease for 13 
MAMd3M (3%), odontogenic cyst for 5 MAMd3M (1%); orthodontic/orthognathic 
indications for 5 MAMd3M (1%); and external resorption for 2 MAMd3M (<1%). 
Additionally, a total of 14 (3%) MAMd3M were prophylactically removed due to 
potential risk to of Md2M DCC.   
Md2M DCC, pericoronitis, C&RD, odontogenic cyst and periodontal disease were 
defined as the principal disease indicators as they are the most significant in terms of 
frequency and clinical significance. Only these disease indicators for MAMd3M are 
included in the descriptive analysis as the frequency of the others spread across the 




Figure 4.2. Percentage distribution of disease/principal indication for 
MAMd3M removal for 413  MAMd3M in 319 patients (225 unilateral 
and 94 bilateral) 
 
Legend: This table demonstrates the percentage distribution of diseases associated with the removal 









DIAGNOSIS FOR MAMd3M REMOVAL 
 
 





1 – Md2M DCC  180 44% 
2 – Pericoronitis 131 32% 
3 – Caries & Related Disease (C&RD) 62 15% 
4 – Periodontal disease 13 3% 
5 – Prevention DCC 2nd molar 14 3% 
6 – Odontogenic cyst 5 1% 
7 – Pre-orthodontic/orthognathic  5 1% 
8 - External resorption of 2nd molar 4 0.3% 
9 – Prophylactic secondary to GA 1 0.2% 
   
Total number of MAMD3M removed 413 100% 
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4.2.2 Age and Disease MAMd3M 
For the principal diagnoses related to patients having a MAMd3M removed, the mean 
age of patients with a diagnosis of pericoronitis was 25.5 years (n=97, SD: 4.7 years, 
range 17-38 years); for C&RD the mean age was 30.6 years (n=53, SD: 8.7 years, range 
18-67 years); for Md2M DCC, 32.8 years (n=147, SD: 7.4 years, range 21-55 years); 
for periodontal disease, 34.6 years (n=12, SD: 4.6 years, range 24-40 years): and for 
odontogenic cyst, 43.8 years (n=5, SD 5.9 years, range 38-53 years) (Figure 4.3).  
 
Figure 4.3. Mean age (years) of patients requiring MAMd3M removal based on 
principal diagnoses. 
 
Legend: the mean age of patients (in years) requiring MAMd3M removal based on the principal 
diagnoses and compared with all Md3M removed.  This graph demonstrates that, for the most common 
diseases, the mean age of patients who had MAMd3M removed varies with the type of disease. Patients 
who had pericoronitis are significantly younger than patients with Md3M caries (p<0.001; d.f. 149, 
F=21.8) or patients with Md2M DCC (p<0001; d.f. 243, F=74.5) (McArdle et al., 2019). (Standard 
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4.2.3 DMFT MAMd3M 
 
The mean DMFT was calculated for patients who had MAMd3M removed due to 
pericoronitis, Md2M DCC, and C&RD, and for 10 year age-ranges to allow 
comparison with the 2009 Adult Dental Health Survey (ADHS) (Figure 4.4) (HMSO, 
2011).  In addition, the mean DMFT was calculated for all patients from the larger 
study of 1011 patients, having all Md3M removed for the same 10 year age ranges 
(McArdle et al.,  2018). 
For the most common MAMd3M diseases, the mean DMFT for each 10 year age-range 
was comparable with each other. For each 10 year age-range, all patients having a 
MAMd3M removed had a mean DMFT score comparable with  the mean DMFT of all 
Md3M removed but approximately 50% less than the comparable age range mean 
DMFT from the ADHS 2009 (Figure 4.4). Similarly, the mean DMFT score of 
patients, based on the main diagnoses was approximately 50% less compared with the 
ADHS. The only exception to this was patients in the 45-54 age range with a diagnosis 
of C&RD, who had a mean DMFT comparable to patients from the ADHS 2009.  
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Figure 4.4. Mean DMFT of patients with MAMd3M based on principal 
diagnoses compared with all Md3M and ADHS 2009. 
 
Legend: The mean DMFT score of patients requiring MAMd3M removal based on principal diagnoses 
and all MAMd3M compared with all Md3M removed and the ADHS 2009. (Data labels report each 
DMFT value). This graph demonstrates that, for the most common diseases, the mean DMFT of patients 
who had MAMd3M removed were comparable with all patients requiring Md3M removal, though 
approximately 50% lower than the AHDS 2009 for comparable age groups (McArdle et al., 2019). 
(Standard Deviation bars illustrated for mean age, see text for values). 
 
4.2.4 Disease Distribution MAMd3M 
The distribution of the principle MAMd3M diseases was also considered in relation to 
the age cohorts of patients (Figure 4.5). In younger age groups pericoronitis was the 
most common indication for the removal accounting for 78% of all MAMd3M removed 
in 15-19 years olds (n=18); 55% of 20-24 year olds (n=39); 41% of 25-29 year olds 
(n=55), and 14% of 30-34 year olds (n= 13). Md3M C&RD ranged between 10-20% 
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in patients under the age of 20 years, however the proportion of Md2M DCC as the 
primary indication for MAMd3M removal in 20-24 year olds was 20% (n=15 
MAMd3M), rising to 35% in 25-29 year olds (n=47 MAMd3M) and 68% of 30-34 year 
olds (n=63 MAMd3M). The proportion of MAMd3M removed due to Md2M DCC in 
each of the older groups averaged in excess of 60%, however, the total number of 
patients within each of these older groups decreased with age as the total number of 
patients retaining third molars as a proportion of their peer group into later life 
contracts.  
 
Figure 4.5  Percentage distribution of principal disease indicators for 
MAMd3M removal based on 5 year age cohorts (n=390). 
 
Legend: A total of 413 MAMd3M were removed from the cohort of 319 patients. This graph 
demonstrates those 390 MAMd3M with the most common diseases as opposed to all diseases. The 
proportion of MAMd3M removed due to pericoronitis reduces as patients become older and conversely 
the proportion of MAMd3M removed due to Md2M DCC increases with age. These other indicators 
constituted a small proportion of patients and offered no descriptive analysis. Age range of all patients 
is 12-67 years, age range of patients with principal disease indicators is 17-67 years (one single 
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4.4 Results HORZMd3M 
Of the 151 patients who had a HORZMd3M removed, 104 patients had a single 
HORZMd3M removed and 47 patients had bilateral removal; a total of 198 HORZMd3M 
were removed. The mean age of all patients was 31.7 years, (n=151, SD: 10.3 years, 
range 14-87 years).  
 
4.4.1 Disease HORZMd3M 
The most common indications for the removal of a HORZMd3M was pericoronitis, 
accounting for 106 (53%) of all HORZMd3M removed. C&RD accounted for 22 
HORZMd3M (11%); periodontal disease for 25 HORZMd3M (13%), Md2M DCC 
accounted for 18 (9%) of all MAMd3M removed with 2 patients having bilateral 
MAMd3M removal due to bilateral Md2M DCC. Odontogenic cyst accounted for 16 
HORZMd3M (8%) with orthodontic/orthognathic indications for 4 HORZMd3M (2%).  
Additionally, a total of 3 (1%) MAMd3M were prophylactically removed due to 
potential risk of Md2M DCC and for all other indications 4 (2%) HORZMd3M were 
removed.  
Pericoronitis, periodontal disease, C&RD, Md2M DCC, and odontogenic cyst were 
defined as the principal disease indicators as they are the most significant in terms of 
frequency and clinical significance. Only these disease indicators for HORZMd3M are 
included in the descriptive analysis as the frequency of the others spread across the 




Figure 4.6. Percentage distribution of disease/principal indication for 
HORZMd3M removal for 199 HORZMd3M in 151 patients (105 
unilateral and 47 bilateral). 
 
Legend: This table demonstrates the percentage distribution of diseases associated with the removal 
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1 –  Pericoronitis  106 53% 
2 –  Periodontal disease  25 13% 
3 –   Caries & Related Disease (C&RD) 22 11% 
4 –  Md2M DCC 18 9% 
5 –  Odontogenic cyst  16 8% 
6 –  Pre-orthodontic/orthognathic 4 2% 
7 –  Prevention Md2M DCC 3 1% 
8 -   all other indications combined 4 2% 
   
Total number of HORZMD3M removed 198 100% 
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4.4.2 Age and Disease HORZMd3M 
For the principal diagnoses related to patients having a HORZMd3M removed, the mean 
age of patients with a diagnosis of pericoronitis was 27.5 years (n=80, SD: 5.2 years, 
range 17-44 years); for C&RD the mean age was 31 years (n=19, SD: 6 years, range 
20-42 years); for Md2M DCC, 32.1 years (n=16, SD: 6.5 years, range 22-46 years); 
for periodontal disease, 40.3 years (n=18, SD: 7.2 years, range 32-57 years): and for 
odontogenic cyst, 44.2 years (n=16, SD 20.5 years, range 14-87 years) (Figure 4.7).  
 
Figure 4.7.  Mean age (years) of patients requiring HORZMd3M removal based 
on principal diagnoses. 
 
Legend: the mean age of patients (in years) requiring HORZMd3M removal based on the principal 
diagnoses and compared with all Md3M removed. 3.  This graph demonstrates that, for the most 
common diseases, the mean age of patients who had HORZMd3M removed varies with the type of 
disease. Patients who had pericoronitis are significantly younger than patients with Md3M caries 
(p=0.012; d.f. 98, F=6.55) or patients with Md2M DCC (p=0.0026; d.f. 95, F=9.57). (Standard 
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4.4.3 DMFT HORZMd3M 
The mean DMFT was calculated for patients who had HORZMd3M removed due to 
pericoronitis, Md2M DCC, and C&RD, and for 10 year age-ranges to allow 
comparison with the 2009 Adult Dental Health Survey (ADHS) (Figure 4.8) (ADHS, 
2011).  In addition, the mean DMFT was calculated for all patients from the larger 
study of 1011 patients, having all Md3M removed for the same 10 year age ranges 
(McArdle et al., 2018). 
For the most common HORZMd3M diseases, the mean DMFT for each 10year age-
range was comparable with each other. For each 10 year age range, all patients having 
a HORZMd3M removed had a mean DMFT score approximately 50% less than the 
comparable mean DMFT from the ADHS 2009 (Figure 4.8). Similarly, the mean 
DMFT score of patients, based on the main diagnoses was approximately 50% less 
compared with the ADHS. The only exception to this was patients in the 45-54 year 
age range with a diagnosis of C&RD, who had a mean DMFT comparable to patients 
from the ADHS 2009.  
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Figure 4.8. Mean DMFT of patients with HORZMd3M based on principal 
diagnoses compared with all Md3M and ADHS 2009. 
 
Legend: The mean DMFT score of patients requiring HORZMd3M removal based on principal diagnoses 
and all HORZMd3M compared with all Md3M removed and the ADHS 2009. (Data labels report each 
DMFT value). This graph demonstrates that, for the most common diseases associated with HORZMd3M, 
the mean DMFT of patients were comparable with all patients requiring Md3M removal, though 
approximately 50% lower than the AHDS 2009 for comparable age groups. The Md2M DCC DMFT 
value for the 15-24 year age group and the 45-54 year age group relate to a single patient and offers 
no statistical deviation value). There were no patients in the 45-54 age group who had an HORZMd3M 
removed due to pericoronitis or Md3M C&RD. (Standard Deviation bars illustrated for mean age, see 
text for values). 
 
4.4.4 Disease Distribution HORZMd3M 
The distribution of the principle diseases related to HORZMd3M was also considered in 
relation to the age cohorts of patients (Figure 4.9). In younger age groups pericoronitis 
was the most common indication for the removal accounting for 73% of all 
HORZMd3M removed in patients under the age of 30years of age (n=102). In patients 
over the age of 30 years pericoronitis tapers in its frequency and accounts for 33% of 
all HORZMd3M removed with the majority of HORZMd3M in the 30 years plus age group 































15-24years 25-34years 35-44years 45-54years
Mean DMFT of patients with HORIZMd3M by diagnoses compared 
with all Md3M and ADHS 2009




tapering reduction in frequency of pericoronitis as patients become older. Md3M 
C&RD demonstrated an increasing frequency as patients became older whereas the 
frequency of Md2M DCC appeared to be relatively uniform in frequency in older age 
groups and ranged between 10-20% in all age groups from 15-19 years through to 50-
54 years. Periodontal disease was the second most common disease attributable to the 
removal of the HORZMd3M and represented an increasing proportion of HORZMd3M 
removed in older aged groups. The numbers of HORZMd3M removed totalled 198 with 
105 HORZMd3M removed due to pericoronitis. The fractionalised volume and spread 
of HORZMd3M removed across the age spectrum for each disease becomes relatively 
small for each age cohort. Consequently, the true descriptive statistical picture may 
not permit an accurate interpretation.    
 
Figure 4.9.  Percentage distribution of principal disease indicators for 
HORIZMd3M removal based on 5 year age cohorts (n=181). 
 
Legend: A total of 198 MAMd3M were removed from the cohort of 151 patients. This graph 
demonstrates those 181 HORZMd3M with the most common diseases as opposed to all diseases. The 
other indicators constituted a small proportion of HORZMd3M and offered no descriptive analysis. The 
number of HORZMd3M removed due to Md2M DCC is small but the proportion removed is comparable 
in each of age group cohort; similarly with Md3M caries and related disease.  range of all patients is 
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Pericoronitis is commonly reported as the main indication for the removal of Md3M 
and is the most commonly reported indication for the removal of MAMd3M (Brickley, 
1996; Knutsson et al., 1996; Nordenram et al., 1987).  However in this study the 
primary indication for MAMd3M removal was Md2M DCC, accounting for 44% of all 
MAMd3M. In contrast with the MAMd3M, the HORZMd3M had a relatively low 
frequency of Md2M DCC of approximately 9% (McArdle et al., 2018). 
It has been previously demonstrated that as the mean age of patients increases, the 
frequency of caries and its variants (C&RD) also increases as the primary indicator for 
Md3M removal (McArdle and Renton, 2012).   Furthermore, the increased frequency 
of Md2M DCC seen now in patients can also be attributed to the fact that patients 
having Md3M removal are presenting later in life than previously reported with a 
different spectrum of disease (McArdle and Renton, 2012).  In younger patients, 
Md2M DCC is seen infrequently as this disease will generally take a long period of 
time to develop after failed eruption of the third molar (Bruce et al., 1980; McArdle 
and Renton, 2006). The overall low incidence of Md2M DCC in studies where 
prophylactic removal is common and the consequent mean age of patients is younger 
conceals the true potential of Md2M DCC as early removal will eliminate its potential 
(Brickley and Shepherd, 1996; Worrall et al, 1998). Now that early prophylactic 
removal is proscribed and Md3M are retained for longer, the opportunity for Md2M 
DCC to develop is established and an increase in frequency is observed in patients 
who are consequently older. 
For patients with MAMd3M, the mean age of patients with pericoronitis was 25.5 years 
compared with 30.6 years for C&RD (P<0.0001; d.f. 149, F=21.8) and 32.8  years for 
Md2M DCC (P<0.0001; d.f. 243, F=74.5). Likewise, for HORZMd3M, the mean age 
for patients with pericoronitis was 27.5 years and was lower than for both C&RD 
(mean age 31 years.  p=0.012; d.f. 98, F=6.55) and for Md2M DCC (mean age 32.1 
years. p=0.0026; d.f. 95, F=9.57). The significant difference in mean age of patients 
with pericoronitis endorses that pericoronitis is principally a disease of younger 
patients and is seen relatively soon after failed eruption of the Md3M (Figures 4.3 and 
4.7). 
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Based on the master database, 55% of all MAMd3M are removed before the age of 30 
years of age with pericoronitis being the most common indication for their removal 
(49%). In comparison, Md2M DCC accounts for 27% of all MAMd3M in the under 30s 
but 65% in the over 30s age groups. Pericoronitis accounts for only 10% of all 
MAMd3M removed in the over 30s with the majority of these being in the 30-34 age 
range (Figure 4.5). C&RD accounts for approximately 15% of all MAMd3M requiring 
removal, however, the frequency of C&RD compared between each of the age cohorts 
remains relatively uniform (range10-20%). This increase in frequency of Md2M DCC 
as patients become older has been suggested previously but these studies either did 
not reflect nor compare with other clinical indications for Md3M removal or that the 
age groups were incomparable (Bruce et al., 1980; Ozeç et al., 2009). It is noteworthy 
that for MAMd3M and HORZMd3M, the frequency of C&RD remains relatively constant 
for each of the age ranges but the frequency of Md2M DCC related to MAMd3M does 
not correspond with this even though both diagnoses are caries related. As patients 
become older, the frequency of Md2M DCC associated with MAMd3M increases. It is 
significant as it suggests that DCC will form on a substantial majority of Md2M 
associated with a retained MAMd3M the longer that they are left. 
The majority of MAMd3M are removed before the age of 30 years primarily due to 
pericoronitis. This substantial loss of MAMd3M leaves an ever-decreasing pool of older 
patients retaining their MAMd3M. However, it is these patients who will potentially 
succumb to the possibility of Md2M DCC. As patients get older, the incidence of 
pericoronitis as the main indicator for MAMd3M removal demonstrates a tapering 
linear decline, whereas a reciprocal linear increase in Md2M DCC is observed as 
patients become older (Figure 4.5). Most patients with a MAMd3M will succumb to 
pericoronitis before the potential of Md2M DCC can be realized but those patients 
who retain their MAMd3M into later life are at significant risk of Md2M DCC 
developing. All partially erupted MAMd3M pose a substantial risk to the Md2M for the 
formation of DCC, the fact that we do not observe it in all cases is due to the fact that 
a significant proportion of MAMd3M are removed before Md2M DCC can occur. In 
contrast the frequency of Md2M DCC associated with HORZMd3M is 9% in total but 
across the older aged cohorts, accounts for approximately 10% of HORIZMd3M 
removed in each of the four age-groups between 25 and 49 years. Unlike with 
MAMd3M there is no increase in frequency of Md2M DCC for patients with 
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HORZMd3M as they become older. This makes predicting the potential for Md2M DCC 
in HORZMd3M problematic compared with the potential with MAMd3M where the 
frequency increases with age. The numbers of patients with HORZMd3M removed due 
to Md2M DCC is relatively small however (16 patients with 18 HORZMd3M removed), 
and a larger patient group dataset would ideally be required to assess this further. 
It has been previously reported that mean DMFT scores of patients with Md2M DCC 
are approximately 50% less than mean DMFT scores for comparable age matched 
control groups when compared with the AHDS 2009 age matched control groups  
(McArdle and Renton, 2006; McArdle et al., 2014).   This suggested that patients with 
low DMFT scores may be more likely to experience Md2M DCC, as low scores 
suggested better oral hygiene; a reduced likelihood of pericoronitis, and consequent 
retention of the MAMd3M into later life. In this study, the mean DMFT scores for 
patients with Md2M DCC were similarly, 50% lower for similar age groups when 
compared with the 2009 ADHS. (ADHS, 2011)  However, for all the main types of 
disease associated with both MAMd3M and HORZMd3M, the mean DMFT scores of 
patients, for similar age groups, was also approximately 50% less than the 2009 ADHS 
(Figures 4.4 and 4.8). 
Good dental health, as measured by DMFT cannot, therefore, be used as a predictor 
of any specific Md3M disease and suggests that all patients with Md3M are at risk of 
experiencing disease rather than implying that patients with better dental health are 
more prone or less prone to third molar disease. Low DMFT scores cannot, therefore, 
be used to refute the possibility of third molar disease occurring.  
The relative incidence of Md2M DCC in patients requiring Md3M removal has been 
reported to be between 4% to 14%  (Brickley et al., 1996; Bruce et al., 1980; Chu et 
al., 2003; McArdle et al., 2018; McArdle and Renton, 2006; Pepper et al., 2017).  
These figures are representative of all types of impaction but disguises the reality as 
approximately 91% of Md2M DCC primarily affects patients with MAMd3M and the 
remaining 9% with HORZMd3M (McArdle et al., 2018).  By including patients with 
other types of Md3M impactions that are not associated with Md2M DCC, its 
prevalence and clinical significance is underestimated. Justifying widespread 
prophylactic removal of all Md3M based upon the apparent small proportion of 
patients (14% of all Md3M) who actually succumbed to Md2M DCC would therefore 
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be inappropriate. However, with 44% of all MAMd3M, and 65% in patients over 30 
years of age being removed due to Md2M DCC then debate is needed for early 
intervention in those patients with MAMd3M. In terms of HORZMd3M, the potential for 
Md2M DCC is still apparent, albeit with a relatively uniform age related prevalence. 
In most Md3M disease, the principal disease that indicates the removal will 
specifically affect the third molar. In such cases leaving the third molar until disease 
occurs may be appropriate but where long-term retention of the Md3M has significant 
detrimental effects on the other important dental tissues, in this case the Md2M, then 
consideration needs to be given in the prevention of DCC forming if there is a 
significant likelihood of it. Watchful waiting and radiographic observation are 
pointless as when the disease has occurred, the opportunity to prevent Md2M DCC 
has been lost (McArdle, 2013; McArdle et al., 2016). 
It is apparent that with an ever-increasing frequency of Md2M DCC in older patients 
that all Md2M with an associated MAMd3M or HORZMd3M are at risk of DCC. If the 
potential for this disease to occur is significant then it re-opens the debate for early 
intervention and the prophylactic removal of impacted Md3M; in particular, the 
MAMd3M.  
The results of this study suggest that the ability to qualify and quantify the relative 
risks of Md2M DCC for patients is becoming more predictable. NICE relies upon 
outcomes of RCTs to determine policy however this level of evidence cannot exist to 
support nor refute prophylactic Md3M removal as the use of RCTs in measuring the 
outcome of Md3M retention would be unfeasible and unethical (Ghaeminia et al., 
2016; NICE, 2000; Song et al., 2000).  Consequently, there is a lack of acceptable 
evidence to NICE that offers any support for or against prophylactic removal.  Case 
series studies such as these are often discarded due to potential bias however they are 
the best evidence available and should not be considered as bad evidence. 
NICE’s guidance advises against the removal of disease free impacted third molars 
stating that there is no reliable evidence to support any health benefit. (NICE, 2000)  
It is apparent that the available evidence suggests that there is an oral health detriment 
associated with the retention of MAMd3M in particular and the formation of Md2M 
DCC. With such a detriment outcome as this then the decision to be made is to either 
accept the potential and deal with it when it occurs or intervene before it is realised. 
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Md2M DCC is a significant oral health impairment due to a retained MAMd3M and 
with its development resulting in the loss of 40% of Md2M is significant (McArdle et 
al., 2016).   Early intervention may involve removal of the third molar or where risk 
of inferior dental nerve injury is apparent consideration may be given to prophylactic 
coronectomy, or no treatment at all. 
 
4.6 Conclusion 
NICE’s policy has resulted in patients who require third molar removal becoming 
older, on average, than previously reported. The number of patients requiring third 
molar removal has increased beyond the levels pre-NICE and, moreover, the spectrum 
and frequency of Md3M disease has also changed with Md3M caries and Md2M DCC 
becoming a more frequently reported finding  (Adeyemo et al., 2008; McArdle et al., 
2018; McArdle and Renton, 2012; Toedtling et al., 2016). 
Md2M DCC has become the most common indication for the removal of partially 
erupted MAMd3M (McArdle et al., 2018).  It is a disease mainly of patients over the 
age of 30 years. All patients with partially erupted MAMd3M and HORZMd3M are 
susceptible to Md2M DCC and patients should not be presumed to be at negligible 
risk. Due to the nature of dental caries, Md2M DCC will take a lengthened period to 
develop after failed eruption of the MAMd3M. During this period a significant 
proportion of MAMd3M will succumb to pericoronitis before Md2M DCC can form. 
However, for those MAMd3M that are retained into later life the likelihood is that they 
will be removed due to Md2M DCC. Md2M DCC is preventable if the MAMd3M is 
removed before Md2M DCC becomes established. In terms of the HORZMd3M, the 
frequency appears to remain constant in older age groups but the number of patients 
and HORZMd3M assessed was a relatively small proportion of the total number of 
patients included in the study.  
The evidence suggests that all patients with an asymptomatic partially erupted 
MAMd3M or HORZMd3M are informed of the relative risks related to the long-term 
retention of their impacted third molars and that consideration is given to early, 
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The established definition of Md2M DCC is a carious lesion which forms on the distal 
cervical root surface of the second molar which can then progress through the structure 
of the tooth and eventually invade the pulp chamber with consequent dental abscess 
formation (McArdle and Renton, 2006; Oderinu et al., 2012).  It is typically seen in 
association with MAMd3M teeth that impact against the distal aspect of the Md2M but 
is also seen with horizontal impactions to a lesser extent. The impaction of the 
MAMd3M against the Md2M results in two contributory factors to the development of 
DCC in the Md2M.  
 
In the normal anatomical relationship, the interproximal alveolar septal bone between 
two adjacent teeth should be found just below the amelo-cemental junction of each 
tooth. Generally, the amelo-cemental junction of adjacent teeth will be at the same 
vertical height as each other resulting in the interproximal bone forming a vertical 
pillar to the level commensurate with the amelo-cemental junction (Figure 5.1). 
However, mesial and horizontal impactions of Md3M disrupts this relationship 
resulting in the mesial amelo-cemental junction of the Md3M sitting at a more inferior 
vertical level than the second molar’s. The interproximal bone cannot maintain its 
normal interproximal relationship and anatomically has to adapt between the two 
teeth. This consequently results in the bone settling at a lower level on the distal Md2M 
root surface to accommodate the mesial amelo-cemental junction of the Md3M at a 
lower vertical plane. Consequently, the aberrant relationship between the two teeth 
results in a deficient gingival collar around the distal aspect of the Md2M which, in 





Figure 5.1. Relationship between interproximal alveolar bone to 
amelocemental junction of teeth. 
 
 
Legend: This image highlights the normal interproximal bone level between the first and the second 
molar and the irregular interproximal bone level between the second and the third molar. Note the 
reduced bone level distal to the second molar resulting in exposure of its distal root surface. The bone 
level around the mesial aspect of the third molar is at its amelocemental junction. 
 
Secondly, the anatomical relationship of the two teeth creates a location that is difficult 
to clean with the resultant preferential risk of formation of cariogenic bacterial plaque 
in the interproximal space. The exposed cementum and dentine of the distal root 
surface of the Md2M is less resistant to the effects of cariogenic plaque acid than 
enamel which causes caries to form on the exposed distal root surface of the Md2M. 
The presence of DCC on the Md2M necessitates the removal of the third molar tooth 
to facilitate the restoration of the second molar. In certain cases, however, the second 
molar may be unrestorable and extraction of this tooth may also be indicated. 
Impacted, partially erupted MAMd3M that contact the second molar in the region of 
the amelo-cemental junction, place the Md2M at risk of developing DCC 
(FDSRCS(Eng), 1997; Knutsson et al., 1996; McArdle and Renton, 2006; van der 
Linden et al., 1995). 
 
Interproximal bone level of 
Md3M just below level of AC 
junction. 
Distal bone level of Md2M more 
inferior than mesial level, exposing 
distal root surface.
Interproximal bone level 
between Md1M and Md2M 
just below level of AC 
junction 
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In relation to disease associated with impacted third molar teeth, Md2M DCC occurs 
later in life compared with pericoronitis and is a consequence and complication of 
retention of an impacted Md3M tooth (McArdle and Renton, 2006; Falci et al., 2012; 
Chang et al., 2009; Ozec et al., 2009).  It has not been seen in the absence of an 
impacted third molar tooth and has not been seen with other impactions such as 
vertical, disto-angular or ectopic impactions. Md2M DCC is seen primarily in patients 
with retained MAMd3M teeth and accounts for the majority of all cases of Md2M DCC 
with HORIZMd3M accounting for a small proportion (McArdle and Renton, 2006; 
McArdle et al., 2014; McArdle et al., 2018). 
 
In 2006, the salient features of patients with DCC in the second molar due to the 
presence of a mesio-angular impacted third molar were defined (McArdle and Renton, 
2006). The main characteristics of these patients were that they tended to be 5-years 
older than the average age of patients undergoing third molar removal and that they 
had better dental health than the average for grouped age cohorts compared with the 
1998 ADHS (McArdle and Renton, 2006). It was suggested that patients presenting 
with Md2M DCC did so because they had not experienced any significant Md3M 
disease, such as pericoronitis, earlier in life that would have indicated the removal of 
the Md3M. Consequently, the retention of the Md3M preserves the unfavourable local 
anatomical environment which facilitates the formation of Md2M DCC.  
 
5.1.1 Aims 
As part of this thesis a cohort of patients with Md2M DCC was collated over a 2-year 
period (cohort 2013) and was compared with the results from a previous preliminary 
cohort of patients from an earlier study in 2005 (cohort 2005) (McArdle and Renton, 
2006). The evaluation and comparison of ‘cohort 13’ of patients with ‘cohort 2005’ 
was reported in 2014 (McArdle et al., 2014). This paper corroborated the findings 
from McArdle (2006) in that patients with Md2M DCC tended to be older, had better 
dental health and that Md2M DCC was associated primarily with a MAMd3M 
(McArdle et al., 2014; McArdle and Renton, 2006).   
 
This aim of this chapter was to assess the characteristics of patients from ‘cohort 13’ 
with a third cohort of patients with Md2M DCC (‘cohort 15’) identified from the 
master database of 1011 patients who had Md3M removed. 
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5.1.2 Ethics  
The local ethics committee of KCL Dental Institute was approached for advice 
regarding the need for ethical approval and as data collection would neither identify 





Two cohorts of patients (‘2013’ and ‘2015’) who had Md3M teeth removed due to 
Md2M DCC were collated and evaluated over two individual and separate time 
periods, then compared with each other and subsequently combined together to form 
a single cohort.  
 
For ‘cohort 2013’, 239 patients who had Md3M removed due to Md2M DCC were 
evaluated. Data were prospectively collected over a 24month period independently 
and prior to the collation of the master database of patients. The variables recorded 
were; age, gender, eruption status of the Md3M, DMFT score and Md3M angulation. 
Data was recorded directly onto an Excel spreadsheet on a smartphone then analysed. 
 
Patients included in ‘Cohort 2015’ were identified from those patients in the master 
database of 1011 patients assessed for Md3M removal. From this, 163 patients were 
identified who had had Md3M removed due to Md2M DCC. Data was originally 
collected prospectively over a 24 month period. The variables recorded were; age, 
gender; eruption status of the Md3M, DMFT score and Md3M angulation.  
 
DMFT score was used as a basic measure of dental health as it is easily calculated 
with direct reference to the patient and relevant radiographs. In the calculation of 
DMFT, all teeth demonstrating dental decay, a dental restoration, or if the tooth was 
missing were included in the total, however the Md2M was excluded from the 
calculation if DCC was the only lesion associated with the tooth. The rationale behind 
this was identify patients whose DMFT would otherwise have been zero and that the 
DCC would not have otherwise formed had it not been for the influence of the 
impacted Md3M.   
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For cohort 2013, the mesial angulation of the third molar tooth was calculated by 
measuring the angle of intersection between the mandibular occlusal plane and the 
occlusal plane of the third molar: this angle being synonymous with the mesial 
inclination of the third molar relative to the vertical plane of the second molar (Figure 
5.2) (McArdle and Renton, 2006). For ‘cohort 15’, the angulation was defined 
empirically as either mesio-angular or horizontal (see chapter 3, Figure 3.1). 
 
Figure 5.2  Calculating mesial angulation of the Md3M for ‘cohort 13’. 
 
Legend: This image demonstrates the method of calculating the mesial inclination of the Md3M for 
‘cohort 13’. The angle of intersection of the mandibular occlusal plane and the occlusal plane of the 
Md3M is equal to the mesial inclination of the Md3M relative to the vertical inclination of the Md2M. 
The method of calculating the angle of impaction is analogous with that shown in figure 3.1. 
 
5.1.2 Statistical analysis. 
The sample and outcome characteristics were summarised using descriptive statistics. 
Sample means, number, range and standard deviation of age were calculated for each 
cohort. Sample means, number, range and standard deviation were calculated for 
DMFT for age matched groups. The mean age of the two cohort groups presenting 
with Md2M DCC were compared using one way ANOVA.  In addition, the mean 
DMFT was compared with the 2009 ADHS for significance using one way ANOVA. 
The comparison of Md2M with DCC, and the Md3M angulations of impaction were 
carried out using Z test for proportions Statistical significance was assumed at 5% 
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level and the analyses were carried out using SPSS version 23.0 and MedCalc online 
software. 
 
5.2 Results ‘cohort 2013’ 
For ‘cohort 2013’, there were 239 patients in total, 143 males and 96 females (60:40, 
M:F ratio). A total of 288 Md3Ms were extracted due to DCC in the Md2M. 190 had 
DCC in a single Md2M and 49 had DCC in both Md2Ms (bilateral disease). There 
were 144 left-sided Md3M and 144 right-sided Md3M removed.  
 
The mean age of this group of patients was 32.1 years (range 20-65 years, SD 7.85 
years). Dental health was measured by calculating the compensated DMFT score 
(decayed, missing or filled teeth): 161(67%) patients had a DMFT score of 5 or less; 
56 (23%) between 6-10, and 22 (9%) patients with a DMFT score of 11 or more. Of 
note, 50 (21%) patients had a compensated DMFT score of 0 (zero) where the only 
carious lesion was the DCC lesion associated with the second molar tooth. For patients 
aged 15-24 years, the mean DMFT was 2.6 (SD 3.5, n=24); for patients aged 25-34 
years, the mean DMFT was 3.6 (SD 3.7, n=143); for patients aged 35-44 years, the 
mean DMFT was 5.9 (SD 4.9, n=49); for patients 45-54 years, the mean DMFT was 
6.4 (SD 4.5, n=20); and for 55-64 years the mean DMFT was 6 (SD 3.7, n=3) (Figure 
5.3). 
 
Clinically all 288 Md3Ms were partially erupted. Radiographic evaluation established 
that all were in contact with the second molar tooth at, or close to, the amelo-cemental 
junction and the majority were mesio-angularly impacted against the second molar. 
Angulations of the third molar were grouped accordingly: 255 (89%) had a mesial 
angulation of between 400 and 800, 28 (10%) a mesial angulation less than 400, and 5 
(1%) greater than 800; this latter angulation being essentially horizontal. 
 
5.3 Results ‘cohort 2015’ 
163 patients who had Md3M due to Md2M DCC were identified from the master 
database of 1011 Md3M patients. Of these, 102 were males and 61 were females (3:2, 
M:F ratio). Of these 163 patients, 128 patients had DCC in a single Md2M and 35 had 
DCC in both Md2Ms (bilateral disease). A total of 198 Md3Ms were extracted due to 
DCC in the second molar - 97 left-sided and 101 right-sided.  
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The mean age of this group of patients was 32.7 years (range 21-55 years, SD 7.29 
years). Dental health was measured by calculating the compensated DMFT score 
(decayed, missing or filled teeth): 104 (64%) patients had a DMFT score of 5 or less; 
40 (25%) had a DMFT score between 6-10, and 19 (12%) patients with a DMFT score 
of 11 or more. Of note, 34 (21%) patients had a compensated DMFT score of 0 (zero) 
where the only carious lesion was the DCC lesion associated with the second molar 
tooth. For patients aged 15-24 years, the mean DMFT was 3.4 (SD 5.1, n=13); for 
patients aged 25-34 years, the mean DMFT was 3.5 (SD 3.5, n=97); for patients aged 
35-44 years, the mean DMFT was 6.2 (SD 4.1, n=40); for patients 45-54 years, the 
mean DMFT was 8.8 (SD 4.6, n=11); and for 55-64 years the mean DMFT was 8 (SD 
6, n=2) (Figure 5.3).  
 
Clinically all 198 Md3Ms were partially erupted. Radiographic evaluation established 
that all were in contact with the second molar tooth at, or close to, the amelo-cemental 
junction. 180 (90%) Md3M were classified as mesio-angularly impacted against the 
second molar and 18 (10%) classified as horizontally impacted. 
 
Comparisons of the two groups of patients with Md2M DCC demonstrated a similar 
profile. The mean age of patients presenting with Md2M DCC was similar 32.2 years 
and 32.7 years respectively (one way ANOVA p=0.4392), with the majority of patients 
with Md2M DCC associated with a MAMd3M (comparison of proportion of each cohort with 
MAMd3M associated with Md2M DCC p=0.0393).  DMFT scores of both cohorts were 
compared with each other and with the 2009 Adult Dental Health Survey (Figure 5.3).  
 
The Adult Dental Health Survey of 2009 published data on the average number of 
sound, unrestored teeth of patients within given age groups, whereas previous Adult 
Dental Health Surveys had published the average DMFT scores for patients (ADHS, 
2000; ADHS 2011). Email communication with the Office of National Statistics and 
the authors of the 2009 ADHS confirmed that the calculation of average DMFT scores 
based on the results of the 2009 ADHS could be calculated by subtraction of the 
average value for sound, unrestored teeth from 32; the number of teeth within a fully 
dentate individual (Triffit, 2012). Variability exist with the calculation of DMFT 
scores as some authors either exclude or include third molars from the calculation of 
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DMFT. Agenesis of third molars is commonplace and their inclusion in calculating 
DMFT can result in potential overestimation and bias.  DMFT scores for each of the 
2013 and 2015 cohorts were calculated excluding the third molars. The ADHS 2009 
report does not report the standard deviation associated with the calculation of the 
sound teeth but does calculate standard error. Standard deviation can be calculated by 
multiplying the standard error by the square root of the population number (ADHS, 
2011). The DMFT values as calculated from the ADHS 2009 confirmed that for 
patients aged 15-24 years, the mean DMFT was 6.1(SD 4.6, n=650); for patients aged 
25-34 years, the mean DMFT was 8.3 (SD 6.9, n=910); for patients aged 35-44 years, 
the mean DMFT was 11.9 (SD 8.9, n=1280); for patients 45-54 years, the mean DMFT 
was 16.9 (SD 8.7, n=1200); and for 55-64 years the mean DMFT was 20.1 (SD 7.5, 
n=1160). 
 
Data from the 2009 ADHS reports age in cohorts of 10 years. The mean DMFT of 
patients from each cohort was calculated for similar age ranges to allow comparison 
with the 2009 ADHS. The mean DMFT scores for each of the two Md2M DCC cohorts 
were comparable with each other and both were approximately 50% less than the 




Figure 5.3. Comparison of mean DMFT scores of each Md2M DCC cohort 
with the ADHS 2009. 
 
 
Legend: This graph illustrates the mean DMFT scores of patients in each of the two Md2M DCC 
cohorts (2013 and 2015) compared with the 2009 ADHS. It can be seen that the mean DMFT of each 
of the Md2M DCC cohorts are comparable with each other and are approximately 50% less than the 
mean DMFT scores of comparable aged patient cohorts from the 2009 ADHS. (Standard Deviation 
bars illustrated for mean DMFT, see text for values). 
 
5.4 Combined cohorts 2013 and 2015. 
 
Both cohorts of patients with Md2M DCC were combined to create a pooled cohort 
of 402 patients collected over a 4 year period: 245 males and 157 females (6:4,  M:F 
ratio) having a total of 486 Md3M removed due to Md2M DCC. 318 patients had a 
single Md3M removed due to Md2M DCC and 84 patients had bilateral Md2M DCC 
requiring the removal of a further 168 Md3M. A total of 463 Md3M were mesio-
angular impacted (95%) and 23 Md3M were horizontally impacted (5%).  The 
combined mean age was 32.4 years (range 20-64 years, SD 7.64 years) and the 
combined cohort’s mean DMFT scores were calculated based on 10 year age ranges 
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was 2.8 (SD 4.2, n=37); for patients aged 25-34 years, the mean DMFT was 3.6 (SD 
3.7, n=240); for patients aged 35-44 years, the mean DMFT was 6 (SD 4.6, n=89); for 
patients 45-54 years, the mean DMFT was 6 (SD 4.6, n=31); and for 55-64 years the 
mean DMFT was 6.8 (SD 5.5, n=4) (Figure 5.4). 
 





Legend: This graph illustrates the mean DMFT of the combined Md2M DCC cohorts (2013 and 2015) 
– total of 402 patients, compared with the 2009 ADHS. It can be seen that the mean combined DMFT 
of both the Md2M DCC cohorts are approximately 50% less than the mean DMFT scores of comparable 
aged patient cohorts from the 2009 ADHS, (p<0.0001). Suggesting that patients with Md2M DCC have 
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Distal cervical caries in the Md2M has not been reported in isolation without the 
influence of an impacted Md3M tooth (McArdle, 2014). DCC is not, however, 
exclusive to the Md2M. DCC has been observed on the distal root surface of maxillary 
second molar teeth (Mx2M) in association with mesial impacted maxillary third molar 
teeth MAMx3M that are partially erupted. Variants of DCC also exist with other teeth 
were impaction of a tooth causes exposure of the root surface of adjacent teeth. 
Examples of this can be seen with the lingual or palatal impaction of second pre-molar 
teeth and the resultant root exposure of the adjacent first premolar and molar teeth.  
 
Md2M DCC is not seen in isolation. It does not form in the absence of an impacted 
Md3M tooth. Although caries is caused by demineralisation of the dental hard tissues 
by acid production from bacterial plaque, it is the impaction of the Md3M which 
creates a local site unamenable to adequate oral hygiene with resultant bacterial plaque 
accumulation and consequent insult to the distal root surface of the Md2M. 
 
Although caries can form on the distal aspect of any tooth, DCC is distinct in that its 
location is observed at the amelo-cemental junction of the tooth. It is essentially distal 
root caries brought about by the exposure of the distal root surface due to the impaction 
of the Md3M and the inaccessibility for oral hygiene. Md2M DCC is unique and does 
not develop in the absence of the impacted third molar. Concern has been raised that 
in other studies, radiographic cervical burnout artefact may be misdiagnosed as DCC 
resulting in a higher reported incidence (Allen et al., 2009; Littler, 1997). For this 
thesis’ databases, patients whose radiographic images suggested cervical burnout 
artefact were excluded as a diagnosis of Md2M DCC (Figure 5.5). Removal of such 
teeth may still have been undertaken either due to other concomitant clinical 
indications or when patients elected to have their third molar removed to eliminate the 








Figure 5.5. MAMd3M with radiographic burnout of the distal cervical area of 
the Md2M. 
 
Legend: This figure demonstrates an impacted MAMd3M associated with a Md2M that has radiographic 
burnout of the distal cervical area, with the potential to be misinterpreted as Md2M DCC. 
 
 
5.5.1 Md3M Angulation. 
The angulation of the third molar is a significant factor associated with the risk of 
developing DCC in the second molar. This type of second molar caries is seen 
primarily in association with mesio-angular impacted third molars and, as 
corroborated by other studies, a mesial angulation, is the most common (Allen et al., 
2009; Chang et al., 2009; Falci et al., 2012; McArdle and Renton, 2006; Oderinu, et 
al., 2012; Ozeç et al., 2009).  The combined cohorts of patients with Md2M DCC 
accounted for a total of 486 Md3Ms extracted; 463 (95%) of these had a mesial 
angulation and 23 (5%) had a horizontal angulation. These features concur with other 
authors published work however some authors have documented Md2M DCC in 
conjunction with vertical and disto-angular impactions (Allen et al., 2009; Chang et 
al., 2009; Falci et al., 2012; Oderinu et al., 2012; Ozeç et al., 2009; Syed et al., 2017; 
Toedtling et al., 2016). Toetdling (2016) identified patients with other angles of 
impaction, such as vertical impactions, with distal caries on the Md2M (Toedtling et 
al., 2016).  Teotdling’s study, however, included patients with both Md2M DCC and 
with interproximal caries between the Md2M and the Md3M. Toetdling incorporated 
these together and described the condition as distal surface caries (DSC), however, 
Radiographic burnout of distal 
cervical area of Md2M.
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whereas Md2M DCC is exclusive to the Md2M and impacted Md3M, interproximal 
caries is not. Interproximal caries can be seen in relation to any two teeth with a 
proximal enamel contact. Syed et al, (2017) also reported on 979 patients’ OPGs with 
impacted Md3M teeth and noted that 39% of patients displayed radiographic evidence 
of distal caries on the Md2M (Syed et al., 2017).  Impacted MAMd3M accounted for 
60% of patients with Md2M distal caries, with 24% horizontal, 11% vertical, and 3% 
disto-angular impactions. In addition, Falci (2012) reported that DCC was seen in 
vertical impactions in addition to both mesial and horizontal impactions (Falci et al., 
2012).  It is not evident whether any these studies differentiated between DCC and 
interproximal caries as separate entities or combined them in the manner of Toetdling. 
These published papers, unfortunately, only demonstrate clinical images of Md2M 
DCC with MAMd3M but no images of Md2M DCC with vertical or disto-angular 
Md3M. In one other study by Raheem (2015) demonstrated HORIZMd3M to be the most 
common impaction related to Md2M distal caries however numbers of radiographs 
investigated were small (Raheem, 2015). None the less the MAMd3M is by far the most 
commonly reported type of impaction related to the formation of Md2M DCC. 
 
5.5.2 Male:Female ratio 
Both 2013 and 2015 cohorts demonstrated a comparable male:female ratio of 
approximately 3:2 and other studies of Md2M DCC have generally reported a similar 
ratio and predilection towards male predominance (Silva et al., 2015; Syed et al., 
2017).  From the master database of all indications for Md3M removal the ratio of 
male to female demonstrates a reverse predominance of females to male of 3:2. Other 
studies of third molar removal also demonstrate a predominant ratio of female to male 
(Knutsson et al., 1996; Liedholm et al., 1999).  The reason why more males appear to 
be affected by Md2M DCC may be speculative and more complex to translate. From 
the master Md3M database the mean age of patients presenting for Md3M removal is 
32.4 years, however the mean age of males presenting is 35.2 years and for females it 
is 31 years. In general, females do have a tendency to interact with health professionals 
early, whereas, males have a tendency to delay interaction with medical professionals 
regarding health issues. Pericoronitis is a disease which presents early for patients and 
mild symptoms may make females more likely to interact early with dentists than 
males. Consequently, as demonstrated by the mean ages of male and female patients, 
removal may be undertaken at an earlier age for females before patients can develop 
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Md2M DCC. Males tendency to delay or avoid presentation may disadvantage them 
in that they appear to retain their Md3M and are older when they present and more 
likely that Md2M DCC will be their diagnosis.  
 
5.5.3 DMFT scores 
Both the 2013 and the 2015 cohorts of patients had comparable mean DMFT scores 
for each age group. When compared independently and collectively with the 2009 
Adult Dental Health Survey, the mean DMFT score for patients with DCC was 
approximately 50% less than the mean score for comparable age groups in the general 
population (Figures 5.3 and 5.4 p<0.0001). (ADHS, 2011)  This corresponds to a 
previous study in 2005, that was based on the 1998 ADHS in which the mean DMFT 
was also approximately 50% less than comparable age groups (ADHS, 2000; McArdle 
and Renton, 2006).  
 
This data suggests that patients with better dental health, as measured by DMFT score, 
will possibly retain a partially erupted third molar later into life and, in the case of 
MAMd3M or HORIZMd3M, risk the development of Md2M DCC (McArdle and Renton, 
2006).  It also contradicts the notion that susceptibility to Md2M DCC is solely 
associated with an increased susceptibility to dental caries (FDSRCS(Eng), 1997; 
Knutsson et al., 1996; van der Linden et al., 1995).  It would be logical to assume that 
people with low DMFT scores have a good standard of oral hygiene that contributes 
to oral hygiene maintenance of the coronal aspect of the partially erupted third molar 
thus minimising the likelihood of pericoronitis occurring. Minimising the potential for 
pericoronitis would likely result in the longer term retention of the third molar. 
Moreover, in the case of a MAMd3M, with exposure of the distal cervical root of the 
second molar to the oral environment, DCC would be one potential outcome. DCC, 
however, appears to develop in older patients and this may be may be reflected in the 
latent time period that it takes for dental caries to form compared to the development 
of pericoronitis post-eruption of the third molar (McArdle et al., 2018; McArdle and 
Renton, 2006; McArdle and Renton, 2012). 
 
The significance of better dental health and its association with Md2M DCC and an 
impacted Md3M may be explained by the general improvement in dental health over 
the last 40 years. Shepherd (1994a) speculated that there would be an increase in the 
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number of patients requiring Md3M removal in the latter half of the 20th century and 
beyond as the influence of better dental health and well-being becomes established 
(Shepherd, 1993; Shepherd, 1994a).  Dental health prior to the 1970/80s was generally 
poor, however, with the introduction of fluoride dentifrice, better dental attendance 
and an improved attitude to dental health, patients and the professions attitude to 
patients resulted in less teeth being extracted. The early extraction of permanent first 
molar teeth in children was common and resulted in consequent mesial drift of the 
second molar which in turn gave space for the unhindered eruption of the third molar. 
As a more conservative approach became established, the restoration and retention of 
molar segments became the norm which in turn will have increased the rate of 
impacted of Md3M teeth (Shepherd, 1993; Shepherd, 1994a). 
 
5.5.4 Mean age 
The mean age of patients presenting with Md2M DCC is 32.4 years and is equivalent 
to the mean age of patients having Md3M removed as calculated from the master 
database and from HES data of patients having third molar surgery in the UK: 32 years 
(HES, 2018; McArdle et al., 2018;  McArdle and Renton, 2012).  It had previously 
been suggested that the average age of patients with Md2M DCC tended to be 5 years 
older than average compared with the mean age all patients undergoing third molar 
removal. This observation was made from comparison with third molar removal in the 
mid 1990’s and reflected studies that included a significant proportion of patients who 
had prophylactic third molars removed in a younger age group (Brickley et al., 1996; 
de Boer et al., 1995; Nordenram, et al., 1987). In the UK, the mean age of patients 
undergoing third molar removal in the early 1990s was 25 years, however, the mean 
age of third molar patients has steadily increased over the last 30 years and is now 32 
years (HES, 2018; McArdle et al., 2018; McArdle and Renton, 2012).  The mean age 
of all patients has increased primarily due to the introduction of third molar clinical 
guidance by NICE and other stakeholders, such as the Royal College of Surgeons’, 
and the consequent change of professional dogma. Such guidance has resulted in a 
change of practice which has shifted away from prophylactic removal of third molars, 
primarily in younger patients, to removal based on definitive clinical indications 
resulting in the upward change in mean age (NHS Centre for Reviews and 
dissemination, 1998;  McArdle and Renton, 2012; Mettes et al., 2012; SIGN, 2000; 
NICE, 2000). 
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Previously reported data suggests that there is a relationship between the increase in 
the mean age of patients and an increase in the incidence of all third molar related 
caries. As has been discussed in previous chapters, data collection by the NHS HES 
agency does not filter data to allow isolation of caries solely affecting the third molar 
or Md2M DCC attributable to the Md3M DCC. Nonetheless, over the last 30 years, 
as patients have become, on average, older; there has been an increase in the reported 
incidence of caries and related disease, from approximately 7% to 30%: (Figure 5.6) 
(HES, 2018; McArdle and Renton, 2012). 
 
Figure 5.6  Percentage incidence of caries & related disease as main indication 
for third molar removal and mean age increase of patients having 
third molar teeth removed. 
 
Legend: Based solely on HES data from 1995 to 2009, this graph illustrates the increasing annual 
percentage in caries related disease as the primary indication for third molar removal compared with 
the annual increase in the mean age of patients. As the mean age of patients has increased from 28 in 
1995, to 32 in 2009 there has been a corresponding increase in caries related disease from 
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The mean age of this combined cohort of 402 patients with Md2M DCC (32.4 years) 
suggests a similar relationship between increased mean age and the overall increase in 
incidence of third molar related caries and an increasing incidence of DCC in older 
patients (Bruce et al., 1980; McArdle and Renton, 2012).  It has been demonstrated 
that third molar caries & related disease accounts for 27% of all Md3M removed, 
which also re-enforces and corroborates the general increasing trend of third molar 
related caries as suggested by HES and previously reported  (HES, 2018; McArdle et 
al., 2018; McArdle and Renton, 2012). 
Data from the thesis’ main database and reported in 2018, demonstrates that the mean 
age of patients having Md3M removed due to pericoronitis is 27.5 years, 5 years 
younger than average for all patients having Md3M removed (32.4 years) (McArdle 
et al., 2018).  Pericoronitis is still the main clinical indication for Md3M removal and 
accounts for 49% of all Md3M removed and is the major indication for Md3M removal 
in all angles of Md3M impaction apart from MAMd3M where Md2M DCC is the major 
indicator for removal. Pericoronitis accounts for only 32% of MAMd3M removed but 
Md2M DCC accounts for 44% (McArdle et al., 2018).  
Whereas the mean age of all patients has increased, the mean age of patients, based on 
disease, varies as discussed in chapter 3. Patients requiring Md3M removal due to 
Md2M DCC are still 5 years older than patients with pericoronitis affecting Md3M 
teeth requiring removal. Also noteworthy is that the peak percentage frequency of both 
pericoronitis and Md2M DCC is separated by a similar 5 year margin with patients 
between the ages of 25-29 year accounting for 38% of all Md3M removed due to 
pericoronitis (n=698) whereas the peak incidence for Md3M removal due to Md2M 
DCC is in the 30-34 year age group account for 35% (n=198) (Figure 5.7). 
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Figure 5.7. Comparison of the percentage frequency of Md2M DCC and 
Pericoronitis from master database. 
 
Legend: This graph illustrates the percentage frequency of Md2M DCC and Pericoronitis based on 5 
year age cohorts. The peak frequency of pericoronitis occurs between the ages of 25-29 years of age 
accounting for 38% of all Md3M removed due to pericoronitis. The peak frequency of Md2M disease 
occurs between the ages of 30-34 years accounting for 35% of all Md3M removed due to Md2M DCC. 
N=698 Md3M removed due to pericoronitis and N=198 Md3M removed due to Md2M DCC.  
 
The occurrence of DCC in the mandibular second molar in association with impacted 
third molars has become more widely reported and is not isolated to any specific racial 
group (Chang et al., 2009; Falci et al., 2012; Oderinu et al., 2012; Ozeç et al., 2009; 
Raheem et al., 2015; Silva et al., 2015; Syed et al., 2017; Toedtling et al., 2016).  These 
more recent studies have reported the incidence of DCC to be up to 20% in patients 
having third molars assessed, with some reporting an incidence of approximately 40% 
in MAMd3M (Allen et al., 2009; Chang et al., 2009).  Data already published from this  
research demonstrates that Md2M DCC accounts for 14% of all Md3M removed and, 
as mentioned, accounts for 44% of all MAMd3M removed (McArdle et al., 2018). 
 
Older studies tend to report a younger mean age in the region of 25 years for patients 
undergoing third molar removal with pericoronitis being the most common indication 
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Lysell, 1988; Nordenram, Hultin et al., 1987).  These older studies were published at 
a time when prophylactic removal in younger patients was common thus biasing 
towards a younger mean age for third molar removal. In younger patients, caries, as 
an indication for third molar removal, is relatively low and historically the reported 
incidence of Md2M DCC in younger patient groups has also been relatively low: 2-
5%, if reported at all  (Brickley et al., 1996; Bruce et al., 1980; McArdle and Renton, 
2006).  From the database Md2M DCC is seen infrequently in younger age groups and 
accounts for 5% of all Md3M removed in the patients under the age of 25 years and 
16% in all patients over the age of 25 years. 
 
It can be reasoned that the relative risk of developing DCC on a Md2M is significant 
with DCC now being responsible for a rising percentage of third molars removed  
(Allen et al., 2009; Bruce et al., 1980; Chang et al., 2009; Falci et al., 2012; Oderinu 
et al., 2012; Ozeç et al., 2009; Silva et al., 2015).  Pericoronitis though, is still the most 
common indication for all third molar removal but is diagnosed more frequently in 
younger patient groups (Brickley et al., 1996; Bruce et al., 1980; Knutsson et al., 1996; 
Lysell et al., 1988; McArdle et al., 2018; Nordenram et al., 1987; van der Linden et 
al., 1995).  From the main database 65% off all Md3M are removed due to 
pericoronitis in the under 30s (McArdle et al., 2018). The removal of Md3Ms in 
younger adults due to pericoronitis removes the main contributing factor for DCC of 
the Md2M, specifically the MAMd3M. With the third molar absent the local anatomical 
factors that would contribute to the development of DCC are eliminated thus 
preventing the opportunity for formation of DCC on the Md2M. If pericoronitis were 
not such a common feature of third molar disease in younger patients, then the 
proportion of third molar teeth retained later into life would be greater. As a 
consequence, it had been suggested that the incidence of DCC of the second molar 
will rise accordingly as is the case with the frequency of general caries in relation to 
third molars in older patient groups (Bruce et al., 1980; HES, 2018; McArdle et al., 
2018; McArdle and Renton, 2012). As was demonstrated in chapter 4 the frequency 
of Md2M DCC as the primary indication for the removal of MAMd3M increases with 
age and now accounts for over 60% of MAMd3M removed in the over 30s (McArdle 





In summary, the common features of patients requiring Md3M removal due to Md2M 
DCC are of similar age to all patients having Md3M removed for all indications. 
However, patients are generally 5 years older, on average, than patients requiring 
Md3M removal due to pericoronitis which is the most common indication for all 
Md3M removal. There is a 3:2 predilection for males to present with the condition and 
the majority (95%) of Md2M DCC cases have an associated impacted MAMd3M as the 
main contributing factor, with HORIZMd3M responsible for approximately 5%. Patients 
general dental health as measured by DMFT scores are 50% less than the average for 
comparable age ranges as compared with the ADHS of 2009. However, patients 
requiring Md3M removal have better dental health in general when compared with 
patients from the 2009 ADHS (ADHS, 2011). The frequency of Md2M DCC increases 
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As has been observed, partially erupted MAMd3M are a causal factor in the 
development of DCC on Md2M (Allen et al., 2009; Chang et al., 2009; Falci et al., 
2012; McArdle and Renton, 2006; McArdle et al., 2014; Oderinu et al., 2012; Ozeç et 
al 2009).   As a consequence of DCC formation, treatment of the Md2M, either in the 
form of restoration of the Md2M or removal of the Md2M will be indicated. Moreover, 
the diagnosis of Md2M DCC will require the removal of the Md3M, not only to 
facilitate the restoration of the second molar but also to eliminate the risk of recurrence 
of DCC in the second molar.  
Although the specific treatment of the second molar will be determined by various 
clinical and patient factors, the definitive treatment outcomes for patients with Md3M 
related DCC of the Md2M has not been quantified. This study evaluates the treatment 
outcomes for Md2M teeth affected by DCC in a cohort of patients who had their 
Md3M removed as a consequence of DCC and estimates the relative costs of 
managing this disease.    
6.1.1 Aims  
The aims of this study were to determine the treatment outcomes of the Md2M for 
patients affected by Md2M DCC who had Md3M removed due to DCC of the Md2M. 
In addition, to estimate the number of patients in England who are treated for Md2M 
DCC on an annual basis and to calculate the relative direct and indirect financial costs 
of treating Md2M DCC including the costs Md3M removal.  
6.1.2 Ethics 
The local ethics committee of GSTT NHS Foundation Trust was approached for 
advice regarding the need for ethical approval and as data collection would neither 
identify individual patients nor influence treatment or outcomes, formal ethical 
approval was not required. 
6.1.3 Methodology 
Data from two previous published studies of patients with DCC in 2006 and 2014 were 
combined (McArdle and Renton, 2006; McArdle et al., 2014).  This data identified a 
total of 339 patients who had their Md3M removed due to DCC of the Md2M. Of 
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these 339 patients, 121 patients had contemporary contact details. These patients were 
contacted to ascertain what the treatment outcome was for their Md2M tooth, 
subsequent to the removal of their third molar tooth:  a total of 84 patients responded. 
Treatment outcomes for the Md2M would either be extraction or restoration of the 
tooth. 
To estimate the total number of patients undergoing third molar removal a number of 
datasets were accessed. NHS HES datasets for admitted and out-patient procedures 
were reviewed for 2013/14 (HES, 2018). Procedure codes F0910 and F0930 relate to 
removal of third molar teeth and collectively identify the estimated total number of 
patients undergoing a third molar procedure in the NHS. In addition to codes F0910 
and F0930, which relate solely to third molar procedures, the procedure code F0920 
(removal of impacted tooth) was excluded from the calculation. Code F0920 relates 
to surgical removal of impacted teeth but is non-specific in identifying which specific 
impacted tooth was removed. Although the majority of impacted teeth in the dentition 
are third molars, this code encompasses other impacted teeth such as impacted 
maxillary canines and impacted premolar teeth as well third molars. For this group, 
the mean age of patients was 21 years, suggesting that a significant proportion of 
patients were young and not at an age were third molars would be routinely removed. 
Consequently, this code was excluded from evaluation, however its exclusion may 
result in an under estimation of true numbers of third molar removal (HES, 2018).  
The total volume of patients having third molar removal in hospital secondary care 
with all types of anaesthesia was estimated using HES data and the ratio of patients 
having third molar removal in secondary care from the actual numbers and ratio of 
patients at Guy’s and St Thomas NHS Foundation Trust Hospital (GSTT) having third 
molar surgery undertaken in 2014 (GSTT, 2015). HES data only includes patients who 
have treatment as a day-case procedure under general anaesthesia or sedation as 
opposed to out-patient procedures under local anaesthesia. The number of day-case 
and outpatient procedures was calculated from annual recorded data. The ratio of this 
GSTT data and HES data was used to estimate the total volume of patients having 
secondary care third molar removal in England on an annual basis. 
The volume of patients having Md3M removal in primary care was estimated using 
the last recorded annual data for Md3M from NHSBSA datasets along with the 
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percentage increase in the number of patients having secondary care third molar 
removal, as reported in chapter 2, was used to estimate the volume Md3M removed in 
primary care.  
The estimated total volume of patients in England presenting with Md2M DCC and 
requiring Md3M removal was calculated using these figures along with the percentage 
frequency of Md2M DCC as reported in chapter 3. 
Costs for treatment related to Md3M and Md2M were calculated using NHS national 
tariffs for primary and secondary care, and indirect costs based on UK national average 
earnings. NHS costs were based on 2014 figures and were accessed from the online 
NHS national tariff payment system (NHS, 2014). UK national average earnings were 
based on 2014 figures of the annual survey of hours and earnings available online from 
the Office of National Statistics (ONS, 2014a)  
 
6.2 Results 
Of the 84 patients, 44 were female and 40 were male. All respondents had had a single 
Md3M removed due to Md2M DCC. Of these 84 patients, 38 were from the 2006 
cohort and 46 from the 2014 cohort.  Of the 2006 cohort; 24% of second molar teeth 
had been extracted, 45% were restored and 31% could not recall what treatment they 
had. Of the 2014 cohort: 35% had been extracted, 41% were restored and 24% could 
not recall what treatment they had. In total 26 patients (30%) confirmed that their 
Md2M had either been extracted at the time of third molar removal or subsequent to 
third molar removal; 26 patients (30%) confirmed that they had had the second molar 
tooth restored and that it was still present. A further 10 patients (12%) confirmed that 
they had endodontic treatment of the second molar prior to restoration of the tooth. 22 
patients (27%) could not recall what treatment they had for their second molar and 




Figure 6.1 Reported treatment outcomes for patients with DCC in 
Md2M. 
 
Legend: This graph illustrates the percentage distribution of clinical outcomes for Md2M who had 
Md3M removed due to DCC on the Md2M. 30% of patients were aware that the Md2M had been 
removed; 30% restored; 12% restored including endodontics, with 27% of patients unsure of the 
treatment related to the Md2M (McArdle et al., 2016). 
 
Of the 62 patients who could recall the treatment outcomes for their second molar 
tooth, 26 patients (42%) had their second molar removed, 26 patients (42%) had their 
second molar restored and 10 patients (16%) had their second molar endodontically 






















Treatment outcomes of Md2M teeth with DCC
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Figure 6.2 Known reported treatment outcomes for patients with Md2M 
DCC. 
 
Legend: This graph illustrates the percentage distribution of known clinical outcomes for Md2M who 
had Md3M removed due to DCC on the Md2M. 40% of Md2M were extracted; 40% restored, and 16% 
restored including endodontics (McArdle et al., 2016). 
 
6.3 Discussion. 
The majority of Md2M DCC is related to MAMd3M, which accounts for 90% of all 
cases, whereas a smaller incidence of Md2M DCC is observed with HORIZMd3M. 
Md2M DCC has not been observed in association with vertical, disto-angular, or 
ectopic Md3M impactions and has not been seen in the absence of an impacted Md3M 
(McArdle and Renton, 2006; McArdle et al., 2014). 
Treatment outcomes for patients with Md2M DCC will generally include removal of 
the Md3M to facilitate restoration of the Md2M. Conservative treatment of the Md2M 
may involve uncomplicated restoration of the tooth but in some cases the tooth will 
also require endodontic treatment and more complex and expensive restoration. In 
other cases, it may not be possible to restore the Md2M and removal may be indicated 
either concurrent with the removal of the Md3M; later if restoration of the Md2M 
becomes unfeasible, or ultimately it may, in its own right, fail at a later stage once 
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Known treatment outcomes for patients
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not feasible to restore the Md2M and this tooth is indicated for removal, the Md3M 
may, in some cases, be retained if it is disease free, as removal of the Md3M may be 
clinically meaningless. In the majority of cases of patients with Md2M DCC the 
immediate and long-term prognosis for this tooth is poor and the likelihood of the 
Md2M lasting indefinitely would be guarded. 
Restoration of the Md2M whilst overlooking the need for removal of the Md3M is not 
clinically pragmatic. Retention of the Md3M will make restoration of the Md2M 
difficult and ultimately the Md3M will persist in compromising the Md2M either from 
the risk of secondary DCC or periodontal problems (Figures 6.3). In cases where 
potential Md3M removal will have a significant risk of IDN injury consideration may 
be given to undertaking a coronectomy procedure on the third molar to eliminate the 
casual influence and the potential effect of the third molar (McArdle et al., 2014).   
Retention of the Md3M will not eliminate the compromised anatomical relationship 
between the Md2M and the Md3M, and persistence of the Md3M will still restrict oral 
hygiene and result in subsequent secondary decay on the Md2M.  
 
Figure 6.3  Images of further disease in compromised Md2M. 
  
 
Legend: These images illustrate further Md2M disease associated with MAMd3M. the left-side image 
demonstrates secondary Md2M DCC and periodontal disease as a result of retention of a MAMd3M. 
the right-side image demonstrates a restored Md2M that has been endodontically treated due to an 
impacted MAMd3M with secondary periodontal disease and a poor distal restoration on the Md2M. 
 
 137 
In estimating the cost of DCC, a number of factors need to be considered. The number 
of patients with DCC and the proportion of different treatment outcomes related to 
these patients have to be calculated. In addition, the direct monetary cost of each of 
treatment modality and the indirect costs of treatment need to be quantified. The cost 
of second molar DCC may be more difficult to calculate as, although the loss or 
restoration of a tooth has a financial cost, the ongoing long-term costs of maintenance 
and possible loss will change with individual circumstances. In addition, costs tend to 
be qualified, not only by these direct costs of the intervention, but also by the indirect 
costs for the patient such as loss of patients’ earnings due to time off work, loss of 
productivity due to absence from work and intangible costs such as pain, incapacity 
and compromised occlusal function if the second molar is lost.  
 
6.4 How many patients may be affected by DCC?  
The incidence of caries as an indication for third molar removal has risen from less 
than 10% in 2000 to 30% in 2010 (McArdle, 2013; McArdle and Renton, 2012).  This 
data was extracted from HES online datasets which doesn’t allow caries to be 
categorised independently between caries affecting the Md3M and Md2M DCC as the 
primary indication for Md3M removal.  It has been previously reported that Md2M 
DCC may contribute to between 5% - 40% of all Md3M removed (Allen et al., 2009; 
Bruce et al., 1980; McArdle and Renton, 2006).   These figures, however, may be 
underestimated, and may be increasing as a consequence of the changing practice in 
the management of third molar teeth (McArdle, 2013; McArdle and Renton, 2012; 
Renton et al., 2012).   The mean-age of patients having third molar removal has 
increased from 28 to 32 during this time period also which has been confirmed by the 
results of the study from chapter 2 (McArdle, 2013; McArdle and Renton, 2006; 
McArdle et al., 2014; McArdle and Renton, 2012).   As the mean age of patients has 
increased and the incidence of caries has also increased, and it may be reasonable to 
presume that the rate and incidence of Md2M DCC will also have risen during this 
period. Data from chapter 3 highlights that the combined incidence of caries, C&RD 
and Md2M DCC, now accounts for 41% of all Md3M removed with Md2M DCC 
accounting for 14% of all Md3M removed (McArdle et al., 2018). In terms of patients, 
as opposed to the number of Md3M removed, Md2M DCC accounts for 16% of all 
patients from the dataset of 1011 patients having Md3M removed. Furthermore, DCC 
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is seen predominately related to MAMd3M teeth and consequently the likely incidence 
of DCC solely related to mesio-angular third molar impactions will be substantially 
more (Allen et al., 2009; Chang et al., 2009; Falci et al., 2012; McArdle et al., 2014; 
McArdle and Renton, 2012; Oderinu et al., 2012; Ozeç et al., 2009).  From this 
research, it has been demonstrated that Md2M DCC accounts for 44% of all MAMd3M 
removed and 9% of all HORIZMd3M removed (McArdle et al., 2018). 
Data collection related to third molar removal is deficient in the UK as there is no 
accurate summative record of patients undergoing third molar removal on an annual 
basis (HES, 2018; McArdle, 2013; McArdle and Renton, 2012). In 2005, a new NHS 
General Dental Services contract was introduced and one of the consequences was 
that the NHSBSA no longer recorded any specific data for patients’ treatment in 
primary dental care. Consequently, no data exists for third molar removal in primary 
care since 2004/5. In secondary care, in-patient and day-case activity is recorded and 
published through HES online and since 2004 HES has also published out-patient third 
molar removal as well but HES does not specify if the out-patient data relates to 
treatment undertaken solely under local anaesthesia or with dental chair conscious 
sedation (sic). Historically, and contemporarily, most out-patient third molar removal 
has been recorded as a non-descript, ‘out-patient episode’ and tariffed accordingly  
(HES, 2018).   Consequently, an out-patient appointment for third molar removal 
cannot be differentiated from an out-patient appointment for a review or any other out-
patient treatment. Out-patient third molar removal under local anaesthesia is poorly 
recorded, underestimated and accounts for a significant proportion of secondary care 
third molar activity (HES, 2018).  Nonetheless, using data from online Hospital 
Episodes Statistics (HES) and internal hospital dataset statistics we can estimate the 
volume of third molar removal undertaken on an annual basis.  From HES online it 
was calculated that in 2013/14 there were approximately 67k patients requiring third 
molar removal as an in-patient or day-case hospital admission in England and 16k on 
an out-patient basis (HES, 2018). HES confirms that all out-patient treatment episodes 
only represent a proportion of all third molar activity as third molar removal under 
local anaesthesia within the hospital secondary care setting has generally not been 
recorded as an actual third molar treatment episode (HES, 2018).   
Guys and St Thomas’s NHS Foundation Trust (GSTT) is a large tertiary teaching 
hospital in central London. The Oral Surgery Department undertakes in excess of 
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2,300 patient treatment episodes for third molar removal on an annual basis. GSTT 
datasets, for 2014/15 were reviewed for procedure codes F0910 (surgical removal of 
impacted third molar) and F0930 (surgical removal of third molar).  These determined 
that approximately 1500 patients were admitted for third molar removal under day-
case general anaesthesia or sedation and 800 patients on an outpatient, local 
anaesthetic basis (GSTT, 2015). 
If we consider the oral surgery department of GSTT NHS Foundation Trust to be 
representative of a typical secondary care oral surgery provider in England, and we 
extrapolate the GSTT ratio (15:8) of admitted third molar procedures to out-patient 
procedures and confer this ratio to national figures then based on the figure of 67k 
patients in England who had third molar removal on an admitted basis, then we can 
estimate the total combined volume number of patients in England having third molar 
removal in a secondary care setting. Based on this calculation we can estimate that 
nationally, in England, in the region of 38k patients have third molar removal on an 
out-patient local anaesthesia basis giving an estimated total of 105k patients for 
secondary care activity. These figures are conservative estimates of treatment volume 
and the expectation is that the numbers are more due to inefficient reporting of 




Figure 6.4 Calculation - estimated annual number of patients having third 
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Legend: This figure illustrates the calculation of notional patients having third molar surgery in 
England. Based on the actual figure of 67000 patients having third molar removal on an admitted/day-
case basis and a ratio of 15:8, It is estimated that 38000 patients have third molar removal as an out-
patient – total of 105000 patients/annum. In addition, it is estimate; based on a 72% increase in 
secondary care activity mirrored in primary, care that 48000 Md3M are removed on an annual basis. 
Combined total of 153,000 patients. These data trends suggest that these figures are fluid and that the 
numbers continue to rise on an annual basis.  
 
As stated, the NHS does not now record the number of patients having third molar 
removal undertaken in NHS primary care. The last year for which the NHS Business 
Services Authority (NHSBSA) recorded data was in 2004/5 and in this year, 
approximately 28k Md3M were removed in NHS primary care (NHSBSA, 2006).  
NHSBSA data recorded the actual number of third molar teeth removed as opposed to 
HES which records the number of patients having at least one third molar removed 
(McArdle and Renton, 2012; NHSBSA, 2006). It is not, therefore, possible to calculate 
the true volume of primary care third molar activity, as there are no contemporary 
datasets to make an accurate calculation. However, from 2002/3 to 2013/14 there had 
been increase in day-case hospital based activity of 72% (McArdle and Renton, 2012). 
For England, if the 72% increase in secondary care activity is mirrored in primary care 
treatment in England, then it can be estimated that 48k Md3M are being removed in 
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primary care on an annual basis. This could relate to a minimum number of 24k 
patients having two Md3M removal in a single treatment episode or a maximum 
number of 48k patients who had a single Md3M removed in primary NHS care (Figure 
6.4). The latter figure may be a more accurate estimation as NICE has encouraged the 
removal of only single asymptomatic third molars rather than combining with 
asymptomatic removal. Based on these actual and estimated numbers the minimum 
number of patients having third molar removal in England may, therefore, be in the 
region of 153k patients, however the actual number, in reality, may well be much 
higher (Figure 6.4). 
For secondary care and based on 16% incidence of patients with Md2M DCC and the 
potential total of 105k patients per annum; and for primary care with an estimated 
number of 48,200 patients with 14% of 48,200 Md3M removed, it can be estimated 
that in England, potentially 23.5k patients per annum may now be being diagnosed 
with DCC in a Md2M tooth due to an impacted Md3M (Figure 6.5). In addition, it has 
been reported that approximately 20% of patients with Md2M DCC, as an indication 
for the removal of the third molar, have bilateral DCC (McArdle and Renton, 2006; 
McArdle et al., 2014).   This results in a potential of approximately 27k Md2M teeth 
that may be affected by DCC as a result of an impacted Md3M tooth with 27k Md3M 
being removed as a consequence (Figure 6.5). Based on the outcome data of treatment 
of Md2M with DCC this may result in potentially 11.4k (42%) Md2M being extracted 
and requiring possible replacement; 11.4k (42%) that will require restoration, and 4.2k 
(16%) requiring root canal treatment and restoration (Figure 6.5). In addition, a 
proportion of patients may have complex restorative treatment undertaken then later 
lose the Md2M as well adding to the consequent cost. This proportion of patients is 




Figure 6.5 Calculation - estimated annual number of patients with Md2M 
DCC having third molar surgery undertaken. 
Estimation of 
Md2M DCC 
  Total 
Day 
case/admissions 
16% of 67k patient 
cases (2013/14) 
10,720cases/annum 
(20% bilateral DCC) 
12,864 Md3M/annum 
Out-patient 16% of 38k patient 
cases (2013/14) 
6,080 cases/annum 




14% of 48.2k 
Md3M 
6,750 cases/annum 6,750 Md3M/annum 
  23,550 cases/annum 26,910 Md3M/annum 
 
Legend: This figure illustrates the calculation of patients having third molar surgery due to Md2M 
DCC in England and the estimated number of Md3M removed due to Md2M DCC. 16% of patients 
attending for Md3M removal have Md2M DCC. 14% of all Md3M are removed due to Md2M DCC. 
This variation is due to the fact that 20% of patients have bilateral Md2M DCC when attending. 16% 
of 67,000 patients having third molar removal on an admitted/day-case basis and 16% of 38,000 
patients have third molar removal on an out-patient – accounts for 10,720 patients and 6,080 
patients/annum respectively (16,800). With 20% of these patients having bilateral disease this results 
in a total of 20,160 Md3M removed due to Md2M DCC. In addition, 14% of 48,200 Md3M removed in 
primary care, accounts for 6,750 patients/teeth on an annual basis. Total number of Md3M removed 
due to Md2M DCC approximately 27,000.  Data trends suggest that these figures are fluid and that the 
numbers continue to rise on an annual basis.  
 
6.5 Direct financial costs. 
Due to the idiosyncratic system of funding of NHS treatment in England, the true 
financial cost of treating this disease is difficult to quantify as primary care NHS 
treatment costs are based on courses of treatment rather than the actual service 
provision of a specific item of treatment. Courses of treatment are remunerated on 
units of dental activity (UDAs) which are remunerated at a variable financial rate 
dependent upon the individual dentist’s contract. An UDA can attract a monetary 
value in the realms of £25 per UDA (NHSBSA, 2005). Courses of treatment are 
banded according to relative complexity with restorations and extractions identified 
as band 2 courses of treatment which attract 3 UDAs per course of treatment. More 
 143 
complex treatment requiring a prosthesis will be classed as a band 3 course of 
treatment and attract 12UDAs per course of treatment.  Consequently, based on the 
funding provisions in England, the actual cost of either a simple restoration of the 
second molar or its removal in primary care may be in the range of £75 per case but 
for more complex treatment, including endodontics with a crown/inlay restoration, 
this may be in the region £300 per case (based on rate of £25/UDA) (Steele, 2009). 
For those patients with bilateral disease, treatment of both teeth during a single course 
of treatment will attract a single course of treatment fee so potentially the cost of 
remedial dental treatment for Md2M DCC will be isolated to 23.5k courses of 
treatment. The cost in terms of patients who choose private dental treatment and 
specialist NHS provision will be substantially more, however the calculations related 
to cost are based solely on NHS funding. The permutations of patients’ treatment are 
many and complex. Some patients may have treatment done in a single course of 
treatment and others two courses of treatment. In addition, some patients will have 
more complex and expensive treatment undertaken which will reflect in the overall 
cost. At the one end of the spectrum 23.5k patients affected by Md2M DCC may 
require a single band 2 course of treatment which would cost in the region of £1.7m 
for remedial treatment. At the other end, the cost may be in the region of £3m if those 
requiring endodontic treatment also require a crown to restore the tooth. This type of 
treatment would be in band 3 and attract a larger fee for 12UDAs of remedial 
treatment. Figure 6.6 demonstrates some of the permutations of treatment. 
Accordingly, based on NHS primary service funding, the primary care cost of treating 
Md2M DCC conservatively may be between £1.7m - £3m per annum in England. 




Figure 6.6 Estimated costs of treating Md2M DCC in NHS primary care 
based on 2013/14 estimated figures. 
Treatment outcomes for 
patients with Md2M DCT 
(% proportion) 
 Md2M Extraction 
(early and late) 
Md2M Restoration Md2M endodontics 
and restoration (cost if 
Rx includes crown) 
  42% 42% 16% 
Estimated number of 
Md2M (27,000) in 23.5k 
patients 
 11400 11400 4200 
Unit cost for treatment. 
Primary care £25/UDA  
Band2 = 3UDAs 







Cost for 23.5k band2 
courses of treatment - if all 
patients with bilateral 
disease (20%) are treated as 
a single course of Rx. 
23.5k x £75 
= 
£1.7m 
   
Cost for 23.5k courses of 
treatment – with 84% 
band2 and 16% band3 
course. 
£2.6m £0.75m £0.75m £1.1m 
Cost for 27k band2 courses 
of treatment - if patients 
with bilateral disease 
(20%) are treated as two 
courses of Rx. 
27k x £75 
= 
£2m 
   
Cost for 22.8k band2 
courses of treatment – and 
4.2k band3 course of 
treatment  
22.8k x £75 
+ 
4.2k x £300 
= 
£3m 
   
Total cost for Rx (£1.7m - 
£3m) 
(£3m if all endodontically 
treated and crowned) 
 £0.85m £0.85m £0.3m (£1.3m) 
 
Legend: This figure illustrates the estimated cost of remedial dental treatment of Md2M for patients 
with Md2M DCC.  Based on band 2 course of treatment (£75) and band 3 course of treatment (£300). 
Sample permutations of 23.5k courses of band 2 treatment costing £1.7m. If those patients requiring 
endodontic treatment also have Md2M crown placed (4.2k) then cost at upper limit would be £3m. Total 
cost of remedial treatment £1.7m-£3M 
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In hospital based secondary care the total cost of third molar removal will be in the 
range of £1000 per case for day-case procedures and £400 per out-patient procedure 
as based on the 2014 NHS treatment tariffs (NHS, 2014). These costs are inclusive of 
initial outpatient consultations, radiographs, etc. For patients with Md2M DCC, the 
cost amounts to approximately £10.7m for third molar management under day-case 
[(67k patients x 16% proportion with Md2M DCC – 10,720 cases) x £1000/case = 
£10.7m] and £2.4m for third molar management on an out-patient basis [(38k patients 
x 16% proportion with Md2M DCC – 6,080 cases) x £400 = £2.4m]: A total of £13.1m 
per annum (Figure 6.7).  
Management of impacted third molars in primary care is now being regularly provided 
by primary care based oral surgery specialist services. In NHS primary care, oral 
surgery specialist care costs are in the region of £150-£250 per case (NHS England, 
2014). Unfortunately, the NHS does not calculate the amount or proportion of work 
provided by this group, however if the primary care estimate of 48k Md3M is accurate 
then the volume of primary care Md3M removals due to DCC, may be of the order of 
6,580 cases (14%). This would result in an estimated cost of primary care Md3M 
removal between £1-£1.7m per annum (Figure 6.7). 
 
Figure 6.7 Cost of third molar removal in the NHS based on 2013/14 
estimated figures. 
Costs for third molar 
removal of Md2M 
DCC patients  
    
Day case/admissions 16% of 67k 
cases 
£1,000/case 10,720cases/annum £10.7m 
Out-patient 16% of 38k 
cases 
£400/case 6,080 cases/annum £2.4m 





6,750 cases/annum £1m-£1.7m 
 
Legend: This figure illustrates the calculation of costs for patients having third molar surgery due to 
Md2M DCC in England. The estimated cost of Md3M removal in secondary care is £13.1m per annum 
and for primary specialist care, £1m-£1.7m. A total of £14.1m -£14.8m per annum (2013/14) 
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The loss of the Md2M tooth may not significantly influence masticatory function or 
aesthetics so, consequently, clinical indications to replace this tooth will be limited.  
However, potential over-eruption of the opposing maxillary second molars and patient 
choice to maintain an optimal functional dentition may otherwise indicate replacement 
of the Md2M tooth. Treatment options would exclude conventional bridge-work due 
to the lack of a distal abutment and patients would generally respond poorly to 
replacement with a conventional denture. Consequently, the optimal treatment choice 
for the replacement of the Md2M would be with an implant retained crown. Not all 
patients may be suitable for dental implant treatment but patients with Md2M DCC 
do tend to have better dental health than average and would probably be suitable for 
implant treatment (McArdle and Renton, 2006; McArdle et al., 2014).   Patients, 
however, may also be less inclined to undergo implant treatment due to the 
requirement of further surgery; of potential inferior dental nerve morbidity and the 
time commitment of such a treatment option. It is difficult, therefore, to speculate how 
many patients would wish to replace a Md2M tooth, but with the cost of this treatment 
being, on average approximately £2.5k per implant-retained crown, this treatment 
option could total £28m per annum if all patients (11.4k/annum) who are estimated to 
have lost their Md2M elect to have this treatment. Implant treatment on the NHS is 
generally limited to patients who have lost teeth due to trauma or malignancy, or who 
have missing teeth due to hypodontia or failed orthodontic alignment of impacted 
canines.  
It is unlikely that NHS commissioners would fund the replacement of the Md2M with 
an implant retained crown as the clinical indications for replacement would not fulfill 
NHS implant treatment guidelines. However, patients may become sensitive to the 
fact that the retention of the impacted Md3M has resulted in DCC of the Md2M and 
that early removal could have prevented this from arising.  As awareness of this 
condition and its causes becomes more widespread claims for repair and replacement 
of the Md2M may become commonplace. Patients and medico-legal lawyers may 
perceive a failure to intervene early with the at risk Md2M as supervised clinical 
neglect and argue that loss of the Md2M and consequent function was avoidable had 
the dentist addressed the potential for DCC in the Md2M. As the increase in frequency 
of Md2M DCC has been brought about by the indirect consequences of NICE 
guidance it may be that the NHS will be indirectly liable for these costs. 
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6.6 Indirect financial costs. 
Indirect costs are made up of loss of patient’s earnings and loss of access for other 
patients, however these indirect costs of third molar removal can be more difficult to 
quantify. 
Costs such as loss of patient’s employment productivity and potential loss of earnings 
for patients having to attending for both third molar removal and for remedial dental 
treatment may add another notional £7.4m/annum loss of earnings for time of work 
for third molar surgery and recovery plus £1.5m/annum loss of earnings for the time 
spent on remedial treatment of the second molar (Figure 6.8). The former is calculated 
from the number of patients requiring third molar removal due to DCC (23.5k 
patients/annum), the average recovery period for patients having third molars removed 
(3 days) and the resultant loss of earnings based on the UK average earnings value 
(£27.2k/annum) ref. The latter is similarly calculated from the potential number of 
patients experiencing DCC (23.5k patients/annum with 27k second molars/annum); 
an estimated average of 3 hours/Md2M tooth of a patient’s time to attend the dentist 
for remedial treatment (including traveling time); and the loss of earnings based on 
UK average earnings value (£27.2k/annum) (Mitchell, 2011; ONS, 2014a; Phillips et 
al., 2010).  The financial cost to the economy is more difficult to quantify, however as 





Figure 6.8  Indirect patients cost for treatment of Md2M DCC. 
Indirect costs, national 










Notional 27k Md2M 
to be treated for 
remedial work 
Time off work for 
Md3M surgery 
Average 3 days 
£315/patient 
£7.4m  
Time off work for 
remedial dental 
treatment 




Legend: This figure illustrates the calculation of indirect costs for patients having third molar surgery 
due to Md2M DCC in England. The estimated indirect costs of Md3M removal are £7.4m for loss of 3 
days earnings after Md3M removal and £1.2m for 3 hours loss of earnings of attending the dentist for 
remedial treatment of the Md2M: total of £8.6M (2013/14) 
 
For the dentist, themselves, remedial treatment may require an additional 27k work-
hours/annum.  Treatment for 27k Md2M in 23.5k DCC patients is treatment that is 
potentially avoidable and this treatment time and money should be spent on treating 
other patients. Remedial treatment for Md2M DCC, in effect, diverts resources and 
reduces access for other patients that will still have to be treated. This could be another 
27k courses of band 2 treatment to the work load of the dentist and calculated at £75 
per band 2 course of treatment (calculation based on a notional 30 min clinical time 
for simple band 2 course of treatment at £75 and 27k courses of treatment).  This may 
add a further notional £2m/annum in indirect costs. This should not be considered as 
double accounting, as dentists undertaking treatment for potentially avoidable Md2M 
DCC will still be have to provide access and treatment for other patients’ treatment. 
Overall the potential costs of treating second molar DCC are substantial and could 
potentially eclipse £55m per annum (Figure 6.9).  
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Figure 6.9  Total costs of treating patients with Md2M DCC. 
 Total costings of 
treating patients 
with Md2M DCC 
Actual additional costs of 
managing Md2M DCC 
excluding Md3M management 
Md3M removal £14.1m - £14.8m  
Md2M DCC management £1.3m – £3.1m £1.3m – £3.1m 
Patients’ costs, loss of earnings, etc. £8.6m £1.2m 
Dentist costs, additional work. £2m  
Potential cost of replacing Md2M with 
implant retained crown 
£28m £28m 
Total £54m-£56.5m £2.5m – £32.3m 
 
Legend: This figure illustrates the summary calculation of all costs for patients having third molar 
surgery due to Md2M DCC in England. The estimated total costs inclusive of Md3M removal are £26m 
-£28.5m if implant treatment excluded and £54-56.5m if implant treatment included. The true additional 
costs are £2.5m to £32.3m. (2013/14) 
 
6.7 Supplementary considerations 
NICE guidance has resulted in a change of practice towards managing teeth rather 
than managing patients (McArdle, 2013; NICE, 2000).  NICE proscribes the removal 
of an asymptomatic impacted third molar tooth even when a separate symptomatic 
third molar is being removed.  Patients often have only a single problematic third 
molar removed in isolation whilst other impacted, but as yet asymptomatic, third 
molars are disregarded.  It would seem prudent; therefore, to consider the long-term 
potential of disease from leaving these asymptomatic impacted third molars rather 
than ignoring it to deal with disease in the future. As Md2M DCC is a late presenting 
disease many patients with it may be subjected to multiple treatment episodes for 
individual third molar management over a long-term period rather than a single 
treatment episode for all third molars (McArdle, 2013; McArdle and Renton, 2006; 
McArdle, et al., 2014).  This in itself increases potential costs, as tariffs for third molar 
removal will be based on treatment episodes, irrespective of how many third molars 
are removed. With patients having a potential four third molars this could theoretically 
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translate into four treatment episodes rather than a single, collective treatment episode 
for patients with third molars. Patients who have multiple treatment episodes will 
invariably cost the NHS and other funders more to treat over a lifetime than a single 
treatment episode. An holistic approach, whilst considering the potential for further 
problems of third molars may, in fact, be less detrimental to the patient and save 
money in the long-term (McArdle, 2013).  In terms of the diseased Md2M the 
restoration of the Md2M DCC may only be the start of further restoration, future 
endodontic treatment and eventual removal of the tooth with each and subsequent 
intervention adding to the overall financial burden and pushing up consequential costs 
further. 
All mesio-angularly impacted Md3M teeth pose a risk of DCC to the second molar 
tooth (McArdle, 2019; Toedtling, 2015, Falci et al., 2012).  The risk and consequence 
of Md2M DCC is not always realised as a significant proportion of third molars are 
removed prior to the formation of DCC. As has been shown pericoronitis accounts for 
the majority of Md3M removal in patients who are generally younger than those with 
Md2M DCC. It is those susceptible teeth that are retained later into life that result in 
Md2M DCC formation, hence the apparent small proportion of patients who 
experience the disease. With more patients retaining third molar teeth into the fourth 
decade of life and the incidence of third molar related caries rising then this is a 
situation that will only deteriorate further with more additional costs. By considering 
prophylactic third molar removal in this situation, we are not providing unnecessary 
treatment with an unnecessary financial cost to the NHS or independent funder.  We 
are investing in an intervention that will reduce the global cost for treatment in an 
individual as well as the overall cost for the NHS. If left these patients will cost more 
to treat with mounting ongoing costs. If the risk of Md2M DCC is high, then removal 
of these retained Md3M has a definitive cost-benefit for the patient, the NHS and 




In this chapter, the outcomes of treatment for patients with Md3M related DCC of the 
Md2M and the potential costs for its management have been highlighted. Md2M DCC 
is an avoidable and preventable disease of the Md2M tooth. The risk of DCC forming 
on the Md2M can be eliminated by the removal of the Md3M tooth before DCC occurs 
but this would involve the prophylactic removal of those third molars that pose this 
risk. The cost of preventing DCC on the Md2M tooth would still involve the direct 
and indirect costs of Md3M removal so the actual savings to be made in a management 
model that advocates prevention may be limited to the direct costs of managing the 
Md2M and the indirect costs to the patient in terms of loss of earnings: this would still 
be in the range of £2.5m-£32.3m per annum. Intangible costs such as pain and occlusal 
compromise are more difficult to quantify from a financial perspective. These costs 
are wholly avoidable if the potential for Md2M DCC is identified early and the 
appropriate intervention of Md3M removal is advocated. However, if we continue to 
treat third molar teeth in isolation and only when symptomatic, patients’ long term 
dental health will be compromised rather than consider patients as a whole, then these 
potential multiple treatment episodes will incur further unnecessary costs of multiple 
third molar removal. Potentially, this may, at the worst, double the cost of third molar 
removal for each of these patients by another £20m per annum 
Accepting all the assorted costs, both financial and subjective, of managing Md2M 
DCC as consequence of avoiding early prophylactic removal is inappropriate as this 
underlines a degree in apparent corporate institutional obstinacy. If groups of patients 
are at risk of Md2M DCC then both dentist and patient need to be educated to the risks 
and the relevant treatment options rather than be constrained by NICE guidance. The 
2013 Supreme Court determination on the Montgomery v Lanarkshire Health Board 
determination regarding patients right to being informed of ‘…any material risks’, 
related to an intervention hold as equally as to being informed of the material risks of 
non-intervention (Montgomery, 2015). Patients have the right to know what the 
potential outcomes of third molar retention are. Patients at risk of Md2M DCC should 
be informed of this potential and allowed to decide if their impacted third molar teeth 










The mean age of patients requiring third molar removal has risen steadily from 26 
years in the early 90s through to 28 years by the turn of the century and for the last 10 
years has been 32 years.  
As the mean age of patients has increased, the frequency of ‘caries & related disease’ 
has also increased. Pericoronitis is still the most common disease indicating the 
removal of impacted mandibular third molars in 49% of cases. Based on HES figures, 
‘caries & related disease’ has increased in frequency as an indication by over 300%; 
from approximately 7% of patients prior to the introduction of NICE guidance to 30% 
of patients in 2010. In this data set 41% of mandibular third molars are removed due 
to caries and related disease.  
Over the last 20 years distal cervical caries of the mandibular second molar has 
become a more frequent diagnosis and accounts for 14% of all mandibular third molars 
requiring removal. Distal cervical caries is only seen in association with mesio-angular 
and horizontal mandibular impacted third molars; accounting for 9% of horizontal 
impacted mandibular third molars and 44% of all mesio-angular impacted mandibular 
third molars. It is not seen in the absence of an impacted mandibular third molar. 
Distal cervical caries is more commonly seen in patients over the age of 30 years with 
the incidence of distal cervical caries associated with mesio-angular mandibular third 
molars increasing with age whilst pericoronitis decreases. For patients between the 
age of 20-29 years of age, 30% of mandibular third molars are removed due to distal 
cervical caries. For patients 30-39 years, the incidence is 62% and for patients 40-49 
years, 70%. Pericoronitis in contrast accounts for 46% in the 20-29 year range, 13% 
in the 30-39 year range and 0% in the 40-49 year range.  
In relation to patients requiring removal of mesio-angular impacted mandibular third 
molars, the mean age of patients with a diagnosis of pericoronitis is 25 years; 31 years 
for caries & related disease and 33 years for distal cervical caries of the second molar. 
Pericoronitis is generally a disease observed in younger third molar patients with 
caries & related disease, and distal cervical caries observed in older patients. Not all 
patients at risk of distal cervical caries do develop it; as a significant cohort of potential 
patients with impacted third molars succumb to other diseases, notably pericoronitis, 
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before distal cervical caries can occur on the second molar. Predicting who will get 
distal cervical caries has a clinical paradox as all patients with a mesio-angular 
mandibular third molar are theoretically at risk of getting it but most patients will lose 
their third before the age of 30 years due to other diseases and therefore for a 
significant proportion of patients distal cervical caries of the second molar will not be 
realised. The increasing frequency of patients having third molars removed due to 
distal cervical caries as they age suggests that the majority of partially erupted mesio-
angular mandibular third molars would eventually result in distal cervical caries of the 
second molar.   
The potential population pool for distal cervical caries becomes smaller as patients age 
because patients will steadily lose their impacted third molar teeth due to disease but 
those that retain them are more likely to have them removed due to distal cervical 
caries.  
Pericoronitis and distal cervical caries of the mandibular second molar do not have 
distinct ICD10 codes and consequently NHS datasets do not record data appropriately 
to measure disease rates on a national level. Ideally these diseases should be given 
appropriate codes to address this. 
The common features of patients with distal cervical caries of the mandibular second 
molar include; an impacted partially erupted mesio-angular or horizontal mandibular 
third molar tooth; better dental health than average with a DMFT score approximately 
50% less than the average, from comparable age groups in the ADHS 2009 patients; 
and they tend to be, on average, 5-8 years older than patients requiring mandibular 
third molar removal due to pericoronitis. 
Diagnosis of mandibular second molar distal cervical caries will require the removal 
of the impacted third molar to facilitate treatment of the second molar. Approximately 
40% of mandibular second molar teeth associated with distal cervical caries will 
eventually require removal; 15% will require root canal treatment and restoration and 
40% will be conservatively restored. The long term prognosis of all restored 
mandibular second molar teeth will remain uncertain.  
Bacteriological studies of distal cervical caries lesions demonstrate that these lesions 
are typical of other deep dentine penetrating lesions on teeth. Dilaster, Prevotella and 
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Lactobacillus genus are the predominant bacteria found with these lesions and that 
inter patient bacteriological profile of distal cervical caries lesions are comparable 
with one another. 
The cost of treating Md2M DCC, exclusive of the cost of removing the mandibular 
third molar, will be in the estimated range of £1.7m-£3.0m per annum for clinical 
treatment and £1.5m per annum for patients’ loss of earnings and productivity: up to 
£4.5m per annum. If remedial implant replacement treatment for the second molar is 
factored into this then a further £28m could be added. Total additional cost in the range 
of £3.2m - £32.6m per annum. 
The partially erupted mesio-angular impacted mandibular third molar is significantly 
linked to the development of distal cervical caries on the second molar and becomes 
increasingly more frequent in patients who retain their impacted third molars into later 
life. The early removal of mesio-angular impacted third molars will prevent formation 
of this disease. Appreciation of the progression and the disease outcomes of retained 
impacted third molars should be acknowledged and consideration should, therefore, 
be given to early intervention. 
In this series of studies, we had identified the null hypothesis to be that the introduction 
of NICE guidance has not affected the profile of disease or treatment of third molars. 
In relation to the null hypothesis, the evidence demonstrates that the introduction of 
NICE guidance has resulted in a change in the profile of third molar disease with 
patients demonstrating a higher frequency of caries related disease as the primary 
indication for third molar removal. Patients were found to be older and the data 
demonstrated that more patients were having impacted third molars removed than 
prior to the introduction of NICE guidance. The rate of increase in patient numbers 
was greater than the rate of population change.  





7.2 Management of Md2M DCC. 
Not every Md2M associated with a partially erupted MAMd3M or HORZMd3M will 
result in DCC, however it is not the case that only some Md2M will be at risk; 
hypothetically all MAMd3M and HORZMd3M will have the potential to cause DCC. The 
reason we do not see DCC in all cases is that DCC is a late consequence of Md3M 
retention and in most cases the partially erupted Md3M will be removed before DCC 
will occur. Approximately 60% of all impacted Md3M are removed before the age of 
30 years with pericoronitis accounting for 65% of all Md3M removed in patients 
below this age (McArdle, 2018). Consequently, a large number of patients who could 
otherwise succumb to DCC become eliminated from the ‘at-risk group’ before DCC 
can result because their Md3M is removed before it can form. Conversely, those 
patients who retain a partially erupted MAMd3M demonstrate an increasing frequency 
of DCC as they become older, suggesting that the longer the third molar remains 
retained, the likelier it will be to result in Md2M DCC (McArdle et al., 2018).  As 
patients age, the total number of patients retaining an impacted Md3M will continually 
diminish as third molar disease will eventually occur resulting in removal. It is 
estimated that 80% of all patients with impacted third molars will require removal by 
the time they are middle aged (McArdle et al., 2018; Brickley et al., 1996: Hugoson, 
1988) 
 
7.2.1 Prevention and treatment of Md2M DCC. 
The asymptomatic partially erupted MAMd3M or HORZMd3M should not be overlooked 
as a source of disease potential. Md2M DCC lesion can be difficult to detect clinically 
and although it has been suggested that regular review and radiographic assessment of 
patients at risk of DCC should be undertaken to aid in diagnosis of those at risk, this 
approach is counter-productive (Toedtling et al., 2016).  The location of DCC can be 
deep on the root surface of the Md2M and consequently routine bitewing radiographs 
may not localize the lesion. Radiographic monitoring has one significant limitation, 
as once the caries has established itself then the removal of the third molar is indicated 
to permit restoration and to prevent re-occurrence of the DCC. In effect, an 
opportunity has been missed to prevent the formation of DCC.  
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As stated, the majority of patients who succumb to DCC have better than average 
dental health as measured by DMFT (McArdle et al., 2014).  NICE’s guidance on 
dental recalls would notionally afford patients with low DMFT scores the longest 
recall period of 24 months between dental examinations due to their relatively good 
dental health (NICE, 2004). This may again be counter-productive in that if DCC 
becomes established in a Md2M then its progression may go unchecked for some time 
resulting in a more extensive lesion that may require root canal treatment or even 
extraction. 
In terms of overall patient management, this poses a problem in that the potential 
development of DCC would suggest that consideration should be given, contrary to 
NICE guidance, that the MAMd3M or HORZMd3M should be removed before DCC can 
occur. In managing patients with an asymptomatic partially erupted MAMd3M or 
HORZMd3M, both the dentist and the patient need to appreciate that there is material 
risk of DCC forming due to the long-term retention of these types of Md3M. A 
discussion, therefore, should be had with patients who are at risk of DCC occurring 
about their individual long term risk, the potential complexity of restoring DCC on the 
Md2M or the possible need for its removal, and the added necessity for third molar 
removal as well. In the opinion of the author all partially erupted MAMd3M or 
HORZMd3M pose this risk and all should be considered and recommend for 
prophylactic removal. It is always a patient’s right to decline advice or treatment, 
however the dentist has a duty to the patient to put their interests first and advise them 
accordingly. Retaining an impacted MAMd3M or HORZMd3M that has the risk of 
contributing to disease on adjacent teeth with the potential long-term loss of the Md2M 
cannot be overlooked even if NICE’s guidance proscribes us from recommending 
removal of such an otherwise asymptomatic tooth.  
Where indicated, patients should be advised of the relative risk of DCC and 
consideration be given to early intervention – in most cases this would indicate the 
removal of the Md3M, however the nature of the intervention and the material risks 
of removal must also be considered.  Post-operative surgical morbidity, in terms of 
pain and recovery, are generally self-limiting; surgical complications such as alveolar 
osteitis and infection can be relatively common post-extraction, though treatment is 
relatively simple. More significantly the relative risk of inferior dental nerve (IDN) 
and lingual nerve (LN) injury needs to be considered and correctly assessed – there is 
 158 
no advantage in securing the long-term health and retention of the Md2M but causing 
permanent IDN or LN injury as a consequence. In confirmed high risk cases for IDN 
injury coronectomy may be an appropriate intervention to ensure longevity of the 
Md2M whilst minimising the risk to the IDN. Indeed, no intervention may be decided 
upon if IDN injury risk is high and acceptance that the loss of the Md2M may be an 
ultimate but acceptable consequence – the possible long-term loss of the Md2M will 
be, by far, a better outcome than third molar removal and permanent nerve injury 
(Figure 7.1). 
Figure 7.1 Management algorithm of patients at risk of Md2M DCC. 
 
Legend: This figure demonstrates the clinical algorithm for managing patients who are at risk of Md2M 
DCC. Consideration should be given for the removal of the Md3M unless the risk of inferior dental 
nerve injury is high as a consequence of Md3M removal.  
Consent can be a complex process and it is important that patients understand the 
nature and outcomes for any treatment intervention, however they also need to 
understand the outcomes of no treatment as well. Where no treatment may result in 
consequent disease and more complex treatment at a later stage then patients should 
be informed of this risk and the potential outcomes. The Montgomery v Lanarkshire 
Health Board case emphasised the notion of material risk and the value that a patient 
may place on the relative risks of an intervention, however this principle is also true 
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duty-of-care to inform a patient of the relative material risks of non-intervention too 
(Montgomery, 2015). In this way, patients can make informed choice related to risk 
and possible treatments. It is equally important that when identifying risk that any 
discussion with the patient, related to risk is recorded in the clinical notes. In the face 
of the evidence, failure to appreciate risk and to document decisions related to it could 
be misinterpreted as clinical ignorance or at worst as supervised neglect.  Relevant 
documentation will support the clinician if patients question the reasons for not 
intervening early with a third molar when posing a risk to a now carious and 
unrestorable second molar. 
For those patients who become diagnosed with DCC, restoration or extraction of the 
Md2M is indicated. Where restoration is planned the third molar will have to be 
removed to facilitate restoration. Attempting to restore the Md2M with the Md3M still 
present can result in a compromised restoration and leave the Md2M at risk of further 
DCC. If the Md2M is unrestorable, or if the patient chooses removal then 
consideration may be given to retaining the Md3M, especially if the risk of IDN injury 
is high. Often the Md2M can be restored, however access can be difficult due to the 
relative depth of the DCC on the root, restricting positioning of a matrix band distally 
to a good margin for a restoration. Endodontic treatment of the second molar is often 
indicated as caries can rapidly penetrate into the pulp resulting in more extensive and 
expensive treatment.  
NICE presents us with a paradox when faced with DCC of the Md2M. The early, 
prophylactic loss of the Md3M will prevent DCC from forming but this is contrary to 
NICE’s guidance were removal is indicated only in the presence of disease. NICE 
guidance does need to be reviewed and improved but NICE’s guidance is not solely a 
list of clinical indications for third molar removal. NICE supports any decision related 
to third molar management as the guidance clearly states that it is just that – guidance; 
it is neither a guideline nor a treatment algorithm. Unfortunately, non-clinical 
stakeholders, such as the NHS and private commissioners of care, have been 
misinterpreting the guidance in a monochrome manner to justify fiscal policies of 
saving money and not focusing on the needs and benefits of the individual patient. 
With finite amounts of resources, the general objective is to optimise resources and 
minimise cost where possible and third molar management is easy prey to such a 
policy.   
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7.3 Summation 
It is practically impossible to ascertain whether all partially erupted MAMd3M or 
HORZMd3M would result in Md2M DCC given appropriate time. A confirmative 
answer to this would indicate the need to consider early prophylactic removal before 
DCC ensues and this would have significant repercussions for NICE, the dental 
profession, and for patients. However, the data presented in this thesis and published 
papers does suggest that prophylactic Md3M removal should have a role to play in the 
prevention of DCC in the Md2M tooth.  
The data presented in this thesis provides only part of the evidence towards 
understanding the features and the comparative risk of DCC occurring. However, the 
data and knowledge accumulated go in part to understanding the nature of DCC, the 
patients who succumb to it and the need to consider prophylactic Md3M removal as a 
legitimate treatment for the prevention of Md2M DCC. Further research is required 
on a national scale which can further the understanding of the requirements for 
selective prophylactic Md3M removal.  
The nuances of DCC, combined with ideal research strategies and the complexities of 
statistical data evaluation do not necessarily compute with one another in easily 
determining if prophylactic removal of MAMd3M or HORZMd3M should be undertaken 
to prevent DCC from forming.  
Proving that all MAMd3M or HORZMd3M will eventually give rise to Md2M could be 
undertaken with a longitudinal cohort study observing a group of patients with 
partially erupted MAMd3M or HORZMd3M to see how many succumb to the disease. 
However, the length of time required to observe the required outcome would be far 
too proscriptive to adequately acquire the necessary information. With the mean age 
of patients being 32.7 years and the SD of 7.3 years would suggest that patients would 
have to be followed up until they are at least 40 years of age to adequately observe the 
occurrence of DCC. Patients within one standard deviation of the mean age would 
capture approximately 80% of patients. Patients would have to be recruited as soon as 
their Md3M teeth showed signs of partial and failed eruption in a MAMd3M or 
HORZMd3M position and would be expected to remain part of the study for a significant 
proportion of their formative life through to early middle age. Failed eruption of the 
Md3M could be anytime between 18 and 24 years thus making the time frame of 
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observation in the region of 20 years. These individuals constitute a relatively mobile 
population group and following them up over such a time period would be extremely 
impractical. In addition a significant proportion of patients will readily succumb to 
pericoronitis early on (mean age 25 years), resulting in the observational cohort 
shrinking in size as patients become older as a consequence of early disease processes 
indicating the removal of the Md3M. Eventually this would highlight that only a 
certain proportion of all patients developed DCC. Patients would be lost to follow up 
and other disease and mobility. The numbers to recruit would be in the 10s of 
thousands to allow for a final cohort of 500-1000 patients – hugely impractical and 
almost a career for any willing investigator. 
Alternatively, a randomised control trial comparing treatment (early prophylactic 
removal) with no treatment (prescribed retention of the third molar). A cohort of 
patients would have their Md3M removed early – as soon as eruption has failed and 
then observed for a period of time to see how many developed DCC and how many 
did not. Obviously, none would develop DCC, however outcomes in terms of 
morbidity, complications and costs would have to be determined and compared 
eventually with the second cohort. The second cohort recruited would ideally have 
their Md3M intentionally retained until they were 40 years of age to see how many 
developed DCC – recurring episodes of pericoronitis would be treated palliatively 
with antibiotics and local measures, with no surgical intervention permitted. Only once 
DCC formed would the patient be allowed removal of the Md3M and therefore leave 
the study. At the end of the study this group could be assessed to see how many 
episodes of pericoronitis that patients may have suffered, how many succumbed to 
Md3M caries and how many succumbed to Md2M DCC. In addition how many 
impacted Md3M remained asymptomatic with no disease could also be ascertained. 
This would, however, involve another 20 year study with a large number to recruit and 
probable high fall out rate. However, ethics would never be granted for a such study 
that requires patients to suffer one disease to see if they eventually succumb to another. 
Measuring the relative risk of DCC forming will be difficult to truly calculate as 
although the group exposed to the risk of DCC may only demonstrate a limited number 
of cases over a defined period of time. The fact that DCC is seen in mainly in older 
patients and in a contracting population of potential patients masks the paradoxical 
bias that earlier removal due to pericoronitis will have on the relative risk and the 
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eventual outcome for the patient. It could be wrongly concluded that not all patients 
get DCC so those that did not were never at risk. However, the converse is true in that 
all are at risk but early disease and disorders have contrived against the formation of 
DCC by creating an indication for the earlier removal of the Md3M before Md2M 
DCC can occur. 
Proving that every patient with a partially erupted MAMd3M or HORZMd3M tooth is at 
risk of Md2M DCC, is therefore difficult to substantiate. Standard research protocols 
do not often sit comfortably with clinical research due to the ethical issues and time 
frames that they require. Acquiring high level research to determine best practice is 
therefore problematic and lower levels of research and consensus opinion may become 
the only source of research from which to determine best practice. These lower levels 
of research are often seen as poor or bad research as they do not eliminate research or 
personal bias from the equation however they may be the only source of research data 
available to us. This lack of research evidence of the required level does not indicate 
evidence of absence of any beneficial or detrimental effect of what is being proposed. 
However, the lack of high level evidence continues to obstruct meaningful debate 
between stakeholders such as NICE and the dental profession. RCTs appear to be the 
only language that stakeholders will countenance whilst lower levels of evidence are 
rejected and deemed inadmissible. If high level evidence does not exist and cannot be 
acquired, then other levels of evidence become the pinnacle of evidence base and 
should not be ignored nor discarded. NICE needs to move its mind set into the reality 
of what research is achievable and available rather than what is ideally best. We live 
in the real world and the concept of real-world evidence is becoming an important tool 
to compliment RCTs or where RCTs are impractical to give a certain degree of 
authority to other forms of clinical research that reflect the true reality (Survana, 
2018). 
Although NICE appears to have rigid clinical indications for third molar removal, the 
guidance does attest that, ‘...the guidance does not override the individual 
responsibility of health professionals to make the appropriate decisions in the 
circumstances of the individual patient and in consultation with the patient.’. This 
fact is often ignored by non-clinical stakeholders who merely see the guidance as an 
instrument of compliance, ignoring the fact that the health and well-being of the 
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Appendix I  
Third molar proforma. 
Third molar study 










Third molar Present-Absent Primary indication 
for removal 








 removal not indicated  
 
Erupted   
P/Erupted  
Unerupted  
M/A   
D/A   
Vertical   
Horizontal  









 removal not indicated  
 
Erupted   
P/Erupted  
Unerupted  
M/A   
D/A   
Vertical   
Horizontal  









 removal not indicated  
 
Erupted   
P/Erupted  
Unerupted  
M/A   
D/A   
Vertical   
Horizontal  









 removal not indicated  
 
Erupted   
P/Erupted  
Unerupted  
M/A   
D/A   
Vertical   
Horizontal  
Ectopic   
 
Notes: 
Examples for mandibular third molar removal – pericoronitis; caries in third molar; DCC in 2nd molar; periodontal disease, 
abscess 20 to caries?/perio?; early/established cyst formation; orthodontic/gnathic; resorption of adjacent tooth; etc, etc. 
Examples for maxillary third molar removal – as above but may also include, cheek biting; food packing; overeruption; 
prevention of overeruption, etc.  
do not restrict to NICE guidance. If tooth is removed for prophylactic reasons – please state. 
Angulation: please indicate your assessment of the tooth’s angulation in relation to the long axis of the second molar. 
Eruption status: tooth is erupted if it has complete gingival collar around cervical margin of tooth. Tooth is partially erupted if 
gingival collar extends even minimally above or over crown of third molar. 






Bacteriological profile of third molar related distal cervical caries of 





Radiographically, distal cervical caries of the Md2M develops at the distal amelo-
cemental junction of the Md2M with a predilection for caries to penetrate through the 
cemental surface of the root into dentine (Figure II(i) a,b,c,d). The root surface of any 
tooth is more susceptible to caries as cementum and dentine are more vulnerable to 
demineralisation than enamel; enamel by contrast is protective and resistant to 
demineralisation. In the presence of a partially erupted MAMd3M or HORZMd3M, the 
root surface of the Md2M will become exposed to the oral environment due to the 
anatomical distortion of the normal relationship between the Md2M and the Md3M.   
In the adolescent dentition, the developing Md3M will sit distally to the second molar 
within the follicular crypt and will appear to be develop in a mesio-angular position 
(Richardson, 1975). This mesio-angular orientation of the Md3M is normal at this 
stage and as the tooth begins its eruption process the position of the tooth will change 
due to differential root growth which should allow eruption into a vertical and 
functional position (Kjær, 2014). In a normal anatomical relationship, the alveolar 
wall of bone between a Md2M and a fully erupted Md3M is a vertical pillar of bone 
that forms the mesio-distal socket wall between the two teeth. This will normally 
extend vertically to just below the amelo-cemental junction between the two teeth and 
in disease-free teeth the inter-dental cervical bone is generally about 1mm below the 
amelo-cemental junction. This bone will also support the soft tissue of the gingivae 
and gingival papillae resulting in a shared circumferential collar of gingivae between 
each of the teeth.  
The mesial impaction of the Md3M against the Md2M disrupts this normal anatomical 
relationship of the cervical bone between the two teeth. Comparison of the cervical 
bone level around both the Md3M and the Md2M demonstrates the cervical bone level 
around the Md3M appears to be at the normal level for the Md3M, however as the 
mesial cervical area of the Md3M is significantly lower than the cervical area of the 
Md2M the normal relationship is disrupted. As a consequence, the local anatomy is 
altered resulting in the loss of an intact gingival collar around the circumference of 
Md2M with the bone level distal to the Md2M being lower on the Md2M than would 
be expected. This gives the impression of distal bone loss which may be mistaken for 
periodontal disease and may give rise to a periodontal pocket. This pocket formation 
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is not a result of periodontal disease but is a consequence of the failed eruption of the 
Md3M and the adaptation of the local anatomy to the impaction. This results in an 
acquired pocket rather than a pathological one, where the Md2M distal root surface 
below the level of the amelo-cemental junction will be exposed to the oral 
environment and colonisation with oral bacteria. This distal cervical area is not 
necessarily amenable to adequate oral hygiene in the form of tooth-brushing or 
interproximal cleaning and as a consequence disease can ensue either in the form of 
periodontal disease or DCC of the Md2M.  
As with all carious cavities, DCC will begin with a small lesion and steadily progress 
to larger lesions with eventual penetration into the pulpal tissues (Figure II(i).). The 
distance from the distal root surface and the pulp chamber is much shorter than from 
the occlusal surface and because penetration of the caries is solely through cementum 
and dentine, DCC will tend to, once established, penetrate more rapidly into the pulp. 
Evidence has demonstrated that 40% of all Md2M with DCC associated with impacted 
Md3M are removed as a result (McArdle et al., 2016).  The location of the disease 
compromises restoration, as the caries can transgress inferiorly down the root surface 
making restoration impossible. Early lesions can mimic radiographic burnout at the 
cervical margin which is caused by radiographic superimposition of the follicle of the 











Figure II(i).  Progression of Md2M DCC. 
Figure IIi. (a)   Early Md2M DCC 
 
Legend: this image is a periapical radiograph demonstrating 
early DCC on the Md2M consequent to the retained and 
impacted Md3M. note the level of the interdental bone distal 
to the Md2M which is much lower than the mesial interdental 
bone. The bone level at the Md3M has approximated at the 
level of the amelo-cemental junction of the Md3M. 
Figure IIi. (b)   Progressing Md2M DCC. 
 
Legend: this image is a bitewing radiograph of the same 
patient in figure IIi. (a). taken approximately 3 years later. 
It demonstrates progressing DCC present on the Md2M 
consequent to the retained and impacted Md3M. 
Figure IIi. (c)   DCC penetrating dental pulp. 
 
Legend: this is a cropped image of a dental panoramic 
radiograph demonstrating DCC on the Md2M invading into 
the dental pulp of the Md2M consequent to the retained and 
impacted Md3M. Again, note the level of the interdental bone 
distal to the Md2M which is much lower than the mesial 
interdental bone. Even at this late stage the bone level at the 
Md3M maintains approximation at the level of the amelo-
cemental junction of the Md3M. 
Figure IIi.(d)  Carious destruction of the second molar by 
DCC. 
 
Legend: this photographic image is of the extracted Md2M 
in figure IIi. (c) demonstrating gross DCC on the Md2M 





The nature of DCC of the Md2M has not been investigated from a bacteriological 
perspective. Radiographic observation of early Md2M DCC suggests that it originates 
at the amelo-cemental junction of the Md2M at the point of contact with the Md3M 
and selectively advances on the root surface. Md2M DCC would tend to be 
comparable with Class V buccal root surface caries found on patients with periodontal 
induced gingival recession or possibly root surface radiation caries as the lesion 
appears to start at the amelo-cemental junction.  
II.i Aims 
This study aims to look at the nature of the micro-flora of DCC lesions in an attempt 
to identify the spectrum of cariogenic bacteria contributing to DCC. 
II.ii Ethics  
(IRAS protocol, Patient information, ethics approval, and Research and Development 
approval letters are included at end of appendix II). 
Local ethical committee advise was sought and as patients would be requested to 
provide tissue samples a full ethics approval application was undertaken. IRAS 
application was submitted (IRAS project ID 146708) and was assessed by the West of 
Scotland Research Ethics Committee. Research approval was granted (7th October 
2015) by the Proportionate Review Sub-Committee (REC reference 15/WS/230) 
subject to local R&D approval which was granted (6th April 2016).  Tissue samples 
were originally to be processed by the microbiology department of King’s College 
London, however once all samples were collected, KCL were not in a position to 
process and microbiology support was sought elsewhere. The Blizzard Institute, 
QMUL, University of London was approached and agreed to process the samples, 
however this altered the original protocol and consequently an IRAS substantial 
amendment was applied for to reflect the change in the processing laboratory. 
Substantial amendment was accepted and approved by the West of Scotland Research 




II.iii Methodology  
Patients attending for Md3M removal due to Md2M DCC, where the Md2M was 
unrestorable, or when the patient elected to have the Md2M removed, were invited to 
participate in this study. The study involved the direct sampling of Md2M DCC lesions 
from the extracted tooth and the sampling of ipse-lateral and contra-lateral plaque from 
the same patients. Only patients who had Md2M extracted were enrolled as opposed 
to retained Md2M DCC as access to the carious cavity in a retained Md2M was 
deemed inaccessible for optimal curettage due to possible cross contamination. The 
aim was to recruit 15-20 patients for the study. 
Although patients’ treatment would remain as clinically indicated and planned, 
patients would be invited to consent to samples of plaque to be taken from the oral 
cavity and for their second molar tooth to be retained for caries sampling prior to 
standard disposal.  
Mr. L. McArdle was chief investigator of the study and undertook overall study 
design; study protocol and patient information; R&D and research ethics application; 
recruitment and consent of patients, sample collection and storage. Professor W Wade 
and Dr Erica Prosdocimi at the Blizzard Institute undertook the processing of 
samples, sample analysis and provided a provisional results report.   
II.iv Protocol 
Patients treatment planned and attending for removal of both the Md3M and Md2M 
where the indication for removal was Md2M DCC were invited to participate in this 
study. Patients had the study explained to them and given the opportunity to read 
through the study protocol and asked to sign a consent form if in agreement. Patients 
consented to plaque samples being taken and these were taken from the disto-buccal 
tooth surface between the Md2M and the Md3M that was being removed (ipsilateral 
side) and from the corresponding area of the contralateral Md2M. In addition, consent 
also included the temporary retention of the Md2M to allow sampling of the caries 
from the distal cervical cavity of the Md2M. 
Plaque samples were taken using sterile paper points and placed in sealed cryogenic 
storage tubes and labelled accordingly. Once the Md2M was removed, caries was 
excavated from the distal cervical cavity with a sterile curette and similarly placed in 
 182 
a sealed labelled cryogenic storage tube. The cryogenic storage tubes were initially 
retained in a polystyrene container with dry ice. Within 30 minutes, samples were then 
transported to and stored in a cryogenic freezer at -85 degrees Celsius until all samples 
had been collected.  
A total of 16 patients were enrolled into the study providing 3 samples per patient; 
sample 1 (ipsilateral plaque); sample 2 (contralateral plaque), both from the distal 
aspect of the second molar and sample 3 (DCC) from the distal cavity of the second 
molar tooth. Once all Md2M were sampled they were disposed of as per standard cross 
infection protocols. Plaque samples from patients C, D, E, and F were accidentally 
placed in the contrary plaque labelled cryogenic tubes. Ipsilateral plaque samples were 
placed into the cryogenic storage tubes marked for the contralateral plaque samples 
and vice versa. This was acknowledged and documented so that all samples were 
processed and reported accordingly.  
 
II.v Sample analysis - method 
Once all 48 samples (16 x 3 samples/patient) had been collected, they were transported 
to the Blizzard Institute, QMUL for analysis. Tissue samples were transported 
according to the Human Tissue Act protocols.  
Samples were processed to permit analysis and identify the bacteriological profile of 
each of the plaque and carious samples. DNA was extracted from the samples by 
means of the GenElute DNA extraction kit (Sigma) with the addition of a pre-
incubation with lysozyme to ensure lysis of Gram-positive bacteria. From each DNA 
extract, the variable regions V1 and V2 of the 16S rRNA gene were amplified by 
polymerase chain reactions (PCR) using the primers 27F-YM 
(AGAGTTTGATYMTGGCTCAG) and 338R-R (TGCTGCCTCCCGTAGRAGT). 
The primers incorporated the Illumina MiSeq adapters and sequence tags to achieve a 
double indexing system as determined by Kozich et al. 2013 (Kozich et al., 2013).  
Control PCR reactions were performed from two DNA extraction negatives and one 
mock community DNA (ZymoBIOMICS Microbial Community Standard, Cambridge 
Bioscience). A negative control without template DNA was included in each PCR 
plate. Amplicons were purified and normalised using four plates of SequalPrep 
Normalization Plate Kit (ThermoFisher Scientific), and a pool was obtained from each 
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plate mixing 5 µl of each amplicon. The DNA in the four pools was quantified using 
the Picogreen Assay Reagent (ThermoFisher Scientific), and mixed in equimolar 
proportions. The sequencing was performed at the Bart’s and The London Genome 
Center on the Illumina MiSeq machine, using a 2 x 250 flow cell for paired-end 
sequencing with 10% PhiX DNA 12.5 pM. 
The output sequence pairs were filtered using the DADA2 R package according to the 
quality scores, to discard sequences with an expected error over 2 bp (base pairs). The 
first 10 bp of each sequence were trimmed; the forward and reverse sequences were 
truncated respectively at 250 and 200 bp length. The filtered sequences were analysed 
using the Mothur pipeline according to the standard operating procedure (SOP) 
available at https://www.mothur.org/wiki/MiSeq_SOP. (Kozich et al., 2013; Schloss 
et al., 2009). An additional pre-cluster step was performed to merge sequences with 
three or fewer bases differences. Sequence chimeras were removed from the analysis. 
Sequences were clustered into Operational Taxonomic Units (OTUs) at a sequence 
dissimilarity distance of 0.015 using an average neighbour algorithm and then 
classified using a Naïve Bayesian classifier implemented in Mothur with the Human 
Oral Microbiome Database reference dataset. 
Alpha diversity indexes (and the Inverse Simpson's diversity index) were calculated 
by Mothur from each sample, by randomly subsampling 7099 sequences and 
averaging the results over 1000 replicas. The mean number of observed taxa and 
inverse Simpson’s index in different sample types were compared by means of the 
Wilcoxon rank sum test. 
Distance matrices were constructed comparing the beta diversity of samples from 
comparisons based on the Jaccard Index and thetaYC metric. Principal Coordinate 
Analysis (PCoA) and non-metric multidimensional scaling (nmds) analyses were 
performed and displayed as ordination plots. Analysis of Molecular Variance 
(AMOVA) comparisons between groups were performed to determine if there were 
statistical differences in the microbial composition of sample groups. Differentially 
abundant OTUs between groups of interest were identified using the LDA Effect Size 




A total of 850,193 sequences were available for analysis after quality filtering and 
chimera removal. The biofilm samples were sub-sampled to 7099 sequences for OTU-
based comparisons. There were no significant differences in the richness (number of 
observed OTUs) of bacterial communities from different sample types (Wilcoxon) 
(Figure II(ii).). There was no difference in the diversity of the bacterial communities 
from the two plaque samples between ipsilateral and contralateral plaque samples or 
between contralateral plaque samples and the caries sample but the diversity of the 
caries samples was significantly lower than ipsilateral plaque samples (p<0.05, 
Wilcoxon) (Figure II(ii).). 
Figure II(ii).  Richness and diversity of the sample microbiotas. 



















Legend: Figure II(ii).  demonstrates that there were no significant differences in the richness of 
bacterial communities from different sample types (i.e. the number of observed Operational Taxonomic 
Units) (Wilcoxon) There was no difference in the diversity of the bacterial communities from the two 
plaque samples between ipsilateral and contralateral plaque samples or between contralateral plaque 
samples and the caries sample but the diversity of the caries samples was significantly lower than 






A principal co-ordinates analysis (PCoA) plot based on thetaYC metric is shown in 
Figure II(iii). and shows the relationship between samples on the basis of their 
bacterial composition. It can be seen that, with the exception of two samples, the caries 
samples are clustered together to the right of the plot, suggesting that the 
bacteriological profiles of DCC were similar. This observation was confirmed further 
by analysis of molecular variance (AMOVA analysis) of the composition of the 
bacterial communities in the different plaque samples which showed them to be 
significantly different from the bacterial flora from the DCC samples. Pairwise 
comparisons found no difference between ipsilateral and contralateral plaque samples 
(plaque 1 and plaque 2 samples) but both were significantly different to the caries 
samples (plaque 1 p=0.007; plaque 2 p<0.001, significance threshold after Bonferroni 
correction: p<0.016). 
 
Figure II(iii).  Principal coordinates analysis (PCoA) plots of sample bacterial 
community composition based on thetaYC metric. 
 
 
Legend: Figure II(iii). This figure demonstrates a principal co-ordinates analysis plot of the sample 
bacterial community composition. With the exception of two samples, the caries samples (red dots) are 




Figures II(iv) and II(v) show a heatmap and stacked bar chart, respectively, of the 
predominant genera found in the samples. The genera found were those typical of the 
oral microbiota but there were some differences between the plaque and caries 
samples. It can be seen that the relative abundance of Dialister and Lactobacillus 
species was increased in the caries samples while the proportions of Actinomyces, 
Streptococcus and Veillonella were decreased.  
 
Figure II(iv). Heatmap showing relative abundance of bacterial genera in plaque 
and caries samples. 
 
 
Legend: Figure II(iv). This figure demonstrates a heatmap of the bacterial genera found within the 
samples. The genera found were those typical of the oral microbiota but there were some differences 
between the plaque and caries samples. It can be seen that the relative abundance of Dialister and 
Lactobacillus species was increased in the caries samples while the proportions of Actinomyces, 








































































































































































































































































































































































































































































































































































Legend: Figure II(v). This figure demonstrates a stacked bar chart of the bacterial genera found within 
the samples. The genera found were those typical of the oral microbiota but there were some differences 
between the plaque and caries samples. It can be seen that the relative abundance of Dialister and 
Lactobacillus species (lighter green bars) was increased in the caries samples while the proportions of 
Actinomyces (darker green bar), Streptococcus and Veillonella (lighter blue bar) were decreased.  
 
Figure II(vi)a-e confirm these findings and show that the differences in relative 
abundance of these genera were statistically significant except for Dialister where the 
caries to ipsilateral plaque samples comparison was not significant (Wilcoxon test). 
Figure II(vi)f shows the relative abundance the mutans-group streptococci in the 




Figure II(vi). Box plots demonstrating selected genera and mutans-group 









Legend: Figure II(vi). These box plots demonstrate the relative abundance of selected genera from 
plaque and caries samples. Genera Dialister and Lactobacillus are more abundant in caries as opposed 
to plaque samples. Actimomyces, Veillonella and Streptoccus show greater abundance in plaque than 
caries. Upper and lower edges of the boxes are the first and third quartiles; the line inside the box is 













Linear discriminant analysis Effect Size (LefSe) analysis was then performed to 
determine pattern recognition and to consider which species-level Operational 
Taxonomic Units were responsible for the significant differences seen. OTUs which 
were significantly over-represented in the caries samples are shown in figure II(vii). 
This confirmed the genus-level heat-map analysis in that multiple species of Dialister 
and Lactobacillus were caries-associated and also found that proportions of a number 
of other anaerobic species such as Propionibacterium acidifaciens and Olsenella 
profusa were raised. 
Figure II(vii).  OTUs significantly over-represented in caries samples. 
OTU Species Linear 
Discriminant 
Analysis 
 011 Dialister invisus 4.1 
 013 Prevotella denticola 4.0 
 025 Dialister pneumosintes 3.7 
 038 Lactobacillus vaginalis 4.2 
 068 Olsenella profusa 3.7 
 072 Lactobacillus casei 3.8 
 090 Propionibacterium acidifaciens 3.4 
 105 Eubacterium infirmum 3.3 
 114 Shuttleworthia satelles 3.4 
 160 Eggerthia catenaformis 3.2 
 185 Olsenella uli 3.1 
 193 Erysipelotrichaceae G-1 HOT-905 3.0 
 246 Veillonellaceae G-1 HOT-132 2.7 
 409 Dialister pneumosintes 2.5 
 468 Lactobacilli paracasei 2.7 
 506 Shuttleworthia satelles 2.4 
 620 Dialister invisus 2.5 
 641 Prevotella denticola 2.4 
 
Legend: Figure II(vii). This table demonstrates the representation of bacterial genera (Operational 
Taxonomic Units) in the caries samples. 
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II.vii Discussion  
Dental caries is one of the most common diseases that humans experience and is the 
due to the decomposition of dental tissues from acid destruction (WHO, 2012). It is, 
in essence, a bacterial infection of the dental hard tissues, initially fueled by bacterial 
fermentation and metabolism of carbohydrates, such as sucrose, from food sources. 
The carbohydrate metabolism results in the production of acids which, in turn, cause 
demineralisation of enamel with consequent destruction of the dental tissues and 
eventual cavitation. Left untreated this eventually results in bacterial infection of the 
dental pulp and dental abscess formation (Loesche, 1996).  
The external and internal surfaces of the human body are colonised and exist in 
symbiosis with commensal bacteria and other micro-organisms. This creates a 
biological ecosystem which is a normal physiological feature of all life. Commensal 
organisms live in equilibrium with each other and with the host’s immune system, 
however, disturbance of this equilibrium can result in opportunistic growth and 
proliferation of selective micro-organisms, which disrupts this equilibrium with the 
potential to cause disease. 
Commensal bacteria within the oral cavity colonise the surface of teeth and form a 
bacterial biofilm that is commonly referred to as dental plaque. Dental plaque is a 
matrix of bacteria and polysaccharides and this ecosystem promotes the further growth 
and proliferation of bacteria. It is estimated that there are more than 600-1000 bacterial 
species that colonise the oral cavity however not all are implicated in dental disease 
(ten Cate, 2006).   
Typical dental plaque has been shown to include a variety of bacterial groups the 
majority of which are Streptococci group but also Actinomyces, Veillonella and 
Prevotella.  In this study, the samples of plaque from both ipsilateral and contralateral 
supra-gingival tooth surfaces are similar in composition with each other demonstrating 
substantial levels of gram-positive Streptococci, along with Actinomyces and gram-
negative Veillonella. In contrast levels of Lactobacillus tend to be absent or minimal 
in both though studies demonstrate Lactobacillus group to be a feature of plaque. 
Plaque samples from this study tend to be typical of dental plaque and similar to other 
studies (Nyvad, 1987; ten Cate, 2006). 
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Saliva provides the initial nutritional substrate for supra-gingival plaque though 
carbohydrates within the diet act as an additional nutritional source. Streptococci 
break down salivary glycoproteins and produce lactate which in turn is an energy 
source for Veillonella (Loesche, 1996). 
Streptococcal mutans group of bacteria are the main dominant bacterial initiator for 
dental caries. S. mutans have a diverse ability to efficiently metabolise sucrose. 
Sucrose can be metabolised into fructose and glucose then subsequently be 
metabolised via the glycolytic pathway which results in lactic acid production. In 
addition, s. mutans can form complex glucose polymers (glucans) which facilitates 
adhesion of S. mutans to the enamel surface and plaque formation. Other bacterial 
groups such as Lactobacillus are also associated with acid production in plaque and 
early caries lesions, however, S.mutans is the most efficient bacteria for the 
metabolism and utilisation of sucrose and as a result is becomes the most dominant 
species in plaque. Lactic acid production causes a reduction in pH within the plaque 
and as S. mutans and Lactobacillus are aciduric in nature, not only do they produce 
acid but are more resistant to the harmful effects of low pH than other bacteria which 
in turns allows them to be more proliferative and successful in eliminating and 
suppressing other oral commensals in dental plaque. 
The bacteriological profile of dental caries changes with the progression of the carious 
lesion from early carious through to deeper lesions that penetrate into the dentine and 
pulpal tissues (Kianoush et al., 2014; Martin et al., 2002).  In early dental caries 
lesions, mutans-group streptococci and lactobacilli tend to be the predominant 
bacteria present, however as the carious lesion progresses into dentine there is a 
transition in bacterial population from these facultative gram-positive bacteria to an 
anaerobic bacterial population (Kianoush et al., 2014). The DCC samples taken from 
the Md2M were unrestorable and consequently caries lesions were deep and extensive. 
DCC samples had reduced levels of Streptococcus, Actinomyces and Veillonella with 
increased levels of obligate anaerobes such as Dialister, suggesting a substantial 
environmental change from the tooth surfaces.  
DCC is seen on the distal root surface of the second molar. Root surface caries is a 
common finding in older patient groups due to the fact that age related gingival 
recession and periodontal disease results in exposure of the dentine root surfaces. Root 
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surface caries predominates in the buccal root surface although it can affect any 
exposed root surface. In addition, loss of manual dexterity due to age related arthritic 
conditions may play a factor in effective dental hygiene. DCC is generally seen in 
younger patient groups as opposed to the older patients that buccal root surface caries 
would affect, however the location of the carious lesion is not dissimilar to buccal root 
surface in terms of its proximity on the root form though present on the distal surface 
of the tooth rather than the buccal surface. 
For root caries, studies have demonstrated that the bacteria implicated in initial caries 
formation include, s. mutans, lactobacillus and actinomyces, with more established 
root caries lesions also demonstrating a predominance of s. mutans, lactobacillus, 
actinomyces but also prevotella, atopobium and olsenella species (Preza et al., 2008). 
These findings are not dissimilar to the bacterial populations of the DCC samples from 
this study. It would be anticipated that coronal caries would be dissimilar to root caries 
due to the location of the caries on the tooth. Literature suggests that coronal caries is 
mutans-group streptococci, lactobacilli and other aciduric bacteria, however root 
caries is more similar to coronal caries than once thought with Actinomyces being 
implicated (Bowden, 1990). 
II.viii Conclusion 
The findings for the DCC samples here suggests that deep lesions have been formed 
with extensive dentine penetration. The lesions are thus anaerobic and the nutrients 
for the bacteria come from the pulp leaking through the dentine. The fact that caries 
was the cause of the lesions is shown by the persistence of lactobacilli, as previously 
reported. It has been demonstrated from studies of deep advancing carious lesions that 
Propionibacterium, Olsenella, and Lactobacillus were the predominant species in 
deep dentinal caries samples, suggesting that this deeper carious habitat favours 
obligate anaerobes with a primarily proteolytic metabolism (Munson et al., 2004).   On 
the basis of the results of this study, the composition of the caries samples appears to 
most closely resemble that previously reported in carious lesions with substantial 
penetration into dentine (Munson et al., 2004). 
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It is a requirement of Good Clinical Practice (GCP) and the Research Governance 
Framework for Health & Social Care 2005, that all research projects have a scientifically 
sound and ethically valid protocol.  
 
The protocol is the starting point of any high quality research and all research studies 
must be conducted according to the protocol. A protocol provides written evidence for 
the necessity and feasibility of a study, as well as giving a detailed plan of investigation.  
 
This document is to be submitted for approval to a Research Ethics Committee. This 
allows the ethical and peer review processes to validate the scientific and ethical 
considerations of the study. The guidance detailed below is for all research studies of 
Non Investigational Medicinal Products (Non CTIMPs) with the exception of those 
testing a device. 
 
PROTOCOL TITLE:  
Bacteriological profile of third molar related distal cervical caries. 
 
This case-series study wishes to assess the bacteria present in decayed second molar 
teeth. Teeth that are extracted are normally disposed of as clinical waste. We wish to 
retain these specific teeth and sample the dental decay to identify the bacteria 
responsible for that decay. This will be achieved through microbiology laboratory 
testing of the material. We aim to identify the types and proportion of bacteria 
responsible for the decay and compare it with other known caries bacterial profiles. 
Once the decay is sampled these teeth will be disposed of in the normal way, as clinical 
waste. We will also collect as sample of dental plaque from the contra-lateral side of 
the jaw. This sample of dental plaque will be assessed in a similar way and used as a 
comparative control sample.  
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Bacteriological profile of third molar related distal 




 Md2M DCC 
Protocol Version number 
and Date 
 Protocol version 2 (7/4/17) 
Study Phase if not 
mentioned in title 
 Phase 1 
Is the study a Pilot?  yes 
Study Hypothesis   
identify bacterial flora of tooth decay 
 
Study Duration  6months 
Methodology 
 
 Stand alone case-series of clinical specimens 
Sponsor name  KCL 
Chief Investigator  Mr Louis McArdle 
REC number  IRAS 146708   15/LO/1279 
Medical condition or 
disease under investigation 
 Dental Caries 
Purpose of clinical trial  Assess bacteriological profile of caries 
Primary objective  Assess bacteriological profile of caries 
Secondary objective (s)  n/a 
Number of 
Subjects/Patients 
 15-20 maximum 
Trial Design   Case series 
Endpoints  Completion of 15-20 samples 





Glossary of Terms and Abbreviations  
 
AE   Adverse Event   
AR   Adverse Reaction 
ASR   Annual Safety Report 
CA   Competent Authority 
CI   Chief Investigator 
CRF   Case Report Form 
CRO   Contract Research Organisation 
DMC   Data Monitoring Committee 
EC   European Commission 
GAfREC Governance Arrangements for NHS Research Ethics 
Committees 
ICF   Informed Consent Form 
ISRCTN  International Standard Randomised Controlled Trial Number 
MA   Marketing Authorisation 
MS   Member State 
Main REC  Main Research Ethics Committee 
NHS R&D  National Health Service Research & Development   
PI   Principle Investigator 
QA   Quality Assurance 
QC   Quality Control 
Participant  An individual who takes part in a clinical trial 
RCT   Randomised Controlled Trial 
REC   Research Ethics Committee 
SAE   Serious Adverse Event 
SDV   Source Document Verification 
SOP   Standard Operating Procedure  
SSA   Site Specific Assessment 
TMG   Trial Management Group 





Distal cervical caries (DCC) is a form of tooth decay that forms on the distal aspect 
of the mandibular second molar tooth as a consequence of third molar impaction. This 
type of dental caries forms at the cervical margin and initially forms on the root 
surface. The bacteriological profile of this type of caries is unknown. We wish to 
sample this type of caries to ascertain if the bacteria responsible for the root caries on 
the second molar teeth are the same or dissimilar to bacteria that cause other forms 
dental caries. 
 
On occasions the second molar tooth is removed as part of the patient’s treatment 
plan. This is because the patient has elected to have this tooth removed or no other 
treatment is appropriate. Teeth once removed are disposed of as clinical waste. This 
pilot study proposes to retain these teeth for bacteriological sampling and assessment 
of the caries for the bacteriological profile by DNA-DNA hybridisation technique. 
Once sampled the teeth will be disposed of as clinical waste in the conventional 
approved way. 
 
Patient’s treatment will not be altered in any way. There are no risks to patient safety 
and no benefits to patient care.    
 
2 Trial Objectives, Design and Statistics 
2.1. Trial Objectives 
• Primary Objective  - Which types of bacteria are present in dental decay 
lesions from the sample group and the proportions of the types of bacteria 
present in these carious lesions. How do these compare with known caries 
bacterial profiles as reported in the literature and where paired samples are 
taken from each other. 
 
• Primary End Point collection and assessment of 20 clinical samples 
 
2.2 Trial Design & Flowchart 
 
• Removal of decayed tooth 
• Sampling of dental caries in extracted tooth, sampling of dental plaque 
from same patient from secondary site in mouth. 
• Processing of decay/sample. 
• Identification/analysis of bacteria present in tooth decay from sampled 
teeth 
• Disposal of teeth/sample 
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2.3 Trial Flowchart 
1st appointment - patent attends for consultation, treatment plan agreed, treatment 
consent taken. If patient & treatment fulfils inclusion criteria then patient approached 
regarding study and retention of tooth for study.   
2nd appointment – patient attends for treatment, consent confirmed, treatment 
undertaken, patient discharged. Tooth/specimen retained for study. 
 
2.4 Trial Statistics 
Statistical analysis of data is not relevant to this study and collected data will not 
be subject to statistical analysis 
 
3.  Sample Size, Selection and Withdrawal of Subjects 
 
maximum 20. Sample from 20 suitable patients over 6month period. Patients will be 
identified from outpatient consultant clinics. 
 
Inclusion criteria – any patients attending for removal of mandibular second molar 
teeth that demonstrate distal cervical caries.  
 
Exclusion criteria – all other patients. Vulnerable groups who cannot give informed 
consent. Patients who are known carries of blood borne viruses. 
 
 
3.1 Inclusion Criteria  
 
Include: 
• Patients requiring the removal of a mandibular second molar tooth due to distal 
cervical caries.  
• Patients who have the capacity to give informed consent to the retention of their 
tooth for investigation. 
 
 
3.2 Exclusion Criteria  
Patients who do not fulfill the inclusion criteria. all other patients. Vulnerable groups 
who cannot give informed consent. Patients who are known carries of blood borne 
viruses. 
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3.3 Criteria for Premature Withdrawal  
Withdrawal of consent 
4.   Study procedures 
 
Informed Consent Procedures 
Patients who require the removal of their mandibular second molar teeth due to distal 
cervical caries will be advised of the research project. They will be informed of the 
nature of the project and given the information and consent form to read and consider. 
Patients willing to donate their tooth for the purposes of the research will be asked to 
sign the consent form and treatment will proceed as normal. 
 
Patients who do not wish to donate their tooth will have their treatment undertaken as 
normal. 
 
4.1 Screening Procedures - not applicable 
 
4.2 Randomisation Procedures - not applicable 
 
4.3 Schedule of Treatment for each visit  
patient’s treatment will not be altered – only change in treatment management is that 
teeth removed are sampled and then disposed as opposed to direct disposal. 
 
4.4 Follow up Procedures (if applicable)  
no follow up required 
 
4.5 Radiology Assessments  
Standard radiographic examination to aid diagnosis and treatment planning. No 
exceptional nor additional investigations required as part of this project. 
 
4.6 End of Study Definition  
On completion of 20 tooth donations/specimens 
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5. Laboratories  
Sampling of tooth decay from extracted tooth and subsequent dna-dna hybridization 
analysis of bacteria to identify bacterial flora. No human DNA analysis will be 
undertaken. 
 
5.1 Central/Local Laboratories  
microbiology. DNA- DNA hybridisation  
 
5.2 Sample Collection/Labelling/Logging  
Samples will be fully anonymised. Samples will be collected and retained in sample 
pots labelled in numerical order and logged for identification purposes. These will be 
stored cryogenically within 1 hour of sampling. Once the data set has been reached 
they will be cryogenically transferred for processing and assessment. 
 
5.3 Sample Analysis Procedures  
DNA-DNA hybridization of dental caries sampled from extracted tooth and from 
control sample of same patients 
 
5.4 Sample Storage Procedures samples will be cryogenically stored at -800c  until 
processing and assessment – after assessment they will be disposed of as clinical 
waste in the normal manner. 
 
5.5 Data Recording/Reporting  
Data will be recorded and stored on KCL computer systems. Password protected, on 
Excel software. 
 
5.6 Sample Receipt/Chain of Custody/Accountability  
Samples will be hand delivered by chief investigator to laboratory staff. Sample 
Inventory and anonomysed sample records will be recorded and retained. Sample will 
be processed and appropriately disposed of. Once disposed, disposal will be recorded.  
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5.7 Sample Transfer 
In the study, teeth will be retained from patients in accordance with the patient consent 
form and patient information sheet and shall include all tissue samples or other 
biological materials and any derivatives, portions, progeny or improvements as well 
as all patient information and documentation supplied in relation to them. Further, the 
custodian of the Materials and use the Materials for the Study only. For the avoidance 
of doubt Recipient shall only use the Material in accordance with the consent provided 
by the Study Donors (if applicable) and shall always use the Materials with dignity 
and respect and shall always use good laboratory practice in handling Materials 
The teeth and dental plaque will be sampled by Mr Louis McArdle and stored in an 
appropriately designed container. Samples will then be cryogenically stored. The teeth 
will subsequently be disposed of in the normal manner as clinical waste and in 
accordance with the Human Tissue Act 2004. Once 20 cases have been sampled, the 
samples will be cryogenically transferred to either Dr Ken Bruce, KCL or Professor 
William Wade QMUL for analysis. Bacterial DNA will to be extracted from the caries 
to identify bacteria. 
Dr Ken Bruce, KCL, or Professor William Wade will process, and dispose of the 
samples in accordance with all applicable legal and regulatory requirements, 
including the Human Tissue Act 2004 and any amendments thereto. While Provider 
uses reasonable endeavours to ensure the quality of the Materials, the Materials are 
provided ‘as is’ and it makes no representation and gives no warranty or undertaking 
in relation to the Materials, including but not limited to its safety, fitness for purpose 
or use of any kind. 
The teeth will not be transferred to any party not identified in this protocol and are not 
to be processed and/or transferred other than in accordance with the patients’ 
consent.  After ethics approval for the study has expired, the teeth will be disposed of 
in accordance with the Human Tissue Act 2004, and any amendments thereto, or 
transferred to a licensed tissue bank. 
6. Assessment of Safety  
 
not applicable – no safety issues 
 
6.1 Ethics Reporting 
no SAE possible 
7. Trial Steering Committee (if applicable) 
none applicable 
8. Ethics & Regulatory Approvals 
GSTT REC 
9. Data Handling 
Confidentiality  
No patient identifiable date will be collected or retained. Samples will be given a 
sequential numerical code 1 through 20 
Case Report Form - Not applicable 
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Record Retention and Archiving 
Consent forms will be retained in patient’s clinical notes  
Compliance 
The CI will ensure that the trial is conducted in compliance with the principles of the 
Declaration of Helsinki (1996), and in accordance with all applicable regulatory 
requirements including but not limited to the Research Governance Framework, Trust 
and Research Office policies and procedures and any subsequent amendments. 
Clinical Governance Issues 
Audit and Inspection 
Auditing: Definition “A systematic and independent examination of trial related 
activities and documents to determine whether the evaluated trial related activities 
were conducted, and the data were recorded, analysed and accurately reported 
according to the protocol, sponsor's standard operating procedures (SOPs), Good 
Clinical Practice (GCP), and the applicable regulatory requirement(s).” 
 
A study may be identified for audit by any method listed below:  
• project may be identified via the risk assessment process. 
• An individual investigator or department may request an audit. 
• A project may be identified via an allegation of research misconduct or fraud or a 
suspected breach of regulations. 
• Projects may be selected at random. The Department of Health states that Trusts 
should be auditing a minimum of 10% of all research projects. 
• Projects may be randomly selected for audit by an external organisation. 





Non-Compliance        
(A noted systematic lack of both the CI and the study staff adhering to 
SOPs/protocol/ICH-GCP, which leads to prolonged collection of deviations, breaches 
or suspected fraud.) These non-compliances may be captured from a variety of 
different sources including monitoring visits, CRFs, communications and updates. 
The sponsor will maintain a log of the non-compliances to ascertain if there are any 
trends developing which to be escalated. The sponsor will assess the non-compliances 
and action a timeframe in which they need to be dealt with. Each action will be given 
a different timeframe dependent on the severity. If the actions are not dealt with 
accordingly, the R&D Office will agree an appropriate action, including an on-site 
audit. 
 
10. Finance and Publication Policy 
 
Funding of £3,000 allocated from chief investigators KCL Special Fund NPS9104. 
Funding managed by chief investigator. 
 
Name and address of funder Funded through Kings NPS9104 (McArdle Special Fund) 
Name: Mr Louis Wm McArdle 
Address: Dept of Oral Surgery 










Appendix (i) – Information with regards to Safety Reporting in Non-CTIMP Research 
 Who When How To Whom 
SAE Chief 
Investigator 
-Report to Sponsor 
within 24 hours of 
learning of the event 
-Report to the MREC 
within 15 days of 
learning of the event 
 
SAE Report form for 
Non-CTIMPs, 
available from NRES 
website. 





Contact the Sponsor and 
MREC Immediately 




giving notice in 
writing setting out the 
reasons for the urgent 
safety measures and 
the plan for future 
action. 
Main REC and 
Sponsor  
Main REC with a 
copy also sent to the 
sponsor. The MREC 
will acknowledge 






Annually ( starting 12 















Within 90 days 
(conclusion) 
Within 15 days (early 
termination) 
The end of study should 
be defined in the protocol 
End of Study 
Declaration form 
available from the 
NRES website 
Main REC with a 
copy to be sent to the 
sponsor  
Summary of 
final Report  
Chief 
Investigator 
Within one year of 
conclusion of the 
Research 
No Standard Format 
However, the 
following Information 
should be included:- 
Where the study has 
met its objectives, the 




including feedback to 
participants 
Main REC with a 










Third Molar/Distal Cervical Caries study.  
Patient information sheet and consent form 
 




We are undertaking a research study looking at the types of bacteria that cause tooth decay in 
the types of teeth that we are taking out for you. Normally when a tooth is removed it is 
disposed of as clinical waste as directed by the Human Tissue Act (2004). As part of this 
study we would like to keep your tooth for research purposes so that we can test it to identify 
the types of bacteria that may be contributing to the tooth decay in your tooth. In addition, we 
would like to take a small smear of dental plaque from another tooth in your mouth to 
compare. 
 
What does taking part in the study involve? 
 
Your treatment will be no different – you will still have your tooth/teeth removed in the 
normal manner.  We would also wish to take a small smear of dental plaque from the surface 
of another tooth to look at the bacteria present. This will involve wiping another tooth clean 
with a sterile swab. Your tooth & dental plaque sample will then be processed to identify the 
types of bacteria present. Once it has been processed it will be disposed of in the normal 
manner as directed by the Human Tissue Act (2004).  
 
Do I have to take part in this study? 
 
No, it is completely up to you. If you do not wish your tooth to be used in this way then it will 
be disposed of in the normal manner once it has been extracted. Donating your tooth and 





Are there any risks from participating in this study? 
 
There are no additional risks to you as a patient from donating your tooth and dental plaque 
sample. Your treatment will be the same. 
 
Will the information gained from the study be identifiable to me? 
 
The samples and data that we obtain will not include any of your personal information. The 
data obtained will be stored on a computer using a unique identification number. A single 
table file will link this unique identification number with your NHS record number and this 
will be stored on a separate password protected location. Only the principal investigator will 
have access to this file.  
 
 
What if there is a problem? 
If you have a concern about any aspect of this study, you should ask to speak to the researchers 
who will do their best to answer your questions. Please contact: Principle Investigator, Mr L. 
McArdle, email: louis.mcardle@kcl.ac.uk or tel: 020 7188 4345.  
If you have a complaint, you should talk to your research doctor who will do their best to 
answer your questions. If you remain unhappy, you may be able to make a formal complaint 
through the NHS complaints procedure.  Details can be obtained through the Guy’s and St 
Thomas’ Patient Advisory Liaison Service (PALS) on 0207 1887188, address: PALS, KIC, 
Ground floor, north wing, St Thomas’ Hospital, Westminster Bridge Road, London, SE1 7EH 
. 
This trial is co-sponsored by King’s College London and Guy’s and St Thomas’ NHS 
Foundation Trust. The sponsors will at all times maintain adequate insurance in relation to 
the study independently. Kings College London, through its own professional indemnity 
(Clinical Trials) and no fault compensation and the Trust having a duty of care to patients via 
NHS indemnity cover, in respect of any claims arising as a result of clinical negligence by its 
employees, brought by or on behalf of a study patient but you may have to pay your legal 
costs. The normal National Health Service complaints mechanisms will still be available to 
you (if appropriate). 
 
What do I do next? 
 
If you wish to give consent for your tooth & sample to be used in this way we would be 
grateful if you could sign the consent form below. One copy will be stored in your patient file 
and you will be given a copy. 
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Please initial box 
1. I confirm that I have read this information sheet and that I have had the opportunity to 
consider the information, ask questions and have had these answered satisfactorily.  
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my medical care or legal rights being affected. 
 
 
3. I understand that the information collected about me may be used to support 
other research in the future, and may be shared anonymously with other researchers. 
 
4. I agree to take part in the above study. 
 
            
Name of Participant  Date    Signature 
 
            




II.III Md2M DCC bacteriological samples database. 
 
Md2M DCC Bacteriological Samples Database   
     
sample ID date collected Ipsi-lateral plaque Contra-lateral plaque DCC  
sample 
     
A 20/05/2016 A1 A2 A3 
B 27/05/2016 B1 B2 B3 
C 23/06/2016 C2 C1 C3 
D 22/07/2016 D2 D1 D3 
E 01/08/2016 E2 E1 E3 
F 08/08/2016 F2 F1 F3 
G 09/08/2016 G1 G2 G3 
H 12/08/2016 H1 H2 H3 
I 16/08/2016 I1 I2 I3 
J 21/10/2016 J1 J2 J3 
K 04/11/2016 K1 K2 K3 
L 14/11/2016 L1 L2 L3 
M 24/11/2016 M1 M2 M3 
N 25/11/2016 N1 N2 N3 
O 20/12/2016 O1 O2 O3 
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The effects of NICE guidelines  
on the management of third  
molar teeth
L. W. McArdle1 and T. Renton2
If the tooth cannot fully erupt then its 
impaction will also be defined as partial, 
where some of the tooth has erupted into 
the oral cavity; or complete, where the 
tooth is buried and completely unerupted. 
The most common third molar tooth to 
be impacted is the mandibular third molar 
followed by the maxillary third molar. 
Third molar development tends to be bilat-
eral although failure of the third molar to 
develop, either unilaterally or bilaterally, 
is not uncommon. Impacted third molars 
can cause a host of clinical problems that 
may necessitate the removal of the tooth 
to facilitate dental health.
Third molar surgery (TMS) is one of the 
most commonly performed surgical proce-
dures undertaken in secondary care within 
the NHS. When combined with out-patient 
procedures undertaken in both secondary 
INTRODUCTION
Impacted third molars (wisdom teeth) are 
one of the most common developmental 
conditions that affect humans. It occurs 
due to a failure of proper eruption of the 
third molar tooth resulting in impaction of 
the tooth against adjacent teeth, alveolar 
bone, the surrounding mucosal soft tissue 
or combination thereof (Fig. 1). The impac-
tion is defined in relation to the geometric 
angle of impaction such as mesio-angu-
lar, disto-angular, vertical and horizontal. 
Background  Third molar surgery (TMS) is probably one of the most commonly performed surgical procedures undertaken 
in the NHS. In 2000, the National Institute of Clinical Excellence (NICE) introduced guidelines relating to TMS. These recom-
mended against the prophylactic removal of third molars and listed specific clinical indications for surgery. The impact of 
these guidelines has not been fully evaluated and this research hopes to focus the effect of these guidelines over the last 
ten years. Methods  Using data obtained from a variety of NHS databases such as HES (Eng & Wales), the NHSBSA and 
data from NHS Scotland, we looked at the age range of patients requiring third molar removal and the number of patients 
having third molars removed in both primary and secondary care environments from 1989 to 2009. In addition we looked 
at the clinical indications for TMS activity in secondary care. Findings  The mean age of patients increased from 25 years 
in 2000 to 32 years in 2010, with the modal (most common) age increasing from 26 to 29 years. After the introduction of 
clinical guidelines the number of patients requiring third molar removal in secondary care dropped by over 30%, however, 
since 2003 the number of patients has risen by 97%. There is also a significant increase in caries as an indication for third 
molar removal. Conclusions  More patients are requiring third molar removal with an increasing number of patients hav-
ing caries related to their third molars. Patients are, on average, older confirming that the removal of third molars is shift-
ing from a young adult population group to an older adult population group. NICE guidelines did appear to have contrib-
uted to a fall in the volume of third molars removed within the NHS post 2000. However, concluding that this reduction 
demonstrates the success of NICE’s guidance would be a premature assumption. The number of patients now requiring 
third molar removal is comparable to that of the mid 1990s. NICE has influenced the management of patients with third 
molars but this has not resulted in any reduction in the number of patients requiring third molar removal. Coding and data 
collection for third molars is not uniform, leading to potential misrepresentation of data. This perhaps raises the issue that 
an improved universal coding system is required for the NHS and that the NICE guidelines need review.
care and primary dental care it probably 
rates as the most common surgical pro-
cedure undertaken in the whole of the 
NHS. The presence of an impacted third 
molar is a developmental condition and is 
1*-2Consultant Oral Surgeon, King’s College London 
Dental Institute 
*Correspondence to: Dr Louis W. McArdle 
Email: lwmcardle@msn.com 
Refereed Paper  
Accepted 14 May 2012 
DOI: 10.1038/sj.bdj.2012.780 
©British Dental Journal 2012; 213: E8
 Highlights that third molar removal is 
as common now as it was before the 
introduction of clinical guidelines.
 Informs that NICE guidelines have altered 
the dynamics of third molar management 
with patients on average being older.
 Stresses that dental caries associated 
with third molars has escalated by over 
200% in a ten-year period.
 Suggests NICE guidelines may be flawed 
and require review.
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Fig. 1  Mesio-angular impacted third molar 
with caries in-situ and causing caries to the 
second molar. Lower right side
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recognised as such by the World Health 
Organisation within the definitions of the 
International Coding for Diseases (ICD-10).1 
It is accepted that the removal of a diseased 
or symptomatic third molar tooth will alle-
viate pain and symptoms and improve the 
oral health and function for patients.2
The National Institute for Health and 
Clinical Excellence (NICE) issued guid-
ance on the management of third molars 
in 2000.3 They surmised that up to 40% of 
third molars removed had no clinical indi-
cation for removal and that the practice of 
prophylactic removal should be discontin-
ued within the NHS which, in turn, could 
generate an annual saving of £5 million 
for the NHS.
The impact of NICE’s guidelines has not 
been properly evaluated and NICE’s guid-
ance remains the same. This paper aims to 
evaluate the impact of NICE guidance on 
the change in clinical practice based on 
the numbers of patients undergoing third 
molar surgery, the indications for surgery 
and the changes in patient demographics 
over the last 20 years, prior to and after the 
introduction of NICE guidelines.
NICE guidelines on the management of 
third molars followed the introduction of 
other notable clinical guidelines for third 
molar management. In 1979, the National 
Institute of Health in the USA issued their 
guidelines on the management of third 
molars partly as a result of comment by 
medical insurance companies that third 
molars where being removed unnecessarily 
without any evidence-based clinical indi-
cation.4 In 1991, the American Association 
of Oral and Maxillofacial Surgeons intro-
duced their guide and parameters of care 
document.5 The first UK evidence-based 
guide to third molar management was 
issued by the Faculty of Dental Surgery of 
the Royal College of Surgeons of England 
in 1997 and most recently the guidance 
issued by NICE in 2000, complemented 
by the Scottish Intercollegiate Guidelines 
Network (SIGN) guidance also in 2000.3,6,7
NICE’s main advice relates to the indi-
cations for removal of third molars and 
that the routine practice of prophylac-
tic removal of pathology-free impacted 
third molars should be discontinued. 
Specifically, the clinical indications for the 
removal of impacted third molars should 
be limited to patients with evidence of dis-
ease (Fig. 2).
METHODS
To determine the trend in the number of 
patients in the UK having third molars 
removed over the last 20 years. Data was 
collated from the NHS Hospital Episodes 
Statistics (HES) database and the NHS 
Business Support Agency (NHSBSA).8,9 In 
addition data was also collated from the 
Information Services Division (ISD) of the 
NHS in Scotland.
HES is an NHS database that records 
secondary care hospital-based activity 
in England and Wales. Included in the 
database are all patient diagnostic codes 
based on the World Health Organisation, 
WHO ICDN-10 codes and surgical activity 
codes based on the OPCS coding system. 
For England and Wales, primary dental 
care is evaluated by the NHS BSA who, 
in 2005, took over the role that the Dental 
Practice Board (DPB) had previously. The 
DPB recorded all dental procedure codes 
for each individual dentist with a General 
Dental Services (GDS) contract in the UK. 
This allowed treatment profiles of dentists 
to be collated and analysed. Within both of 
these databases, records exist for patients 
who have had third molars removed. 
Unfortunately, the NHSBSA stopped 
recording this data in 2006, as it was not 
part of their remit. From this data we can 
determine the relative level of third molar 
removal activity in the England and Wales. 
For Scotland the same primary care GDS 
and equivalent HES secondary care data 
is collated by the ISD of NHS Scotland. 
Figures for Scotland are reviewed sepa-
rately to allow comparison post 2005 and 
the introduction of the new dental contract 
in England and Wales. In addition to these 
data, we have assessed HES data for the 
change of demographic profiles of patients 
and reviewed the clinical indication for the 
removal of third molars.
It is important to appreciate that the data 
recording by HES and the DPB/NHSBSA 
is different. Patients may have more 
than one third molar removed during a 
course of treatment and if one does not 
appreciate the nuances of data recording 
by these systems then the interpretation 
could be confusing. HES records the num-
ber of patients that have had one or more 
third molars removed whereas the DPB 
records the actual number of third molars 
removed. Consequently from HES data 
we do not know how many third molars 
were actually removed and conversely 
from the DPB data we do not know the 
actual number of patients who had third 
molars removed. Because of this, more 
third molars could be being removed in 
secondary care, as the data would allude 
to, and conversely the numbers of third 
molars being removed in primary care does 
not reflect the total number of patients and 
this has to be taken into consideration in 
collating and analysing the data.
RESULTS
HES finished consultant episodes
Data recorded by HES relates to the num-
ber of patients who have been admitted to 
hospital for either a day-case or in-patient 
procedures under either GA or IV sedation. 
In general, patients who have had third 
molars removed under local anaesthesia 
on an out-patient basis do not get included 
in HES data as this activity is recorded as 
an anonymous out-patient appointment 
and not as an out-patient surgical activ-
ity as with other surgical specialties. More 
recently, however, this type of activity has 
begun to be recorded but the true level 
of out-patient third molar removal is not 
known, and as such these out-patient fig-
ures may significantly underestimate the 
actual number of patients having third 
molars removed.
From the HES data,8 approximately 
50,000 people per annum in England 
and Wales had third molar teeth removed 
in the early period of the 1990s (Fig. 3). 
This number rose to 70,000 by the mid 
1990s and averaged approximately 60,000 
patients per year for the whole of that dec-
ade. In the first half of the 2000s patient 
numbers started to decline significantly 
i. unrestorable caries
ii.
non-treatable pulpal and/or  
periapical pathology
iii. cellulitis, abscess and osteomyelitis
iv.
internal/external resorption of the tooth  
or adjacent teeth
v. fracture of tooth
vi. disease of follicle including cyst/tumour
vii.
tooth/teeth impeding surgery or reconstruc-
tive jaw surgery, and when a tooth is involved 
in or within the field of tumour resection
Fig. 2  NICE’s clinical indications for the 
removal of third molar teeth
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and by 2003 HES data suggests that less 
than 40,000 patients per annum were hav-
ing third molar treatment undertaken in 
a hospital setting as either in-patient or 
day-case procedures: a reduction on the 
1990s average of over 30%.8
From the mid 2000s onwards, the record-
ing of a small amount of out-patient activ-
ity has been included in HES data along 
with in-patient and day-case data. Over 
the latter 5 years of the 2000s the number 
of patients having third molars removed 
had increased to almost 77,000 patients 
per annum in 2009/10 (65,000 in-patient/
day-case; 12,000 out-patient). This equates 
to an approximate increase of 67% of in-
patient and day-case activity recorded 
in the secondary care sector but a 97% 
increase in all recorded patient activity. 
By 2009/10 patients having third molars 
removed in a hospital setting was most 
notably at its highest level for 20 years.8
In Scotland, figures for in-patient/
day-case activity follow a similar trend 
to England and Wales (Fig. 4). For most 
of the 1990s just under 5,000 cases of 
third molar removal were undertaken per 
annum. Subsequent to the introduction of 
the SIGN guidelines a similar trend in the 
number of cases per annum was noted, 
dropping to approximately 1,600 cases per 
annum by 2005: a reduction of approxi-
mately 70%. Post 2005, however, a steady 
year-by-year increase was noted and by 
2009/10, the numbers of patients had 
increased to approximately 2,800 cases: 
an increase of 67% from the low of 2004/5.
NHSBSA/DPB 2204/2205 codes
The NHSBSA/DPB records items of treat-
ment of each patient rather than treat-
ment episodes for patients.9 The Statement 
of Dental Remuneration (SDR) document 
provides the item of service codes used 
previously under the old General Dental 
Services Contract.10 SDR Codes 2204 and 
2205 are third molar specific and although 
third molars would have undoubtedly been 
removed under other codes such as 2101 
and 2201, these codes are not tooth specific 
and cannot be used to identify third molar 
activity. In addition, SDR codes 2204/5 
can identify both mandibular and maxil-
lary teeth separately. This data set is limited 
to exclusively mandibular third molars, as 
the combined total of both maxillary and 
mandibular third molars removed may 
not accurately reflect the actual number 
of patients having third molar surgery. By 
restricting our data set to exclusively man-
dibular third molars we get a less distorted 
perception of the actual number of patients. 
In addition, mandibular third molars tend 
to cause greater clinical problems, are more 
surgically complex and have greater post-
operative morbidity, making them the focus 
for most published research.
For the period of 1992–2005 in England 
and Wales GDS, the trend in third molar 
activity follows a comparatively similar 
pattern to secondary care (Fig. 5). For most 
of the 1990s approximately 80,000 man-
dibular third molars were being removed 
per annum. Subsequent to 2000, the num-
bers of mandibular third molars removed 
declined steadily by over 60% reaching a 
level of 28,000 per annum for 2004/5. Data 
for after this period is not available, as the 





































































































































































































































































Fig. 3  Patients requiring third molar removal in secondary care: England and Wales
Fig. 4  Patients requiring third molar removal in secondary care: NHS Scotland
Fig. 5  Number of mandibular third molars removed in primary dental care: England and Wales
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In Scotland, data for third molar activ-
ity continues to be collated for general 
dental practice (Fig. 6). In the first half of 
the first decade of the new millennium, 
there was a 36% fall in mandibular third 
molars removed, mirroring the yearly 
trend of reduction in England and Wales. 
After 2004, however, mandibular third 
molar removal progressively increased 
and by the end of the decade was 130% 
greater than at its lowest level of 2004. 
This trend cannot be properly compared 
with the post-2005 new General Dental 
Services (nGDS) trend in England and 
Wales but it does complement the upward 
trend of secondary care third molar activ-
ity seen in both England and Wales, and 
in Scotland, which saw an increase of 67% 
over the same time period for day-case/ 
in-patient procedures.
Age
HES data reports that the average age of 
patients requiring third molar removal 
within the NHS has increased over the 
last 20 years. In 1990, the average age 
of a patient having third molars removed 
as a day-case/in-patient procedure was 
25 years. This mean age has steadily risen 
and now the mean age for patients hav-
ing third molars removed as a day-case/
in-patient is 32 (Fig. 7).8
Clinical indications for third molar 
removal in secondary care
HES data also records the main clinical 
diagnosis for third molar removal (Fig. 8).8 
The most common recorded OPCS-10 cod-
ing and indication for third molar removal 
relates to embedded and impacted teeth 
(K01.0/K01.1), paradoxically these are not 
a NICE indication for third molar removal. 
In 1995 embedded/impaction is recorded as 
the main diagnosis for approximately 70% 
of all third molars removed (Fig. 4). Over 
the next 15 years there was an increase in 
the proportion of caries or related peri-api-
cal abscess (K02.9/K04.7) being recorded as 
the main diagnosis from less than 10% in 
1995, rising to almost 30% by 2009. In the 
same period, periodontitis (K05.2/K05.3), 
as a recorded main diagnosis, stayed at a 
relatively constant level at approximately 
15%. One notable anomaly from the cod-
ing system is that pericoronitis is coded as 
periodontal disease and not as a separately 
defined condition.1
DISCUSSION
In 2004, a review of the impact that NICE 
guidance was having over a range of clini-
cal interventions suggested that NICE had 
no discernable effect on the management 
of patients with third molar teeth.11 Data 
used by this study covered the period from 
1995-2001, which observed a downward 
trend in third molar removal during this 
time. It was suggested that the downward 
trend in third molar removal had already 
begun as a consequence of guidance issued 
by the Royal College of Surgeons of England 
in 1997 and by the University of York in 
1998.6,12 The sampling period of data was 
short and only included a single year after 
the introduction of NICE. Data prior to 1995, 
however, suggests that third molar removal 
was at a similar level for most of the 1990s 
with 1995 being the peak year within that 
decade. With the introduction of NICE’s 
guidelines only occurring in 2000, it seems 
inappropriate to make this conclusion after 
only one year’s worth of post-NICE data and 
a relatively short sample period.
It would appear that a decline in patients 
having third molars removed did start 
in the late 1990s with the introduction 
RCS(Eng) guidelines but our data suggests 
a significant reduction of third molar 
removal with the introduction of the NICE/































































































































































































Caries & related infection
Periodontal disease
Impacted or embedded
Fig. 7  Average age of patients requiring third molar removal in secondary care: England and 
Wales
Fig. 8  Main clinical diagnosis for third molar removal in secondary care: NHS England and 
Wales
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the staggered introduction of the RCS(Eng) 
guidelines, the University of York’s clinical 
effectiveness document and the NICE/SIGN 
guidance continued to reinforce the advice 
to the dental profession that third molars 
need not be removed.3,6,7,12
In general dental practice the numbers 
of third molars being removed reduced by 
over 50% by 2005. For secondary care, 
data showed a 40% reduction in patients 
having third molars removed from a peak 
of 70,000 in the late 1990s down to 40,000 
in the mid 2000s. On NICE’s premise that 
40% of all third molars being removed 
had no clinical indication for removal, 
then this data suggests that third molar 
guidelines were having the desired effect 
of reducing the number of third molars 
being removed and therefore reducing 
healthcare expenditure in this area.
Although data post-2005 is not available 
for the GDS in England and Wales, the data 
from Scotland and HES would suggest that 
this dip in primary care third molar activity 
in England and Wales might also be only 
temporary. Within secondary care in England 
and Wales, the fall in third molar activity 
mirrors primary care with numbers stead-
ily falling from the late 1990s until 2002/3. 
Following this, however, the numbers for 
third molar removal in secondary care began 
to rise steadily with an increase from 39,000 
patients per year in 2002/3 to almost 77,000 
patients by 2009/10 (65,000 in-patient/day-
case; 12,000 out-patient): a total increase of 
97% in 7 years. Furthermore, the data from 
NHS Scotland mirrors this increase in third 
molar activity by 67% in secondary care 
provision, and by 130% for general dental 
services for the latter half of the 2000s.
The reasons for this increase in third 
molar activity in the latter half of the 
2000s and the specific increase in second-
ary care activity may be explained by two 
possible hypotheses:
The possible influence of the new 
General Dental Services (nGDS) 
contract in England and Wales in 2005
A link between the increasing age of 
patients and the increasing incidence 
of caries related to third molars.
The new General Dental Services
The new General Dental Services (nGDS) 
contract was introduced in England 
and Wales in March 2006, whereas the 
GDS contract in Scotland has remained 
relatively unchanged. Dental treatment 
was previously provided at a cost per treat-
ment item. The new GDS contract is based 
on the provision of treatment within treat-
ment bands. At present, the treatment band 
generates the fee rather than the service 
item, or the quantity of different service 
items. Consequently, this results in NHS 
dentists receiving the same fee for a course 
of treatment that may include just a single 
restorative procedure and the exact same 
fee for a course of treatment for multiple 
restorative procedures, endodontic proce-
dures and extractions. In this example the 
fee for a band 2 course of treatment may 
be in the region of £60-£70 and realisti-
cally this limited fee for multiple items of 
treatment does not necessarily cover the 
actual cost of providing the treatment.
As the contract does not offer remunera-
tion based on the time the dentist spends 
with the patient, nor for the number nor 
complexity of treatment items, it has been 
suggested that dentists are unwilling to 
undertake some of the more complex 
treatment items on the NHS and are sub-
sequently referring patients to other provid-
ers for treatment.13 The new GDS contract 
allows GDPs to refer patients for treatment 
that they themselves do not feel able to 
provide, whilst still claiming payment for 
the treatment. This may explain why refer-
rals to hospital secondary care providers for 
oral surgery procedures, such as third molar 
extractions, has dramatically increased 
over the last five years. As such, oral sur-
gery referrals to this teaching hospital in 
London have observed a 100% increase 
since 2004/5.14 These observations may only 
be partly attributable to the increase in third 
molar removal in secondary care over the 
last five years, as the trend in secondary 
care third molar removal had already started 
to rise prior to the introduction of the new 
contract. From the trough of 2003 through 
to 2005, the year before the new contract 
was introduced in England and Wales, third 
molar activity was already on the increase. 
In Scotland, this upward trend in third molar 
removal post-2005 is mirrored in both pri-
mary and secondary care settings, suggest-
ing that the upward trend in England and 
Wales may be multi-factorial.
Dental caries and age
In relation to third molars, caries can affect 
the third molar itself or more significantly 
occur in the distal cervical area of the sec-
ond molar tooth due to the mesio-angular 
impaction of the third molar against it. 
Caries is a disease that is relatively slow 
to develop compared with pericoronitis 
and as a consequence caries develops 
later in patients by comparison.15,16 From 
the HES data we have observed a signifi-
cant increase in the number of patients 
requiring third molar removal. For the 
last ten years the recorded incidence of 
caries and its sequalae, as an indication 
for removal, has increased from less than 
10% to almost 30% of all patients requir-
ing third molar removal.8 Over the last 
ten years the recorded incidence of patients 
having third molars removed due to dental 
decay has increased by over 200%.8
It may be that the rapid dip in the 
number of third molar extractions in 
the early 2000s was due to a rigid inter-
pretation and application of third molar 
guidelines and as such third molars were 
actively not removed. This may be true in 
cases of single or mild forms of pericoro-
nitis or solely the presence of a partially 
erupted and impacted third molar that 
may have been used as the indication for 
removal pre-2000.
Third molars are not erupting later in 
life to account for the increase in mean 
age from 26 to 32 during the last 20 years. 
Third molars are being retained for longer, 
either as a result of lack of disease affecting 
younger patients, or a palliative approach 
to the management of third molar disease. 
Patients may be more inclined to be treated 
with antibiotics for recurring episodes of 
pericoronitis and thus avoid, or more 
likely, delay the removal of the third molar.
The fact that patients are retaining third 
molars later into life makes them more vul-
nerable to one of the problematic conse-
quences of the oral environment: dental 
caries. The likelihood of this will be evident 
especially if the teeth are impacted, par-
tially erupted and difficult to clean. Older 
patients with good dental health are more 
prone to having third molar teeth removed 
because of caries related indications such 
as DCC in the second molar.15-19 This data 
confirms that as patients have become 
older, dental caries has become an ever-
increasing problem related to third molars. 
This group of patients may be contributing 
to the rebound increase in the number of 
third molars being removed.
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With the mean age of patients increas-
ing from 26  to 32 years of age, we see 
an increase in the number of patients 
requiring third molar removal due to car-
ies. Over the age of 30, patients are more 
likely to have third molar teeth removed 
due to the effects of caries than those who 
are younger.15-18 Consequently, would it be 
reasonable to consider that any asymp-
tomatic, partially erupted, impacted third 
molar, if retained, may ultimately cause 
patients clinical problems such as caries? 
If these problems are detrimental to the 
dental health of the patient then should 
we not consider defining the optimum time 
for removal – either at the time of disease 
presentation or even prior to the damage 
that the disease may cause – especially if 
the damage is related to the second molar 
in the form of distal cervical caries?
ICD-10 coding
There appears to be a lack of specificity in 
coding as it relates to studies such as this, 
which leads to problems in interpretation. 
Caries as a diagnosis is too non-specific 
for coding purposes. Caries associated with 
the third molar is an indication for third 
molar removal but distal cervical caries 
(DCC) on the second molar in the presence 
of a mesio-angular third molar is also an 
indication for third molar removal. Both of 
these clinical conditions appear to be on 
the rise in older age groups.15-18 The cod-
ing system does not allow us to isolate the 
nature of the decay and as a consequence 
limits our ability to interpret accordingly. 
Nonetheless, caries related to third molars 
is on the increase and its consequences 
have to be managed.
Pericoronitis is a definable clinical prob-
lem that affects partially erupted teeth and 
accounts for the removal of up to 60% 
of all mandibular third molar teeth.20-24 
Pericoronitis is not, however, recognised 
by the WHO-ICDN coding system as a 
unique diagnosis and its classification as 
periodontal disease is erroneous.1 This flaw 
creates serious problems in accurate data 
interpretation. If databases are recording 
ICD-10 codes of K05.2 or K05.3 do they 
mean periodontal disease or pericoronitis? 
Local periodontal disease affecting the sec-
ond molar tooth, in addition to periodontal 
disease of the third molar itself, are distinct 
indications for third molar removal, but to 
classify both pericoronitis and periodontal 
disease together is inappropriate and 
makes data interpretation difficult.
Impaction and embedded teeth are not 
in isolation an indication for third molar 
removal but merely an observation of 
the ectopic position that the tooth devel-
ops into. A tooth’s abnormal position 
is a developmental anomaly and along 
with other developmental anomalies is 
defined within the ICD-10 coding sys-
tem.1 This developmental anomaly ulti-
mately accounts for the disease processes 
that affect impacted teeth, but recording 
the developmental anomaly rather than 
the disease that it predisposes, creates an 
imbalanced observation of the indications 
for third molar removal. In view of the 
actual HES incidence of impaction being 
comparable with the reported incidence 
of pericoronitis, it could be presumed that 
impaction is being recorded instead of 
pericoronitis.2,8,20-24
Accurate data collection in third molar 
studies and clinical coding systems is 
essential if data is to have any meaningful 
value. If the WHO ICD system is to be used 
for third molar data collection then it will 
require an overhaul to be fit for this pur-
pose and to appropriately reflect the actual 
disease processes that afflict third molars.
CONCLUSION
With the introduction of clinical guide-
lines a decline in patients having third 
molars removed has occurred. This trend, 
however, has now been reversed and has 
steadily increased to pre-NICE levels. 
Any initial financial savings would have 
been short-term and with more patients 
attending secondary care for third molar 
procedures, costs are now greater than 
prior to the introduction of NICE. Patients 
are becoming older and more patients 
are experiencing caries as an indication 
for third molar removal even though the 
dental and oral health of the population 
continues to improve.25,26 Indeed patients 
with mandibular third molars who suc-
cumb to DCC on their second molar teeth 
have on average better dental health than 
their peers.16
It has been appreciated for some time 
that as the dental health of the population 
has improved, the early loss of first molar 
teeth in children and adolescents does not 
occur as frequently as before.27 Early loss 
of the first molar results in the forward 
drift and/or tipping of the second molar, 
creating space distally for the third molar 
to erupt unhindered and thus reduces 
the likelihood of impaction. Conversely, 
retention of the first molar restricts this 
space in the retro-molar area and no doubt 
contributes to the likelihood of impaction 
of the third molar tooth.27 The increase 
in third molar surgery seen over the last 
30-40 years may not be due to inappropri-
ate over-prescribing or prophylactic third 
molar removal but may, in fact, be due to 
the paradoxical consequence of improved 
dental health. It is likely that the number 
of patients requiring third molar removal 
will always be substantial.
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Abstract
In 2005 we reported the clinical findings of 100 patients who had mandibular third molars removed because of distal cervical caries in the
mandibular second molar. The aim of this follow-up study was to find out whether the findings in a new group of patients corroborate those of
our previous study. We report on the clinical features of 239 patients (mean (SD) age 32.1 (7.85) years, range 20–65) who had 288 mandibular
third molars removed because of distal cervical caries in the second molar. Patients had better dental health than average, and 67% had a DMF
(decayed, missing, or filled) score of 5 or less. In 89% of third molars the mesial angulation was between 40◦ and 80◦. Distal cervical caries in
second molars is a late complication of third molar retention. The prophylactic removal of a partially erupted mesioangular third molar will
prevent distal cervical caries forming in the second molar tooth.
© 2013 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
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Introduction
Current UK clinical guidelines for the management of third
molars advise against the prophylactic removal of healthy
impacted teeth,1–3 and suggest that there is no reliable evi-
dence to support it. Consequently, current practice is to
remove teeth only if they cause disease.4
Partially erupted, mesioangular impacted mandibular
third molars that are in contact with the second molar around
the amelocemental junction put the second molar at risk of
developing distal cervical caries (Fig. 1),5–8 which is a car-
ious lesion that forms on the distal cervical root surface of
the second molar. Mesioangular impaction of the third molar
on to the second molar creates a deficient gingival collar and
∗ Corresponding author. Tel.: +44 020 7188 3435; fax: +44 02071884360.
E-mail address: louis.mcardle@kcl.ac.uk (L.W. McArdle).
exposes the distal root surface of the second molar to the
oral environment. The area is difficult to keep clean so den-
tal plaque forms and persists, and results in distal cervical
caries in the second molar. The third molar must be removed
to enable restoration of the second molar, but in certain cases
this might not be possible, and the second molar may also
need to be extracted.
In 2005 we reported on 100 patients who had mesioangular
impacted third molars removed because of the presence of
distal cervical caries in the second molar.8 They tended to be
5 years older than the average for patients having third molars
removed and their dental health was also better than average.8
We suggested that these patients presented with distal cervical
caries because earlier in life they had not had any serious
third molar disease such as pericoronitis, which would have
indicated removal of the tooth.8 Consequently, retention of
these teeth promotes the formation of distal cervical caries in
the second molar.
0266-4356/$ – see front matter © 2013 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
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Fig. 1. Radiograph of distal cervical caries in the mandibular second molar
with associated impacted mesioangular third molar.
The aim of this follow-up study was to assess a further
group of patients with distal cervical caries in their mandibu-
lar second molars to find out if the findings corroborated those
of our 2005 study.
Methods
We evaluated 239 patients who had mandibular third molars
removed because of the presence of distal cervical caries in
the second molar. Data were prospectively collected over a
24-month period.
The variables that we recorded were sex, age, angulation
and eruption status of the third molar, DMF (decayed, miss-
ing, or filled) score, and the proximity of the third molar to
the amelocemental junction of the second molar.
As in our previous study, the DMF score was used as
a measure of dental health. In calculating the score we
compensated for, and excluded, the second molar if distal
cervical caries was the only lesion associated with the tooth.
The mesial angulation of the third molar was calculated by
measuring the angle of intersection between the mandibu-
lar occlusal plane and the occlusal plane of the third molar.
This angle equates to the mesial inclination of the third molar
relative to the second molar.8
Results
The study included 239 patients (142 men and 97 women).
In 190 patients, a single second molar was affected, and both
were affected in 49 (bilateral disease). In total, 288 mandibu-
lar third molars were extracted, 144 from each side.
The mean (SD) age of the patients was 32.1 (7.85) years
(range 20–65) (Fig. 2). A total of 161 patients (67%) had a
DMF score of 5 or less; 56 (23%) had a score of between 6
and 10, and 22 (9%) had a score of 11 or more. Of note, 50
patients (21%) had a compensated DMF score of zero as the
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Fig. 2. Age range of patients (years) compared with percentage number of
patients. Mean (SD) age 32.1 (7.85) years (range 20–65).
All 288 teeth were partially erupted. Radiographic exam-
ination showed that all were in contact with, or close to, the
amelocemental junction of the second molar, and all were
mesioangularly impacted against the second molar. Mesial
angulations of the third molars were grouped accordingly:
255 (89%) had an angulation of between 40◦ and 80◦; in 28
(10%) it was less than 40◦, and in 5 (1%) it was more than
80◦.
Discussion
To our knowledge, distal cervical caries in the second molar
has not been reported without an associated mesioangular
third molar, and we have not observed it. Although caries
can form on the distal aspect of any tooth, distal cervical
caries is unique as it is seen at the amelocemental junction
and is, in effect, a variant of root surface caries. We think that
it would not develop without an associated impacted third
molar.
Concern has been raised that in some studies, radiographic
cervical burnout may have been misdiagnosed as distal cer-
vical caries resulting in a higher reported incidence.9 In this
study, as in our previous study, patients whose radiographic
images suggested cervical burnout were excluded from the
study (Fig. 3).
A factor that is associated with the risk of distal cervi-
cal caries developing in the second molar is the angulation
of the third molar. This type of second molar caries is seen
Fig. 3. Radiograph of radiographic distal cervical burnout potentially mis-
interpreted as distal cervical caries.


















Fig. 4. Mean DMF (decayed, missing or filled) score of patients having
third molars removed because of distal cervical caries (2012) (light blue)
compared with mean DMF score calculated from the Adult Dental Health
Survey 2009 (dark blue).15
primarily in association with mesioangular impacted third
molars and, as in other studies, we found that a mesial angu-
lation of between 40◦ and 80◦ was common.8–14 Of the 288
third molars extracted, 255 (89%) were within this range.
Mesial angulations outwith this range and in some cases of
horizontal impaction have been associated with distal cervi-
cal caries in second molars, but it has not been seen in vertical
or disto-angular impactions.
Based on the 2009 Adult Dental Health Survey (ADHS),
the mean DMF score for patients with distal cervical caries
was less than half the mean score for similar age groups in the
general population (Fig. 4).15 This also corresponds to our
findings in 2005 which were based on the 1998 ADHS.8,16 It
supports our suggestion that patients with better dental health
are more likely to retain a partially erupted third molar later
into life, and when this is mesioangular, are at risk of dis-
tal cervical caries developing in the second molar.8 It also
contradicts the notion that susceptibility to distal cervical
caries in second molars is solely associated with an increased
susceptibility to dental caries.5–7
It is logical to assume that people with low DMF scores
have a good standard of oral hygiene and this includes the
coronal aspect of partially erupted third molar teeth. Good
oral hygiene minimises the likelihood of pericoronitis and
results in the long-term retention of such teeth, but in the
case of a mesioangular third molar and a second molar with
a distal cervical root exposed to the oral cavity, distal cer-
vical caries is a potential outcome. It seems to develop in
older patients and this may be reflected in the protracted time
it takes for dental caries to form compared with the time
it takes for pericoronitis to develop after a third molar has
erupted.8,17
The mean age of patients in this study was 32.1 years
(range 20–65), which is comparable with the mean age
(32 years) for all patients who have third molars removed
in the UK.18,19 In our previous study patients with dis-
tal cervical caries tended to be 5 years older than average
whereas this study suggests that they are similar in age.19
This may be because in the UK, the introduction of third
molar guidelines by the National Institute for Health and
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Fig. 5. Increasing percentage incidence of caries and related disease (blue
line) as main indication for removal of third molars, and increase in mean
age of patients (orange line) having third molars removed.18,19
away from the prophylactic removal of third molars, pri-
marily in younger patients, to removal based on definitive
clinical indications.1–4,19 The consequence of this has been an
increase in the mean age of patients from 28 to 32 years.18,19
The incidence of third molars being removed because of
caries and related sequelae such as periapical infection has
also increased from 4% to about 30% (Fig. 5).18,19 The mean
age in our group suggests a relation with an increased mean
age and a higher incidence of third molar caries in general,
as is the case with an increasing incidence of distal cervical
caries in older patients.17,19
It is not possible to isolate data from NHS agencies on
caries that solely affect the third molar or on distal cervical
caries of the second molar that is attributed to the third molar,
but the general trend of an increase in caries related to third
molars is noteworthy.18,19 Distal cervical caries in second
molars in association with impacted third molars is becoming
more widely reported, and is not isolated to any specific racial
group.10–14 Recent studies have reported an incidence of up
to 20% in patients having third molars assessed, and some
report an incidence of about 40% in mesioangular impacted
third molars.10,11
Older studies report a mean age of around 25 years for
patients having third molars removed, and report pericoro-
nitis as the most common indication.20–24 As these studies
were published when the prophylactic removal of third
molars in younger patients was common, their mean age
was lower.20–24 The incidence of third molars being removed
because of caries in younger patients is relatively low, and
historically the reported incidence of distal cervical caries in
second molars in these patients has also been relatively low
(2–5%).8,17,19,20
As distal cervical caries is responsible for a rising per-
centage of third molars being removed we think that there is
a high risk of it developing in a second molar.10–14,17 How-
ever, pericoronitis is still the most common indication for
the removal of third molar teeth, and it is diagnosed more
often in younger patients.5,7,17,20,23,24 In these patients the
extraction of mandibular mesioangular third molars removes
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the main contributing factor for distal cervical caries in the
second molar. If pericoronitis was less common in younger
patients then more third molar teeth would be retained later
into life. As a consequence, we suggest that the incidence
of distal cervical caries in the second molar will rise accord-
ingly, as is the case with that of general caries that are related
to third molars in older patients.17–19
We need to consider whether all partially erupted mesioan-
gular third molars would eventually cause distal cervical
caries in the second molar. A study of this latent potential
would require the enforced retention of a mesioangular third
molar to observe its effect on the adjacent tooth, but this
would be unethical and unavoidably protracted over many
years. The introduction of clinical guidelines such as NICE
has resulted in an older patient population whose third molars
are retained until specific problems indicate their removal. In
some respects the patient whose third molar is retained later
into life is acting as their own control to the long term con-
sequences of retention as is demonstrated by the increasing
incidence of third molar caries (4-30%) correlating with the
increasing mean age of patients (Fig. 5).
The potential risk of distal cervical caries forming in sec-
ond molar teeth that are associated with mesioangular third
molars presents a clinical dilemma: should the third molar
be left until disease develops, or should it be removed, and if
so, when? Clinical risk should influence the decision and the
relative risk – for example, of nerve damage, is an important
consideration. Early removal of a third molar with a high risk
of injury to the inferior dental nerve may not be prudent and
in such a case alternative options such as coronectomy could
be considered.
Conclusion
We do not think that all third molars should be removed pro-
phylactically, but early, prophylactic removal of a partially
erupted mesioangular mandibular third molar will prevent
distal cervical caries forming in the adjacent tooth. Mesioan-
gular third molars will not always cause distal cervical caries
to form as many will be removed because of pericoronitis and
other diseases before it ensues, but we do suggest that every
partially erupted mesioangular third molar has this poten-
tial. Only with further research and debate will we know
whether or not targeted prophylactic removal of such teeth
is acceptable. The cost–benefit and cost–effectiveness of this
are complex issues and are out of the sphere of this paper,
but prophylactic removal will be explored in further ongoing
research.
The results of our 2 studies and others confirm that dis-
tal cervical caries in the second molar is associated with the
retention of a partially erupted mesioangular third molar tooth
into later life.8,10–14 As this study corroborates our previ-
ous findings we suggest that the conservative management
of disease-free, partially erupted, mesioangular mandibular
third molars may be detrimental to dental health.
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a b s t r a c t
Aims: Distal Cervical Caries (DCC) of the mandibular second molar (Md2M) is primarily
related to retained mesially impacted third molars (Md3M). Treatment of this condition
indicates the removal of the Md3M and the restoration of the Md2M and, on occasions, the
loss of the Md2M. The aim of this study was to determine the incidence, treatment out-
comes for patients, and calculate costs related to Md2M DCC.
Methods: A review of 121 patients who had Md3M removed due to Md2M DCC was under-
taken to determine the treatment outcomes for patients. The number of patients affected
by DCC of Md2M was calculated from the incidence of DCC (15%) in a cohort of patients
requiring Md3M removal (1100) and the annual number of patients undergoing third molar
surgery in England. Direct costs were calculated using NHS and independent treatment
tariffs and indirect costs from Office of National Statistics (ONS).
Results: It is estimated that 152,000 patients in England undergo third molar removal on an
annual basis. Approximately 27,000 Md3M are removed annually due to DCC of the Md2M;
costing £27 m to treat with additional costs of £28 m if dental implant replacement of the
Md2M is included. Total cost for treating Md2M DCC: £55 m/annum.
Conclusions: Treating Md2M DCC and its consequences is expensive for healthcare funders
such as the NHS and for patients. Md2M DCC is avoidable if patients who are at risk have
prophylactic Md3M removal. This would offer potential and substantial savings in the
financial cost of treating an otherwise avoidable disease.
© 2016 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and
Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.
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Introduction
The presence of partially erupted, mesio-angular, mandibular
third molar teeth (Md3M) are a causal factor in the develop-
ment of Distal Cervical Caries (DCC) on adjacent mandibular
second molar teeth (Md2M).1e7 DCC is defined as a carious
lesion, which occurs at the exposed disto-cervical amelo-
cemental junction of a tooth and is seen most frequently
related the Md2M.1,7 As a consequence of DCC formation,
treatment of the second molar, either in the form of restora-
tion of the second molar or removal of the second molar is
indicated. Moreover, the diagnosis of second molar DCC will
require the removal of the Md3M, not only to facilitate the
restoration of the second molar but also to eliminate the risk
of recurrence of DCC in the second molar.
Although the specific treatment of the secondmolar will be
determined by various clinical and patient factors, the defin-
itive treatment outcomes for patients with thirdmolar related
DCC of the second molar has not been quantified. This paper
evaluates the treatment outcomes for second molar teeth
affected by DCC in a cohort of patients who had their Md3M
removed as a consequence of DCC and estimates the relative
costs of managing this disease.
Method
Data from two previous published studies of patients with
DCC in 2006 and 2014 were combined.1,7 This data identified a
total of 339 patients who had their Md3M removed due to DCC
of the Md2M. Of these 339 patients, 121 patients had
contemporary contact details. Advice was sought regarding
the need for ethical approval but was deemed not be required.
These patients were contacted and asked to confirmwhat the
treatment outcome was for their Md2M tooth, subsequent to
the removal of their third molar tooth: 84 patients responded.
Results
Of the 84 patients, 44 were female and 40 were male. 26 pa-
tients (30%) confirmed that their Md2M had either been
extracted at the time of third molar removal or subsequent to
third molar removal; 26 patients (30%) confirmed that they
had had the second molar tooth restored and that it was still
present. A further 10 patients (12%) confirmed that they had
endodontic treatment of the secondmolar prior to restoration
of the tooth. 22 patients (27%) could not recall what treatment
they had for their second molar and could not confirm if the
second molar tooth was present or not (Fig. 1).
Of the 84 patients, 38 were from the 2006 cohort and 46
from the 2014 cohort. Of the 2006 cohort; 24% of secondmolar
teeth had been extracted, 45% were restored and 31% could
not recall what treatment they had. Of the 2014 cohort: 35%
had been extracted, 41% were restored and 24% could not
recall what treatment they had.
Of the 62 patientswho could recall the treatment outcomes
for their second molar tooth, 26 patients (42%) had their sec-
ond molar removed, 26 patients (42%) had their second molar
restored and 10 patients (16%) had their second molar
endodontically treated in addition to restoration (Fig. 2).
Discussion
DCC in the second molar is most commonly associated with
Md3M teeth but it is also seen with maxillary third molars.1e7
The majority of third molars associated with DCC on the
second molar are mesio-angularly impacted, with a smaller
incidence observed with horizontal impactions: DCC has not
been observed in association with vertical, disto-angular, or
ectopic impactions.1,7
The presence of the partially erupted mesio-angular third
molar impacting against the second molar creates a deficient
gingival collar around the secondmolar tooth which results in
exposure of the distal cervical root surface of the second
molar to the oral environment.1,7 The inaccessibility of this
area for adequate oral hygiene results in cariogenic plaque
formation and consequent dental caries in this area. The
partially erupted third molar is causal to the formation of DCC
in the second molar as it is not observed in the absence of an
adjacent third molar.1e7
As already stated, treatment outcomes for patients with
DCC include removal of the third molar to facilitate restora-
tion of the second molar tooth. Conservative treatment of the
secondmolar toothmay involve uncomplicated restoration of
the tooth but in some cases the tooth will also require end-
odontic treatment and more complex and expensive restora-
tion. In other cases itmay not be possible to restore the second
molar and removal may be indicated either concurrent with
the removal of the third molar, later if restoration of the sec-
ondmolar becomes unfeasible or; ultimately it may, in its own
right, fail at a later stage. In patients in which it is not feasible
to restore the second molar tooth and this tooth is indicated
for removal, the thirdmolar may, in some cases, be retained if
it is disease free, as removal of the third molar may be clini-
cally meaningless. In the majority of cases of patients with
DCC in the Md2M the immediate and long-term prognosis for
this tooth is poor and the likelihood of the tooth lasting
indefinitely would be guarded.
Restoration of the second molar tooth whilst overlooking
the need for removal of the third molar tooth is not clinically
pragmatic. This makes restoration of the second molar diffi-
cult and ultimately the third molar persists in compromising
the second molar either from the risk of secondary DCC or
periodontal problems (Figs. 3e5). In cases where potential
third molar removal will have a significant risk of IDN injury
consideration may be given to undertaking a coronectomy
procedure on the thirdmolar to eliminate the casual influence
and the potential effect of the third molar.7
In estimating the cost of DCC, a number of factors need to be
taken into account. The number of patients with DCC and the
proportion of different treatment outcomes related to these
patients have to be calculated. In addition, the direct monetary
cost of each of treatment modality and the indirect costs of
treatment need to be quantified. The cost of second molar DCC
may be difficult to calculate as, although the loss or restoration
of a tooth has a financial cost, the ongoing long-term costs of
maintenance and possible loss will change with individual
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Figure 1 e Reported outcomes for patients with DCC in Md2M.
Figure 2 e Known reported outcomes for patients with Md2M DCC.
Figure 3 e Md2M (47) RCT'd and restored with deficient
restoration distally. Retained mesially impacted Md3M (48)
restored due to caries.
Figure 4 e Md2M (37) RCT'd and restored with
compromised periodontium and loss of clinical attachment
distally. Mesially impacted Md3M (38) retained.
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circumstances. In addition, costs tend to be qualified, not only
by these direct costs of the intervention, but also by the indirect
costs for the patient such as loss of patients’ earnings due to
time off work, loss of productivity due to absence from work
and intangible costs such as pain, incapacity and compromised
occlusal function if the second molar is lost.
How many patients may be affected by DCC?
It has been reported that Md2M DCC may contribute to be-
tween 5% and 40% of all Md3M removed.1,2,7 These figuresmay
be underestimated andmay be increasing as a consequence of
the changing practice in the management of third molar
teeth.8e10 The incidence of caries as an indication for third
molar removal has risen from less than 10% in 2000 to 30% in
2010.8,9 DCC is predominately seen in patients in their early
30s and it has been reported that the mean age of patients
having thirdmolar removal has increased from 28 to 32 during
this time period also.1,7e9 In considering both of these factors
itmay be reasonable to presume that the incidence of DCCwill
also have risen during this period. Unfortunately NHS data-
sets do not record DCC as a specific diagnosis for third molar
caries, however audited data based sample of 1100 patients
has demonstrated that second molar DCC accounts for
approximately 15% of all patients requiring Md3M removal.11
Furthermore DCC is seen predominately related to mesio-
angularly impacted third molar teeth and consequently the
incidence of DCC solely related to mesio-angular third molar
impactions will be substantially more.1e7
Data collection related to thirdmolar removal is poor in the
UK as there is no accurate record of patients undergoing third
molar removal on an annual basis.8,9 Primary care data for
thirdmolar removal has not been recorded since 2004/5 and in
hospital admitted in-patient and day-case activity is recorded
but data for out-patient third molar removal under local
anaesthesia is poorly recorded which accounts for a signifi-
cant proportion of secondary care third molar activity.
Nonetheless, using data from online Hospital Episodes
Statistics (HES) and internal hospital dataset statistics we can
estimate the volume of thirdmolar removal undertaken on an
annual basis. From HES online we can calculate that in 2013/
14 there were approximately 67 k patients requiring third
molar removal as an in-patient or day-case hospital admis-
sion in England and 16 k on an out-patient basis.12 These
treatment episodes only represents a fraction of all third
molar activity as historically third molar removal under local
anaesthesia within the hospital secondary care setting is
poorly recorded as an actual third molar treatment episode.
Guys and St Thomas's NHS Foundation Trust (GSTT) is a large
tertiary teaching hospital in central London. Its Oral Surgery
Department undertakes in excess of 2300 patient treatment
episodes for thirdmolar removal on an annual basis. Data sets
relating to these patients demonstrate that approximately
1500 patients are admitted for thirdmolar removal under day-
case general anaesthesia or sedation and 800 patients on an
outpatient, local anaesthetic basis.13 If we consider the oral
surgery department of GSTT to be typical of secondary care
oral surgery provision in England, andwe extrapolate the ratio
of admitted patients versus out-patients to the 67 k patients in
England having third molar removal on an admitted basis,
then we can estimate the total number of patients in England
having third molar removal in a secondary care setting. Based
on this calculation we can estimate that nationally, in the
region of 38 k patients have third molar removal on an
outpatient basis giving a estimate of 105 k patients for sec-
ondary care activity.
Unfortunately, the NHS does not now record the number of
patients having third molar removal undertaken in NHS pri-
mary care. The last year for which the NHS Business Services
Authority (NHSBSA) recorded data was in 2004/5 and in this
year, 28 k Md3M were removed in NHS primary care.14
(NHSBSA data recorded the actual number of third molar
teeth removed as opposed to HES which records the number
of patients having at least one third molar removed9,14). It is
not, therefore, possible to calculate the true volume of pri-
mary care third molar activity, as there are no contemporary
datasets to make an accurate calculation. However, from
2004/5 there has been rebound increase in day-case hospital
based activity of 67%.9 If this increase is mirrored in primary
care then it can be estimated that 47 k Md3M may be being
removed in primary care on an annual basis. Based on these
actual and estimated numbers the minimum number of pa-
tients having third molar removal in England may, therefore,
be in the region of 152 k, however the actual number, in re-
ality, may well be much higher.
Based on a potential 15% incidence of second molar DCC
and the potential 152 k patients per annum it can be estimated
that potentially 22.8 k patients per annum in England may
now be being diagnosedwith DCC in a secondmolar tooth due
to an impacted third molar. In addition, it has been reported
that approximately 20% of patients with DCC of their second
molar as an indication for the removal of the third molar have
bilateral DCC.1,7
This results in a potential of 27 k Md2M teeth that may be
affected by DCC as a result of an impacted Md3M tooth.
Based on the outcome data of treatment this may result in
potentially 11.4 k (42%) Md2M being extracted and requiring
Figure 5 e Mesially impacted Md3M (37) with associated
DCC on Md2M that has previously been crowned.
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possible replacement; 11.4 k (42%) that will require restora-
tion, and 4.2 k (16%) requiring root canal treatment and
restoration.
Direct financial costs
Due to the idiosyncratic system of funding of NHS treatment
in England, the true financial cost of treating this disease is
difficult to quantify as primary care NHS treatment costs are
based on courses of treatment rather than the actual service
provision of a specific item of treatment. However, based on
the funding provisions in England the actual cost of either a
simple restoration of the second molar or its removal in pri-
mary care may be in the range of £75 per case but for more
complex treatment including RCT with a crown/inlay resto-
ration this may be in the region £300 per case (based on rate of
£25/UDA15). The cost in terms of patients who choose private
dental treatment and specialist NHS provision will be sub-
stantially more. Consequently, based on NHS primary service
funding, the primary care cost of treating DCC conservatively
may be between £1.7 me£2.1 m per annum in England.
(calculation based on lower and upper estimations of DCC
patients {22.5 k  £75 ¼ £1.7 m} & {27.5 k  £75 ¼ £2.1 m})
In hospital based secondary care the total cost of third
molar removal will be in the range of £1000 per case for day-
case procedures and £400 per out-patient procedure as based
on the 2014 NHS treatment tariffs.16 For patients with DCC the
cost amounts to approximately £10 m for third molar man-
agement under day-case {(67 k  15%)  £1000 ¼ £10 m} and
£2.3 m for third molar management on an out-patient basis
{(38 k  15%)  £400 ¼ £2.3 m}: A total of £12.3 m per annum.
Management of impacted third molars in primary care is
now being providedmore regularly by primary care based oral
surgery specialist services. In NHS primary care, oral surgery
specialist care costs are in the region of £150e£250 per case.
Unfortunately the NHS does not calculate the amount or
proportion of work provided by this group, however if the
primary care estimate of 47 k thirdmolars is accurate then the
volume of primary care third molars removals due to DCC,
may be of the order of 7 k cases (15%). This would result in an
estimated cost of primary care third molar removal between
£1e£1.75 m per annum.
Although the loss of the second molar tooth may not
significantly influence masticatory function or aesthetics,
potential over eruption of maxillary second molars and pa-
tient choice to maintain an optimal functional dentition may
indicate replacement of the Md2M tooth with an implant
retained crown. Not all patients may be suitable for dental
implant treatment but patients with DCC do tend to have
better dental health than average.1,7 Patients may also be less
inclined to undergo implant treatment due to the requirement
of further surgery; of potential inferior dental nerve morbidity
and the general inconvenience of such a treatment option. It is
difficult, therefore, to speculate how many patients would
wish to replace a second molar tooth, but with the cost of this
treatment being, on average, £2.5 k per implant-retained
crown, this could total £28 m per annum if all patients
(11.4 k/annum) who are estimated to have lost their second
molar elected to have this treatment.
Indirect financial costs
Indirect costs are made up of loss of patient's earnings and
loss of access for other patients, however these indirect costs
of third molar removal can be more difficult to quantify.
Costs such as loss of patient's employment productivity
and potential loss of earnings for patients having to attending
for both third molar removal and for remedial dental treat-
ment may add another notional £7 m/annum loss of earnings
for time of work for third molar surgery and recovery plus
£1.5 m/annum loss of earnings for the time spent on remedial
treatment of the second molar. The former is calculated from
the number of patients requiring third molar removal due to
DCC (22.8 k patients/annum), the average recovery period for
patients having third molars removed (3 days) and the resul-
tant loss of earnings based on the UK average earnings value
(£27.2 k/annum). The latter is similarly calculated from the
potential number of patients experiencing DCC (22.8 k pa-
tients/annum with 27.5 k second molars/annum); an esti-
mated average of 3 h of patient's time to attend the dentist for
remedial treatment (including traveling time); and the loss of
earnings based on UK average earnings value (£27.2 k/
annum).17e19 The financial cost to the economy is more diffi-
cult to quantify, however as these patients will generally be
adults in their 30's the cost to the economy will be sizeable.
For the dentist themselves, remedial treatment may
require an additional 27.5 k work-hours/annum to provide
treatment for 27.5 k DCC patients that should be spent on
treating other patients: in effect remedial treatment for DCC
reduces access for other patients that will still have to be
treated. (calculation based on a notional 30 min clinical time
for simple restorations/second molar removal and 90 min
clinical time for more complex treatments per patient). This
may add a further notional £2.1 m/annum in indirect cost
(based on time, average UDA rate of £25 and 27.5 k patient
episodes/annum). This should not be considered as double
accounting, as dentists undertaking treatment will still be
have to provide treatment for other patients.
Overall the potential costs of treating second molar DCC
are substantial and could potentially eclipse £55m per annum
(Fig. 6).
Supplementary considerations
NICE guidance has resulted in a change of practice towards
managing teeth rather than managing patients.8,20 Patients
often have only a single problematic third molar removed in
isolation whilst other impacted, but as yet asymptomatic,
third molars are disregarded. It would seem prudent; there-
fore, to consider the long-term potential of disease by leaving
these asymptomatic impacted third molars rather than
ignoring it. As DCC is a late disease many patients with it may
be subjected to multiple treatment episodes for individual
third molar management over a long-term period rather than
a single treatment episode for all third molars.1,7,8 This in it-
self increases potential costs, as tariffs for third molar
removal will be based on treatment episodes, irrespective of
how many third molars are removed. With patients having a
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potential four third molars this could theoretically translate
into four treatment episodes rather than a single, collective
treatment episode for patients with third molars. Patients
who havemultiple treatment episodes will invariably cost the
NHS and other funders more to treat over a lifetime than a
single treatment episode. A holistic approach, whilst consid-
ering the potential for further problems of third molars may,
in fact, be less detrimental to the patient and save money in
the long-term.8
All mesio-angularly impacted third molar teeth pose a risk
of DCC to the secondmolar tooth.1,7,8 Not all risk is realized as
most third molars are removed prior to the formation of DCC.
It is those teeth that are retained later into life that result in
DCC formation, hence the apparent small proportion of pa-
tients who experience the disease, but with an increase in
third molar retention into the fourth decade of life and the
incidence of third molar related caries rising then this is a
situation that will only deteriorate further with more addi-
tional cost. By considering prophylactic third molar removal
in this situation, we are not providing unnecessary treatment
with an unnecessary financial cost to the NHS or independent
funder. We are investing in an intervention that will reduce
the global cost for treatment in an individual as well as the
overall cost for the NHS. If left these patients will cost more to
treat with possible ongoing costs. If the risk of Md2M DCC is
high then removal of these retained third molars has a
definitive cost-benefit for the patient and the NHS.
Conclusion
This study highlights the treatment outcomes for patients
with third molar related DCC of the second molar and the
potential costs for its management. DCC is an avoidable and
preventable disease of the Md2M tooth. The risk of DCC
forming on the second molar can be eliminated by the
removal of the Md3M tooth before DCC occurs but this would
involve the prophylactic removal of those third molars that
pose this risk. The cost of preventing DCC on the Md2M tooth
would still involve the cost of Md3M removal so the actual
savings to be made in a management model that advocates
prevention may be limited to the direct costs of managing the
second molar tooth, the indirect costs to the patient in terms
of loss of earnings and the intangible costs of pain and
occlusal compromise: this would still be in the range of
£3.6 me£31.6 m per annum. However, if we continue to treat
third molar teeth in isolation rather than consider patients as
a whole, then these potential multiple treatment episodeswill
incur further unnecessary costs of multiple third molar
removal. Potentially, this may, at the worst, double the cost to
the NHS of third molar removal for each of these patients by
another £14 m per annum.
The recent Montgomery v Lanarkshire Health Board
determination regarding patients right to being informed of ‘
… any material risks’ related to an intervention hold as
equally as to being informed of the material risks of non-
intervention.21 Patients have the right to know what the po-
tential outcomes of third molar retention are. Patients at risk
of Md2M DCC should be informed of this potential and
allowed to decide if their impacted thirdmolar teeth should be
removed.
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Diseases associated with mandibular third molar teeth
L. W. McArdle,*1 M. Andiappan,1 I. Khan,1 J. Jones2 and F. McDonald3
teeth can succumb to, or contribute to, a variety 
of dental related diseases that can indicate the 
removal of the Md3M  tooth.1–4 Common 
Md3M diseases include pericoronitis; dental 
caries; caries related disease such as peri-apical 
infection; odontogenic cyst formation and 
periodontal disease. Md3M can contribute to 
and be a causative factor in the development 
of disease in mandibular second molar teeth 
(Md2M) such as distal cervical caries (DCC) 
or periodontal disease.5–17 In addition, Md3M 
may also be removed to facilitate other forms 
of dental treatment such as orthodontics and 
orthognathic surgery.3,4
In 2000  the National Institute of Health 
& Clinical Excellence (NICE) introduced its 
guidance on the removal of wisdom teeth. 
Introduction
The eruption process for mandibular third 
molar teeth (Md3M) can result in two distinct 
end-points. Where present, many can erupt into 
a functional non-impacted position, however, 
many Md3M become impacted having failed to 
erupt into a functional position. Both impacted 
and non-impacted mandibular third molar 
Aims  To evaluate the clinical characteristics of mandibular third molar teeth (Md3M) requiring removal and to compare the 
characteristics of impacted Md3M with non-impacted Md3M. Methods  One thousand and eleven patients who had 1,431 
Md3M removed were evaluated. Features recorded included the age and gender of patients, the primary diagnosis indicating 
removal, the angulation and impaction status of the Md3M. Results  The most common indications for Md3M removal were 
pericoronitis (49%), caries and related disease (C&RD) (27%), and distal cervical caries (DCC) of the mandibular second molar 
tooth (Md2M) (14%). The mean age of patients requiring removal of Md3M was 32.4 years. The mean age of patients, based 
on the angulation of impaction, were 28.6 years for vertical impaction, 30.1 years for mesio-angular impaction, 29.6 years 
for disto-angular impaction, 31.7 years for horizontal impacted and 41.6 years for non-impacted Md3M. The mean age of 
patients, based on the most common diseases were, 27.5 years for pericoronitis, 32.7 years for Md2M DCC, 36.1 years for 
C&RD, and 46.3 years for periodontal disease. Forty-one percent of all patients have Md3M removed due to disease related to 
dental caries with Md2M DCC accounting for 44% of all mesio-angular impacted Md3M removed. Conclusion  Third molar 
disease varies according to the type of Md3M impaction. Impacted Md3M succumb to disease earlier than non-impacted 
Md3M. Pericoronitis remains the most common indication for impacted Md3M removal, however, C&RD and Md2M DCC 
have become more prevalent and are seen in older population groups. Md2M DCC is predominantly seen related to impacted 
mesio-angular third molars. Non-impacted Md3M, when indicated for removal, are generally removed in older patients due 
to C&RD and periodontal disease. The authors conclude that impacted third molars are more likely to be removed in younger 
patients due to pericoronitis while caries related disease (C&RD and Md2M DCC) is more common in older patient groups. 
With Md2M DCC accounting for 44% of all mesio-angular impacted Md3M being removed, consideration should be given to 
early intervention in the management of patients with mesio-angular impacted teeth.
Since then the profile of third molar disease has 
changed.18 During the period of 1995–2010, 
the mean age of patients having third molars 
removed increased from 28 to 32 years, with 
an associated increase in the incidence of 
dental caries as the primary indication for the 
removal of third molar teeth by over 200%.18–20
This paper reports on a prospective cohort 
of 1011 patients attending for Md3M removal. 
The aims of the study were to determine the 
primary clinical indication for Md3M removal 
and to ascertain the variation and spectrum of 
disease based on the nature of impaction of the 
Md3M tooth. Both impacted Md3M and func-
tional non-impacted Md3M were included in 
the study group cohort.
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Provides awareness of the change in third molar 
disease as a consequence of NICE Guidance.
Highlights that an increase in caries is an indication for 
third molar removal.
Discusses increase in mandibular second molar tooth 
distal cervical caries in patients.
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Methodology
Data from 1011 patients attending for Md3M 
removal was collated longitudinally over a 
2-year period from 2013–2015 and then ret-
rospectively analysed. Patients were evaluated 
and the variables recorded were; age, gender, 
the eruption status of the Md3M, the primary 
clinical indication for the removal of the 
Md3M tooth, and the angulation of impaction 
of the Md3M.
The primary aim of the study was to determine 
the clinical diagnosis for Md3M removal 
centred on five year age cohorts of patients to 
determine if there was any age-related variation. 
Furthermore, to assess these clinical diagnoses 
in relation to the eruption and angulation of 
impaction of the Md3M and to determine any 
association with the age of patients.
The eruption status was defined as either 
unerupted, partially erupted, erupted or over-
erupted. Any tooth that was detectable either 
visually or clinically with a periodontal probe 
was deemed exposed to the oral environment 
and consequently defined as partially erupted. 
Teeth with a visible occlusal surface but with 
a high distal gingival collar were also deemed 
partially erupted. Md3M, which were defined 
as erupted, had a complete gingival collar 
below the level of the maximum bulbosity of 
the crown and sitting in a vertical functional 
position on the level of the occlusal plane. 
The angulation of the Md3M was defined by 
convention as either vertical, mesio-angular, 
disto-angular, horizontal, or ectopic (ectopic 
was defined as all other possible angles of 
impaction distinct of the other four; for 
example, inverted.)
The primary diagnosis and clinical indica-
tion for Md3M removal was recorded but was 
not circumscribed: this was to permit any 
possible diagnoses to be recorded. Patients 
requiring Md3M removal due to pulpitis, 
dental abscess, peri-apical periodontitis, 
etc, where caries of the Md3M tooth was 
the promoter lesion for the development of 
these consequent diseases, were defined and 
recorded collectively as ‘caries and related 
disease’ (C&RD), as these diagnoses represent 
specific stages of the progression of dental 
caries. All subgroups of pericoronitis, such as 
acute, chronic, sub-acute and recurrent peric-
oronitis were grouped collectively into a single 
diagnosis of pericoronitis.
All patients attended either a primary 
care-based specialist oral surgery clinic, or 
a secondary care oral surgery department 
of a major teaching hospital. Treatment was 
carried out with either local anaesthesia, local 
anaesthesia and sedation, or day-case general 
anaesthesia.
Statistical analysis
Sample size was determined by power calcu-
lation and the sample and outcome charac-
teristics were summarised using descriptive 
statistics. The comparison of Md3M subgroups 
for the disease variation and the Md3M angu-
lations of impaction were carried out using Z 
test for proportions. The mean age of patients 
for different disease presentation and with 
impaction status were compared using one way 
ANOVA. Statistical significance was assumed 
at 5% level and all the analyses were carried out 
using SPSS version 23.0.
Results
Of the 1011 patients who were assessed, 604 
(60%) were female and 407 (40%) male. In 
total, 591 patients had one Md3M removed 
and 420 patients had bilateral Md3M removed: 
a total of 1431 Md3M were removed. The 
number of Md3M present with no clinical 
indication for removal was 376, and 215 
Md3M were clinically absent. The mean age 
of patients having Md3Ms removed was 32.4 
years, (SD 11.5years, range 12–87 years).
Md3M characteristics and disease
The overall distribution of disease that indicated 
Md3M removal is shown in Table 1. Pericoronitis 
was the most common indication recorded 
accounting for 49% of all Md3M removed. 
C&RD for 27% of Md3M removed; Md2M 
DCC for 14%; periodontal disease for 5%, and 
dental/odontogenic cyst for 2%. Collectively, the 
remaining ten recorded diagnoses accounted for 
4% of all diagnoses, and individually accounted 
for less than 1%. Caries combined, that is, 
C&RD and Md2M DCC, as an overall indica-
tion for removal of Md3M, accounted for the 
removal of 41% of all Md3M.
Of the 1431 Md3M removed, a total of 82% 
Md3M were impacted and 18% were vertical, 
non-impacted and in a functional position. 
Mesio-angular impacted Md3M accounted 
for 29% of the total removed, with horizontal 
Md3M impactions accounting for 14%; disto-
angular Md3M impactions for 15%, and ectopic 
impactions for less than 1%. Vertically impacted 
Md3M accounted for 24% and 18% Md3M were 
vertical and non-impacted. (Table 2.)
If non-impacted Md3M are isolated from 
and compared with impacted Md3M then 
Table 1  Primary diagnosis and distribution of all Md3M requiring removal
Diagnosis for removal Number of Md3M removed
Percentage 
distribution (%)
1 – Pericoronitis 698 49%
2 – Caries & related disease (C&RD) 382 27%
3 – Md2M DCC 198 14%
4 – Periodontal disease 63 5%
5 – Dentigerous/odontogenic cyst 33 2%
6 – Prevention DCC second molar 18 1%
7 – Pre-orthognathic surgery 12 0.80%
8 – Food trap 9 0.60%
9 – External resorption of second molar 4 0.30%
10 – Prophylactic secondary to GA 4 0.30%
11 – Fractured tooth (not caries) 3 0.20%
12 – Pre-orthodontic 2 0.20%
13 – Pre-radiotherapy 2 0.10%
14 – Ramus bone graft pre-implant 1 0.10%
15 – Internal resorption 1 0.10%
16 – Non function 1 0.10%
Total number of Md3M removed 1,431 100%
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the distribution of disease can be considered 
comparatively. Pericoronitis accounted for the 
removal of 58% of impacted Md3M compared 
with 3% of non-impacted Md3M (P <0.0001), 
C&RD for 14% of impacted teeth compared 
with 84% of non-impacted teeth (P <0.0001), 
Md2M DCC for 17% of impacted teeth and 0% 
of non-impacted teeth (P <0.0001), periodon-
tal disease for 4% of impacted teeth and 9% 
of non-impacted teeth (P <0.001), and finally 
dental/odontogenic cyst for 3% of impacted 
teeth compared with 0% non-impacted 
(P <0.01).
The most common eruption status for 
Md3M requiring removal was that of partial 
eruption, which totalled 1133 Md3M (79%). 
Erupted teeth accounted for 251 Md3M 
removed (18%); unerupted teeth accounted for 
43 Md3M (3%), and four Md3M were over-
erupted (<1%).
Md3M disease diagnoses and 
angulations
Disease diagnoses in relation to the angulation 
and impaction of the Md3M were also consid-
ered and are presented in Table 2 and Figure 1.
Of the most common diseases, pericoro-
nitis accounted for the removal of 32% of all 
mesio-angular Md3M compared with 84% of 
all disto-angular Md3M (P <0.001); 78% of all 
vertical impactions (P <0.001); 53% of all hori-
zontal Md3M (P <0.001) and 3% of vertical 
non-impacted teeth (P <0.001).
In contrast C&RD accounted for the removal 
of 15% of mesio-angular Md3M compared 
with 12% of disto-angular Md3M (P = 0.4), 
16% of all vertical Md3M (P = 0.7), 11% of 
horizontal Md3M (P = 0.2), but 85% of vertical 
non-impacted teeth (P <0.001). DCC of the 
Md2M accounted for the removal of 44% of 
all mesio-angular Md3M and 9% of horizontal 
Md3M (P <0.001) but was not recorded in any 
of the other groups (P <0.001).
Periodontal disease accounted for the 
removal of 13% of all horizontal impacted 
Md3M compared with 3% of mesio-angular 
Md3M (P  <0.001); 1.5% of disto-angular 
Md3M (P <0.001); 9% of vertical non-impacted 
Md3M (P = 0.18) and less than 1% of vertical 
impacted Md3M (P <0.001).
The variation of disease seen in the differing 
types of impaction suggests that certain diseases, 
such as Md2M DCC, occur dependent upon the 
angulation of impaction and other disease, such 
as C&RD, independent of the angulation.
Mean age, impaction status & disease
The mean age of patients having Md3Ms 
removed was 32.4 years (range 12–87 years, SD: 
11.5 years). In addition, the mean age of patients, 
based on the impaction status of the Md3M was 
Table 2  Primary diagnosis and distribution of Md3M requiring removal based on angulation and impaction














(N = 1,431) N = 348 (24%) N = 210 (15%) N = 198 (14%) N = 413 (29%) N = 11(<1%) N = 251 (18%)
Pericoronitis 271 (78%) 176 (84%) 106 (53%) 131 (32%) 6 (54%) 8 (3%)
C&RD 56 (16%) 26 (12%) 22 (11%) 62 (15%) Nil 213 (85%)
Md2M DCC Nil Nil 18 (9%) 180 (44%) Nil Nil
Periodontal disease 2 (<1%) 3 (1.5%) 25 (13%) 13 (3%) Nil 22 (9%)
Dentigerous/odontogenic cyst 4 (1%) 4 (2%) 16 (8%) 5 (1%) 4 (36%) Nil
Prevention DCC second molar Nil Nil 3 (1%) 14 (3%) Nil Nil
Pre-orthodontic/ orthognathic surgery Nil Nil 4 (2%) 6 (1%) Nil Nil









































Fig 1  Percentage distribution of main Md3M diseases based on angulation impaction status
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calculated (Fig. 2) and the mean age of patients 
based on the most common diagnoses (Fig. 3).
For patients having a mesio-angular Md3M 
removed, the mean age of patients was 30.1 
years (range 12–67 years, SD: 7.7 years); for 
disto-angular Md3M impactions, the mean 
age was 29.6  years (range 19–86 years, SD: 
8.3 years); for horizontal Md3M impac-
tions–  31.8  years, (range 14–87 years, SD: 
10.3 years); for vertical Md3M impactions – 
28.6 years, (range 16–57 years, SD: 7.5 years); 
for vertical non-impacted Md3M 41.6 years, 
(range 17–83 years, SD: 15.6 years); and for 
ectopic impactions the mean age was 31.3 
years, (range 18–45 years, SD 9.6 years). For 
reference, the Office for National Statistics in 
the UK report that the mean age of the UK 
population is 40.9 years.21
In terms of disease, for the most common 
diagnoses related to patients having a Md3M 
removed, the mean age of patients with a 
diagnosis of pericoronitis was 27.5 years (range 
16–70  years, SD: 5.8 years); for C&RD, the 
mean age was 36.1 years (range 17–86 years, 
SD: 13.3 years); for periodontal disease, 46.3 
years, (range 24–81 years, SD: 13.6 years); for 
Md2M DCC, 32.7 years, (range 21–55 years, 
SD: 7.3 years); and for dentigerous/odonto-
genic cyst, 43.1 years, (range 14–87 years, SD: 
16.4 years). In relation to vertical impacted 
and non-impacted Md3M with a diagnosis 
of C&RD, the mean age of patients with a 
vertically impacted third molar was 31.9 years 
(range 19–65 years, SD: 9.6 years) and for a 
vertically non-impacted third molar it was 
39.7 years (range 17–83 years, SD: 14.7 years).
Discussion
The spectrum of disease and 
impactions
This study, as with other reported studies, reports 
pericoronitis as the most common indication 
for Md3M removal, with dental caries, cyst 
formation and periodontal disease being other 
common diseases associated with Md3M.22,23 
The scope of impacted Md3M angulations in 
this study is similar to other studies.22–24 Most 
Md3M studies do not, however, emphasise 
whether non-impacted Md3M are included in 
individual case-series or whether they have been 
incorporated as vertical impacted Md3M. The 
spectrum of disease related to non-impacted 
Md3M in this study is significantly different to 
the disease spectrum for impacted teeth and in 
a significantly older population (P <0.001).
When considering the disease spectrum 
of Md3M, it is important to consider Md3M 
disease in relation to each type of Md3M 
impaction rather than produce a summative 
account for all Md3M. By categorising disease 
in relation to Md3M impaction, we can reflect 
on the clinical significance that the nature of 
impaction may have on the potential disease 
outcome for patients.
Pericoronitis
Pericoronitis is the most common indication 
for the removal of Md3M as a whole (49%), but 
where it accounts for only 3% of non-impacted 
vertical Md3M, it accounts for 32% of mesio-
angular Md3M, 53% of horizontal impac-
tions, 78% of vertical impaction and 84% of 
disto-angular impactions (P <0.001) (Fig. 1). 
The reasons for the variation in pericoronitis 
related to the differing types of impaction may 
be explained by the local anatomy and the 
presence of an operculum of mucosa overlying 
the occlusal surface of vertical and disto-angular 
impactions. This would create a local environ-
ment conducive to local soft tissue infections 
secondary to poor or inadequate oral hygiene. 
Due to the inclination of a mesio-angular Md3M 
this would tend to elevate the distal aspect of the 
crown away from the soft tissues eliminating 
the operculum and exposing the distal surface, 
which may then be more accessible to oral 
hygiene and reduce risk of pericoronitis.
Caries and related disease
C&RD accounts for 27% of all Md3M extrac-
tions with C&RD in each of the main categories 
of impacted Md3M comparatively uniform. 
C&RD accounted for 15% of mesio-angular 
impactions, 12% of disto-angular impactions, 
11% horizontal impactions and 16% of vertical 
impactions were removed due to C&RD. This 
suggests that the diagnosis and incidence of 
C&RD is independent of the type of Md3M 
impaction. However, compared with impacted 
Md3M, C&RD accounts for 85% of all non-
impacted vertical Md3M removal (P <0.001) 
(Fig.  1). Md3M C&RD has been shown to 
increase with age and vertical, non-impacted 
Md3M tend not to be associated with the 
common diseases of impaction such as pericor-
onitis (P <0.001). In older middle-aged patient 
groups with retained Md3M, non-impacted 













































Fig. 2  Mean age of patients requiring Md3M removal based on Md3M angulation and impaction
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impacted third  molars.25 A non-impacted 
Md3M would not be excluded from the 
potential of experiencing dental disease at some 
point but most would remain functional and 
disease free for a period of time before a propor-
tion of them succumb to dental disease such as 
caries and periodontal disease as reported here. 
This is supported by the observation that the 
mean age of patients with impacted Md3M with 
C&RD compared with non-impacted Md3M 
with C&RD is 31.9 years compared with 39.7 
years respectively (P <0.001).
Md2M DCC
Md2M DCC, as an indication for Md3M 
removal, has been reported as contribut-
ing a relatively small proportion of Md3M 
removal in older studies.5,22,–24 In this series it 
is not associated with vertical, disto-angular or 
ectopic impactions and its significance should 
not be considered collectively with all other 
types of Md3M impactions.
Md2M DCC in this study accounts for 14% 
of all Md3M removed and 17% of all impacted 
Md3M removed. It accounts for 9% of all 
horizontal impactions, however, Md2M DCC 
accounts for 44% of all mesio-angular Md3M 
removed.
The mean age of patients with Md2M DCC 
is 32.7 years compared with patients with 
pericoronitis (27.5 years) (P = 0), with peri-
coronitis being the most common reason for 
Md3M removal. In this case series over 50% 
of all Md3M are removed in patients between 
20–29 years of age suggesting that the majority 
of patients who will require Md3M removal 
will have lost them by the time they are 30 years 
old. This corroborates that Md2M DCC is a 
disease of older patients and, as pericoronitis 
is the most common indication for impacted 
Md3M removal, patients will generally 
succumb to other forms of disease such as this 
before Md2M DCC can occur.
In addition to the loss of the Md3M to 
facilitate treatment of Md2M DCC, it has 
been reported that Md2M DCC has significant 
financial costs attributed to it and results in the 
eventual loss of 40% of Md2M.26 The primary 
risk factor related to Md2M DCC formation 
is the partially erupted mesio-angular or hori-
zontally impacted Md3M and with such a high 
incidence of Md2M DCC in mesio-angular 
impactions, consideration should be given to 
this disease’s potential.
NICE advocated the proscription of pro-
phylactic third molar removal in the late 1990s 
and the change in patient management had 
resulted in the mean age of patients requiring 
third molar removal increasing to 32 years by 
2009/10, with 30% of third molars removed 
due to dental caries as the primary indication 
for removal.18 This data could not differenti-
ate between third molar caries and Md2M 
DCC, however, in this present study Md3M 
C&RD accounted for 14% of all impacted 
Md3M removed and Md2M DCC for 17% 
of impacted Md3M removed: in total 31% of 
all impacted Md3M were removed due to all 
categories of caries disease. With the addition 
of non-impacted Md3M C&RD, a total of 
41% of Md3M were removed due to caries. 
Md2M DCC is the most common indica-
tion in this case series for the removal of a 
mesio-angular Md3M.
As 44% of all mesio-angular and 9% of hori-
zontal Md3M removed due to Md2M DCC this 
qualifies concern that observing and retaining 
mesio-angular Md3M, in particular, until 
disease occurs, may be an unsound manage-
ment strategy. Contrary to NICE guidance, 
early removal of mesio-angular and horizon-
tal Md3M may be indicated and should be 
considered so as to avoid the consequences of 
Md2M DCC.
Periodontal disease
Periodontal disease accounts for only 5% of all 
Md3M removed in this case series, however, it 
should be noted that only the primary indica-
tion for Md3M was recorded as opposed to all 
concomitant diseases that may have been asso-
ciated with a particular Md3M. Nonetheless, 
periodontal disease was the primary indication 
for 12% of all horizontal, 9% of all vertical non-
impacted Md3M, with smaller proportions for 
all other impacted teeth. Periodontal disease 
is generally a quiescent disease that patients 
are often unaware of and generally only gives 
rise to significant symptoms in the later stages 
of the disease. Periodontal disease has been 
reported to be a clinical finding related to 
impacted third molars,13–17 however, this data 
does not contradict these studies but may 
suggest that Md3M will become symptomatic 
and succumb to other Md3M diseases before 
periodontal disease becomes symptomatic and 
then the prime indicator for intervention.
Other disease
All the remaining indications for Md3M 
removal collectively accounted for 4% of all 
indications and less than 1% individually. 
Some of these indications for third molar 




































Fig 3 Mean age of patients requiring Md3M removal based on Md3M diagnosis
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forms of treatment such as orthodontics, 
orthognathic and dental implant treatment, 
others are uncommon such as internal or 
external resorption and others may be very 
weak indicators for removal, such as food 
packing. Food packing, and similar diagnoses, 
should not be dismissed as an indication for 
Md3M removal as these types of problems 
can be a constant source of irritation to a 
patient and the preference of the patient for 
the removal of the offending tooth is as valid 
a treatment option than any. Although a small 
number: 18 (1%) of Md3M were removed for 
the prevention of Md2M DCC, consideration 
has to be given to the weight of evidence for 
the potential for this disease to occur and for 
patients to be able to consider the options of 
intervening early or monitoring accordingly.
Age and diagnoses
The mean age of patients requiring third 
molar removal was 32.4 years, however, there 
was marked variation of patients’ mean age 
based upon diagnoses. One-way ANOVA 
test was used to compare the mean ages of 
patients based on the most common diseases. 
Pericoronitis, with a mean age of patients 
being 27.5 years; C&RD mean age 36.1 years; 
and Md2M DCC, mean age 32.7 years, when 
compared individually with each other, showed 
a statistically significant relationship (P = 0).
The eruption of Md3M is generally accepted 
to occur between the ages of 18–24 years and 
the timing of disease presentation varies. 
Pericoronitis occurs frequently and relatively 
soon after failed eruption of the Md3M; it is 
the most common disease associated with 
impacted Md3M and in general occurs in 
younger age groups. Caries, in comparison, 
is a disease that will take time to develop 
before significant clinical signs and symptoms 
become present. As an indication for Md3M 
removal, C&RD occurs on average in older age 
groups than pericoronitis. Likewise, Md2M 
DCC tends to occur in older patient groups 
but only with those with a mesio-angular or 
horizontal impacted Md3M.
Primary v secondary disease
The primary consequence of third molar 
impaction is the failure of the occlusion 
to reach the endpoint of maturity with the 
resultant dental malocclusion at the posterior 
aspect of the dental arch. An impacted tooth 
is a developmental anomaly and is defined as 
a disease by the WHO within the ICD10 clas-
sifications of diseases (K011).27 Impaction is 
often overlooked as a disease in itself and the 
focus of defining third molar disease is often 
given to the consequent diseases of Md3M 
impaction, such as pericoronitis. However, 
the primary disease affecting the third molar 
is the impaction of the tooth and it is this 
which can then lead to consequential diseases 
such as pericoronitis, etc. These consequential 
diseases will generally occur secondary to the 
impaction, with patients experiencing a variety 
of differing disease. Where the third molar is 
erupted and functional, disease will not occur 
in the same manner as an impacted tooth. We 
should acknowledge that the impaction of the 
third molar is the primary disease that can then 
contribute to the development of secondary 
disease. Only in the non-impacted Md3M can 
we consider that caries, periodontal disease, 
etc, are the primary disease.
Variation in the characteristics of the Md3M 
contributes to when disease may occur and the 
type of disease that may occur. The capacity 
to understand the potential and the ability to 
anticipate third molar disease should guide 
clinical judgement in the management of 
patients. Understanding the spectrum and 
nature of disease in relation to impacted 
Md3M should allow better management of 
individual patients with impacted Md3M. 
Patients with third molars cannot be managed 
as a collective group as this can have negative 
outcomes, especially in relation to diseases 
such as Md2M DCC.
The prevalence of impacted third molars 
in the general population as a whole has been 
reported to be approximately 25%.28 This figure 
is misleading as it would appear to include 
everyone, including people who have had third 
molars removed. This miscalculates the true 
prevalence as it mistakenly presumes that if 
a patient has no third molars that the never 
had any previously. It has been reported that 
the prevalence of impacted third molars in the 
20-30 age group is over 70%.29 It has also been 
reported that for those patients in middle-
age only 13% retain an impacted  Md3M.26 
Although these two later studies are not 
related, if these studies are representative of 
patients then 80% of patients with impacted 
third molars will have undergone third molar 
removal by the time they are middle-aged. 
With such a high potential proportion of 
the adult population requiring third molar 
removal, consideration should be given to 
addressing the potential for secondary disease 
rather than solely addressing secondary disease 
when it occurs.
Conclusions
Md3M can display a wide spectrum of disease 
that varies and is dependent on the type of 
Md3M impaction. Disease occurs in non-
impacted Md3M as well as impacted Md3M 
with diseases affecting non-impacted teeth 
tending to be the typical dental diseases of 
caries and periodontal disease, and in an older 
population. Diseases related to impacted teeth 
reflect the more specific diagnoses of pericoro-
nitis, Md3M caries and and Md2M DCC, and 
in a younger population.
The variation of disease and the mean-age 
of patients seen in the differing types of 
impaction is significant in that some diseases, 
such as Md2M DCC, will occur dependent 
upon the angulation of impaction, and others, 
such as C&RD, independent of the angulation. 
Younger patients are more affected by disease 
such as pericoronitis and less so by other 
diseases such as C&RD, whereas older patients 
are more affected by C&RD and Md2M DCC.
Md2M DCC accounts for 44% of all mesio-
angular impacted and 9% of horizontally 
impacted Md3M removed. The risk factors 
for the development of Md2M DCC have 
been previously reported.5–12 NICE guidance 
is flawed and early intervention in patients 
with impacted Md3M at risk of causing Md2M 
DCC should be considered and prophylactic 
intervention has a role to play in the manage-
ment of patients.
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Abstract
The aim of this study was to identify the indications for the removal of mesio-angular mandibular third molars based on age and dental health
as measured by the DMFT (decayed, missing, and filled teeth) score, and to find out if early intervention should be considered. We studied
319 patients who had 431 mesio-angular mandibular third molars removed. Variables recorded were age, primary indication for removal, and
the DMFT score. Indications for removal included distal cervical caries (DCC) in the mandibular second molar (n = 180, 44%), pericoronitis
(n = 131, 32%), and caries and related disease (n = 62, 15%). The frequency of distal cervical caries (DCC) in the mandibular second molar
increased linearly as patients became older and was the most common reason why mesio-angular third molar teeth were removed. This
suggests that patients should be advised of the consequences of retaining these types of third molars, and offered prophylactic removal of
asymptomatic teeth.
© 2019 Published by Elsevier Ltd on behalf of The British Association of Oral and Maxillofacial Surgeons.
Keywords: oral surgery; third molar; disease
Introduction
Mesio-angular impaction of mandibular third molars
(maMd3M) is the most common type of impaction, and can
contribute to a variety of common disorders such as peri-
coronitis, dental caries, and periodontal disease.1–3 More
importantly, mesio-angular mandibular third molars that are
partially erupted can cause distal cervical caries (DCC) in the
second molar, which can have serious consequences.4–12 A
recent study suggested that this accounts for the loss of up
to 40% of second molars, with the remaining 60% requir-
ing restoration.1 Its incidence varies from 2% − 14% of
patients who have third molars removed, but these figures
∗ Corresponding author. Tel.: 020 7188 4345; Fax: 020 7188 4360.
E-mail address: louis.mcardle@kcl.ac.uk (L.W. McArdle).
relate to all categories of teeth rather than to specific types of
impaction.3,5,13–16
If all, or a large proportion of, partially-erupted third
molars lead to DCC in the adjacent tooth, then early inter-
vention and prophylactic removal of the third molar should
be considered because the risk of retention could outweigh
the cost of early removal.12 If this is the case, then the
National Institute for Health and Care Excellence (NICE)
guidance may be in conflict with the reality of retention (par-
ticularly of mesio-angular mandibular third molars) because
of the risk they pose. However, as we cannot tell which
patients will be affected, early intervention must still be
questioned.
Our aim therefore was to study the characteristics of
patients who had mesio-angular mandibular third molars
removed, and to establish whether early intervention should
be considered.
https://doi.org/10.1016/j.bjoms.2019.02.002
0266-4356/© 2019 Published by Elsevier Ltd on behalf of The British Association of Oral and Maxillofacial Surgeons.
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Method
As part of a larger study, we collated and retrospec-
tively assessed data on 1011 patients who had mandibular
third molars removed over a two-year period (January
2013–January 2015).3 The variables recorded were age, sex,
angulation of the impacted tooth, primary indication for its
removal, and the DMFT score as a basic measurement of
dental health.The primary aim of the present study was to
identify the indications for the removal of mesio-angular teeth
in patients grouped according to age (five-year age groups),
to find out if the disease varied, and to consider the diagnoses
in relation to their dental health as measured by the DMFT
score.
A total of 319 patients had mesio-angular teeth removed
(mesial inclination related to the perpendicular of the occlusal
plane). “Pericoronitis” referred to all variants of the condi-
tion, and “caries and related disease” to all teeth that were
removed because of, or as a consequence of, dental caries.
Statistical  analysis
The original sample size was calculated by a power calculator
(Gpower 3.1.5, Universität Düsseldorf), which allowed for a
CI of 95% with a 5% margin of error (standard power level
of 80% and alpha level of p = 0.05). A sample size of 969 was
calculated, but 1011 patients were ultimately assessed.
The sample and outcome characteristics were summarised
using descriptive statistics. The mean age of the patients for
different diseases and type of impaction were compared using
one-way ANOVA. Significance was assumed at the 5% level,
and analyses were done with the help of IBM SPSS Statistics
for Windows, version 23.0 (IBM Corp).
Results
A total of 319 patients had 413 mesio-angular mandibu-
lar third molars removed (225 unilateral and 94 bilateral).
The mean age of all the patients was 30.1 years (n = 319,
SD:7.7 years, range 12-67 years).
Table 1 shows the indications for removal. DCC in the
second molar, pericoronitis, caries and related disease, odon-
togenic cyst, and periodontal disease, were defined as the
principal indicators because they were the most common and
most important. These only were included in the descriptive
analyses, as the incidence of the others, when spread across
the age groups, was not significant.
Age  and  disease
Fig. 1 shows the mean age of patients who required the
removal of teeth by principal diagnoses. For the most com-
mon diseases, the mean age varied with the type of disease.
Patients who had pericoronitis were significantly younger
Table 1
Disease/principal indications for removal of 413 mesio-angular mandibular
third molars (MAMd3M) (225 unilateral and 94 bilateral) in 319 patients.
Diagnosis for removal of
MAMd3M
No. (%) removed




2 Pericoronitis 131 (32)
3 Caries & related disease
(C&RD)
62 (15)
4 Periodontal disease 13 (3)
5 Prevention of distal
cervical caries in the
second molar
14 (3)




8 External resorption of
second molar
2 (<1)
9 Prophylactic secondary to
GA
1(<1)
Total number removed 413
than those with caries or those with DCC in the second molar
(p < 0001).
DMFT
To allow comparison with the 2009 Adult Dental Health
Survey (ADHS), the mean DMFT score was calculated
for 10-year age ranges of patients who had mesio-angular
mandibular third molars removed because of pericoronitis,
DCC in the second molar, and caries and related disease
(Fig. 2).17 The mean score based on these most common
diseases was comparable with each disease but roughly 50%
lower than the ADHS for each of the 10-year age ranges.
The only exception to this was patients aged between 45 and
54 years who had caries and related disease. In this group it
was comparable to that in the ADHS 2009. The mean DMFT
scores of patients from the main database of 1011 patients
also showed a DMFT that was 50% lower than the ADHS for
each of the 10-year age ranges.3
Disease  distribution
Fig. 3 shows the most common indications for the removal of
mesio-angular mandibular third molars by age group. Other
indications constituted a small proportion of patients and
offered no descriptive analyses. The age range of all the
patients was 12-67 years, and that of those with the principal
diseases was 17-67 years (a 67-year-old patient had one tooth
removed but this is not shown on the graph).
In the younger age groups, pericoronitis was the most com-
mon reason for removal, and accounted for 78% of all the
teeth removed in those aged 15-19 years (n = 18/23 teeth);
55% in those aged 20-24 (n = 39/71 teeth); 41% in those aged
25-29 (n = 55/134), and 14% in those aged 30-34 (n = 13/93).
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Fig. 1. Mean age (years) of patients requiring removal of mesio-angular mandibular third molars (MAMd3M) based on principal diagnoses. The graph shows
that for the most common diseases, the mean age of patients who had MAMd3M removed varied with the type of disease. Patients who had pericoronitis were
significantly younger than patients with Md3M caries (p < 0.001; df 149, F = 21.8) or those with distal cervical caries in the second mandibular molar (Md2M
DCC) (p < 0001; df 243, F = 74.5).
Fig. 2. Mean decayed, missing, filled teeth (DMFT) scores for patients who had mesio-angular mandibular third molars (MAMd3M) removed, based on principal
diagnoses, and compared with all third molars (Md3M) removed and the results of the Adult Dental Health Survey (ADHS) 20093,17 (Md2M DCC = distal
cervical caries in the mandibular second molar). For the most common diseases, the mean DMF of patients who had MAMd3M removed was comparable with
all patients requiring removal of Md3M, though approximately 50% lower than the AHDS 2009 for comparable age groups.
The incidence of caries and related disease ranged from 10%
- 20% in all age groups. No patients under the age of 20 had
DCC in the second molar, but it was the primary indication
for the removal of mesio-angular mandibular third molars
in 21% of those aged 20-24 (n = 15/71 teeth), 35% of those
aged 25-29 (n = 47/134 teeth), and 68% of those aged 30-34
(n = 63/93 teeth). In each of the older age groups the propor-
tion removed was generally over 60%, but the total number of
patients in each of these groups decreased with age, as fewer
third molars are retained into older age.
Discussion
The diseases that contribute to the removal of third
molars are generally reported independent of the type of
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Fig. 3. Percentage distribution of principal disease indicators for removal of mesio-angular mandibular third molars (MAMd3M) based on five-year age groups.
A total of 413 teeth were removed from 319 patients. Other indicators constituted a small number of patients and offered no descriptive analysis and are not
shown on the graph. Overall, ages ranged from 12 to 67 years, and for those with principal disease indicators from 17 to 67 years one patient under 15 years
had 2 MAMd3M removed for orthodontic reasons and a 67-year-old patient had one MAMd3M removed but these are not included on the graph) (Md2M
DCC = distal cervical caries in the mandibular second molar; Md3M C&RD = caries and related disease in the mandibular third molar).
impaction,1,15,18–20 which gives a comprehensive illustration
of the disease, but does not show the effect of variables such
as age and type of impaction. Our study solely evaluated dis-
ease in patients with mesio-angular mandibular third molar
teeth.
Pericoronitis is commonly reported to be the main indi-
cation for the removal of mandibular third molars and those
that are mesio-angular,1,3,15,20 but in our study, most were
removed because of DCC in the second molar (44%). A pre-
vious study reported that as the mean age of the third-molar
patients increased, caries and its variants (C&RD) become
the most common primary reason for removal.21 The large
incidence of DCC in this group also reflects the fact that those
having third molars removed are now older than previously
reported, and present with a different spectrum of disease.
The mean age of patients with pericoronitis (25.5 years
compared with 30.6 years for caries and related disease:
p < 0.0001; df 149; F = 21.8, and 32.8 years for DCC in the
second molar: p < 0.0001; df 243; F = 74.5) confirms that it
is a disease of younger patients (Fig. 1). From the data, 55%
of all mesio-angular third molars were removed before the
age of 30 years, and pericoronitis was the most common
reason (49%). In comparison, DCC in the adjacent second
molar tooth accounted for 27% of the teeth removed in
patients under 30, and for 65% of those removed in older
patients. Pericoronitis accounted for only 10% of all the
teeth removed in those over 30, with most of these being
in the 30-34 age range (Fig. 1). Caries and related disease
accounted for roughly 15% of all the teeth removed, and the
incidence remained relatively uniform across the age groups
(range 10% - 20%). The increasing frequency of DCC in the
mandibular second molar as patients become older has pre-
viously been suggested,6,16 but these studies did not reflect
or compare their results with other clinical indications, or did
not have comparable age groups. It is noteworthy that in this
study the frequency of caries and related disease remained
relatively constant in each of the age groups, but the fre-
quency of DCC in the adjacent tooth increased, even though
both diagnoses are caries.
Most mesio-angular mandibular third molars are removed
before the age of 30 years whilst the number of older people
retaining them decreases. It is this group that may have prob-
lems with DCC in the adjacent second molar. As patients
become older, the frequency of pericoronitis as the main
reason for removal declines, but conversely DCC increases
(Fig. 2). Most patients with a mesio-angular mandibular
third molar will have it removed due to pericoronitis when
younger, before the potential for DCC in the second molar
can be realised. Those patients who retain their mesio-angular
mandibular third molars into later life are at significant risk
of developing DCC in the adjacent second molar. The reason
why we do not always find it is because a large proportion of
mesio-angular teeth are removed before it can occur.
It has been reported that the mean DMFT scores of patients
with DCC in the second molar were roughly 50% lower than
those of comparable age groups in the ADHS 2009.4,5 This
suggested that patients with low scores may be more likely
to have DCC, as low scores suggest better oral hygiene, a
reduced likelihood of pericoronitis, and consequent reten-
tion of the mesio-angular mandibular molar into later life. In
our study the mean DMFT scores for patients with DCC were
also 50% lower than those in the 2009 ADHS, as were the
mean DMFT scores for patients with the other main types
of disease associated with mesio-angular mandibular third
molars (Fig. 1). In addition, the mean DMFT scores for all
patients having mandibular third molars removed was also
roughly 50% less than the comparable age ranges from the
ADHS 2009.4 Good dental health, as measured by the DMFT
score cannot therefore be used as a predictor of any spe-
cific disease in people with mesio-angular mandibular third
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molars. It suggests instead that all patients with partially-
erupted mandibular third molars are at risk of disease, and not
that patients with better dental health are more or less prone.
Low scores cannot, therefore, be used to refute the possibility
of future problems with impacted third molar teeth.
The relative incidence of DCC in patients who require
removal of a third molar has been reported to be between 4%
and 14%.3,5,13–16 These figures, however, include all types
of impaction and disguise the fact that DCC primarily affects
patients with mesio-angular mandibular third molars. Hori-
zontal mandibular third molars are also associated, but the
incidence is only 9%.3 The inclusion of patients with other
types of impactions that do not contribute to DCC of the sec-
ond molar dilutes the clinical significance, and it would be
inappropriate to base the widespread prophylactic removal of
all third molars on such a small proportion of patients. How-
ever, as 44% of all mesio-angular third molars, and 65% of
those in patients over 30 years of age, are removed because
of DCC, then prophylactic intervention may be helpful in
patients with partially erupted mesio-angular mandibular
third molar teeth.
In most cases, third molar disease will principally affect
the third molar tooth alone. In such cases, leaving it until dis-
ease occurs may be appropriate, but the prevention of DCC
must be considered for those patients with mesio-angular
mandibular third molars. Watchful waiting and radiographic
observation are pointless, as once the disease has occurred, it
is too late.12,22 If the potential for DCC to develop is signifi-
cant, then it reopens the debate about early intervention and
prophylactic removal of third molars, specifically those that
are mesio-angularly impacted.
The results of this study suggest that it is becoming eas-
ier to qualify and quantify the relative risks of mandibular
second molar DCC. NICE relies on the outcomes of ran-
domised controlled trials to determine healthcare policy and
guidance,23 but this level of evidence to support or refute pro-
phylactic removal does not exist, and clinical trials to measure
the results of retention would be unethical. Case series such
as these are often discarded because of potential bias, but they
are the best that are available.
The NICE guidance advises against the removal of
disease-free impacted third molars, stating that there is no
reliable evidence to support any benefit to health.24 However,
retention of mesio-angular mandibular third molars risks the
formation of DCC in the second molar and its development
can result in the loss of 40% of second molars.12 Early inter-
vention should be considered in the management of these
patients and will involve removal of the third molar, or coro-
nectomy, where there is a high risk of injury to the inferior
dental nerve.
Conclusion
We recommended that all patients with asymptomatic,
partially-erupted mesio-angular mandibular third molar teeth
are informed of the relative risks of long-term retention and
the development of DCC in the adjacent second molar, and
that consideration is given to the early, prophylactic removal
of mesio-angular mandibular third molars when appropriate.
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